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ABSTRACT 
 
This study aimed to examine the pathogenic role of IgG subclass in ANCA 
associated vasculitis (AAV). Additionally, since AAV targets specific vascular beds, 
the concept was explored as to whether the phenotype of renal endothelial cells 
predisposed them to injury. 
 
Using the flow model, interaction of neutrophils with normal immunoglobulin 
subclasses was compared to interaction with subclasses of ANCA IgG. Neutrophils 
were captured by normal IgG3, less by IgG1 and minimally by IgG2 and IgG4 when 
neutrophils were flowed across immunoglobulins that were bound to a solid-phase 
support. Blockade of CD32 was important in IgG3 interactions but CD16 more 
important in IgG1 and 2. When neutrophils were exposed to soluble ANCA IgG and 
then flowed across cytokine-activated endothelial cells, ANCA subclasses IgG1 and 
IgG3 activated neutrophils, causing them to adhere to endothelial cells, as did IgG4, 
which was surprising since IgG4 is not reported to bind to CD16 and CD32 receptors 
that are constitutively expressed by neutrophils. Blockade of CD32 and CD16 
reduced binding of IgG3 but only CD16 was important in IgG1. Neutrophil activation 
by ANCA and subsequent change in behaviour from rolling to static adhesion is 
therefore Fc receptor dependent. IgG3 ANCA is more potent than IgG1 which is more 
potent than IgG4. These findings may be important in therapeutic design as targeting 
specific immunoglobulin subclass may enable targeting of therapies rather than 
blanket immunosuppression. 
 
 II
Glomerular microvascular endothelial cells (GEC) were compared with human 
umbilical vein endothelial cells (HUVEC), the umbilical vein being a large conduit 
vessel. VCAM-1 was reduced on GEC and in functional studies using the flow model, 
GEC demonstrated reduced leukocyte capture, although this was still VCAM-1 
dependent. While VCAM-1 protein was detectable in both cell types (Western 
Blotting), it was concluded that either the isoform or post-translational modification 
reduces cell surface expression in GEC.  RNA array analysis demonstrated similar 
VCAM-1 gene expression but a reduction in the ST6N gene in GEC responsible for 
post translational modification of the VCAM-1 protein to a sialoglycoprotein. These 
studies demonstrate many similarities between these endothelia but glomerular cells 
also display some unexpected properties, particularly low expressed levels of VCAM-
1. If these findings translate in vivo, reduced VCAM-1 expression by glomerular 
endothelial cells may be a protective mechanism to reduce inflammatory responses, 
potentially disrupted in disease. 
 
ANCA subclass and endothelial phenotype are important in the AAV pathogenesis: 
this may be useful in designing new therapies where targeted therapy reduce the 
need for overall immunsuppressive load. Additionally modification of specific 
adhesion molecule profiles on endothelial cells may enable alteration of conditions of 
one vascular bed whilst reducing impact on unaffected sites. 
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2. INTRODUCTION 
2.1 ANCA associated vasculitis 
Vasculitis is disease causing inflammation of blood vessel walls. There are a 
spectrum of vasculitides depending on the site and size of vessel affected and they 
differ in their pathologies. 
 
In this thesis the two small vessel vasculitides associated with anti-neutrophil 
cytoplasmic antibody (ANCA), Wegener’s Granulomatosis and Microscopic 
Polyangiitis, (termed ANCA-associated vasculitis (AAV)), have been studied. These 
frequently result in pulmonary haemorrhage and renal failure with subsequent 
morbidity and mortality. Current therapies based on high dose corticosteroids and 
cyclophosphamide are highly toxic and non-specific and in themselves cause 
considerable morbidity. Even with current treatments the risk of disease relapse 
remains high. In better understanding the pathogenesis of these diseases, more 
specific treatment could be designed. 
 
These diseases are autoimmune in nature, although the exact pathogenesis remains 
unclear. Understanding pathogenesis has implications for other autoimmune and 
inflammatory diseases. 
 
AAV is an autoimmune disease and antibodies (ANCA) directed against the 
neutrophil enzymes proteinase-3 (PR3) and myeloperoxidase (MPO) are found in the 
serum of most affected patients. One currently accepted paradigm of pathogenesis is 
that neutrophils at various sites, including the glomerulus, are activated by ANCA in 
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the presence of inflammatory cytokines and degranulate, damaging the endothelium 
and setting up a cascade of inflammation drawing macrophages and other 
inflammatory cells into the glomerulus, leading to tissue destruction. In renal tissue 
biopsies taken from patients with established vasculitis, neutrophils can be found 
(unpublished), but not antibody. Macrophages are found in tissue biopsies, and 
granulomas, groups of epithelioid macrophages are found in Wegener’s 
Granulomatosis. ANCA is directed against PR3 on macrophages (Ralston, Marsh et 
al. 1997) as well as neutrophils, and primed monocytes expressing surface PR3, 
release IL-8 in response to anti-PR3 IgG (Ralston, Marsh et al. 1997; Hattar, van 
Burck et al. 2005). 
 
Neutrophils also express PR3 and MPO on their surface. This has been 
demonstrated by flow cytometry in our laboratory (Hewins, Morgan et al. 2006) where 
MPO on the surface of neutrophils was found to be up-regulated by TNFα and PR3 
was found to be expressed on primed and unprimed neutrophils (Haas and Eustace 
2004; Hewins, Morgan et al. 2006). This was not quantified and indeed is difficult to 
quantify as the amounts expressed are small. 
 
It has been suggested that degranulation of neutrophils occurs in or at the wall of the 
blood vessel since ANCA and neutrophils interacting in the blood steam would be 
cleared by the reticular-endothelial system. Neutrophils interact with selectins on the 
blood vessel wall in the presence of inflammatory mediators and roll on the surface of 
the endothelial cell (EC) layer. Interaction with ANCA could cause the neutrophil to 
become abnormally activated, causing it to degranulate and move through the vessel 
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wall. Once in the tissue the neutrophils may undergo dysregulated apoptosis (Harper, 
Cockwell et al. 2001) and form a nidus for inflammation. There is currently no 
evidence indicating where ANCA binds to the neutrophil or where degranulation 
occurs, but one study found some granular deposition of PR3 in human renal 
biopsies of patients with AAV in a linear pattern along the basement membrane 
suggesting degranulation of the neutrophil at the EC surface (Brouwer, Huitema et al. 
1994).   
 
If neutrophils were degranulating in the general circulation it would be likely that an 
increase in PR3 and other neutrophil components would be detected. This has been 
reported in vasculitis, where disease controls had lower levels of PR3 (Ohlsson, 
Wieslander et al. 2003). Whether this is specific to vasculitis or a feature of 
inflammatory disease in general is yet to be established. 
 
It remains unclear as to why vasculitis targets specific organs more than others, 
namely the renal and pulmonary beds. Planted antigens (Ruth, Kitching et al. 2006), 
where degranulated neutrophils leave MPO in the glomerulus which acts as an 
antigen for accumulation of ANCA, may explain the continuation of inflammation in 
one vascular bed. At renal biopsy however, ANCA deposition is not seen. 
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2.2 ANCA  
2.2.1 Animal models 
 
The pathogenicity of ANCA is debated, but supported by available evidence. ANCA 
are sufficient to induce vasculitis in murine models (Xiao, Heeringa et al. 2002). The 
use of MPO knock-out mice immunised with mouse MPO has facilitated these 
studies. When splenocytes from these mice were injected into recombinase-
activating gene-2 (Rag 2 -/-) deficient mice, which lack T and B cells, the mice 
developed necrotising glomerulonephritis and systemic vasculitis including pulmonary 
haemorrhage.  When purified MPO-ANCA IgG was injected intravenously into Rag 2-
/- mice or wild type mice, both strains developed crescentic glomerulonephritis. 
Crescentic glomerulonephritis is an advanced manifestation of vasculitis where the 
capillary ball of the glomerulus ruptures into Bowman’s space causing cells to escape 
there. These cells then appear in a crescent shape around the glomerulus at biopsy.  
MPO-ANCA alone was sufficient to induce vasculitis, but in the presence of an intact 
immune system in wild type mice, the disease was more severe.  
 
Human neutrophil extracts perfused through rat kidneys from animals previously 
immunized with human MPO developed anti-human MPO and anti-rat MPO 
antibodies. Crescentic glomerulonephritis was induced but rather than pauci-immune 
disease found in AAV, this was associated with immune deposits (Brouwer, Huitema 
et al. 1993). 
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Endogenous human PR3 does not elicit vasculitis in mice because there is a low 
homology between human and mouse PR3. PR3/neutrophil elastase double deficient 
mice generate murine PR3 specific polyclonal antibodies after injection of 
recombinant murine PR3. Antibodies transferred into wild type mice did not induce 
vasculitis, possibly because mouse neutrophils (in contrast to human neutrophils) do 
not express PR3 on their surface. However these antibodies significantly aggravated 
the local inflammatory response induced by subcutaneous TNFα administration, thus 
providing evidence to support PR3-mediated tissue damage in vivo (Pfister, Ollert et 
al. 2004). 
 
Rats immunized directly with human MPO developed antibodies which could bind to 
human and rat neutrophils. These animals developed blood and protein in the urine, 
with histological inflammation in the kidney and alveolar haemorrhage (Smyth, Little 
et al. 2003). A further study in rats used intra-vital microscopy to directly observe the 
interactions between ANCA and leukocytes on EC in mesenteric venules (Little, 
Smyth et al. 2005). Wistar-Kyoto rats were immunised with human MPO and 
developed anti-MPO antibodies that cross-reacted with rat MPO. The presence of 
these anti-MPO antibodies increased leukocyte adhesion and migration in response 
to low dose mesenteric superfusion with the chemokine CXCL1 (a neutrophil 
chemoattractant), and induced mesenteric microvascular injury (manifested as 
haemorrhage). When anti-MPO immunoglobulin was transferred to naïve rats, 
leukocyte adhesion and migration were similarly affected. In further work, blockade of 
TNFα in rats resulted in reduced albuminuria, lung haemorrhage and leukocyte 
transmigration in mesenteric venules (Little, Bhangal et al. 2006).  
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 Recent research in our laboratory examined the effect of murine passive transfer of 
high affinity anti-murine MPO IgG in further intravital microscopy studies (Nolan, Kalia 
et al. 2008). After pre-treatment of the cremaster muscle with the murine cytokines 
TNFα, IL-1β or keratinocyte-derived chemokine (the murine functional analogue of 
human IL-8) the animals were injected with anti-MPO IgG raised in an MPO-/- mouse. 
The number of systemic circulating leukocytes fell, rolling leukocyte numbers were 
reduced and the numbers of leukocytes adhering to and migrating across the 
endothelium increased. Blockade of the integrin component CD18 inhibited the action 
of the anti-MPO antibody, as did use of mice negative for the Fc receptor gamma 
chain. This research therefore suggested that both integrins and Fc receptor were 
necessary for the leukocyte activation properties of anti-MPO antibodies. 
 
2.2.2 Immunoglobulin subclass 
 
There are four subclasses of human IgG and their relative concentrations in human 
sera are IgG1>IgG2>IgG3=IgG4 (Figure 1). The subclasses differ in their Fc regions 
(fragment crystallisable) which are responsible for their functional responses (Burton 
and Woof 1992). After the antibody has engaged the relevant antigen, the Fc region 
can then engage the Fc receptor. The principle effector functions of human IgG are to 
enable phagocytosis, antibody-dependent cell killing and complement activation. The 
subclasses differ by deletions, substitutions and additions of amino acids in the 
constant heavy chain.  They are in fact highly homologous in the γ-heavy chains, and 
are most different in their hinge regions between the Fab (fragment antibody binding) 
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and the Fc portion. They are able to flex at the hinge region and this may explain 
some of the differences in their properties. IgG3 has the longest hinge region making 
it the most flexible protein but also the most easily cleaved, with subsequently the 
shortest half life in plasma (7 days compared to 21 for the other 3 proteins). IgG1 and 
IgG3 have a greater response to proteins, IgG2 to polysaccharide and IgG4 to 
prolonged exposure to antigen. Viral antigens are proteins and therefore induce IgG1 
and IgG3 responses, whereas bacterial infections cause a strong IgG1 response. 
IgG3 activates complement significantly more than IgG1, IgG2 activates complement 
minimally and IgG4 is said not to activate complement (Jefferis, Lund et al. 1990; 
Roux, Strelets et al. 1997). (Krapp, Mimura et al. 2003).  
 
 
Figure 1: Four human IgG subclasses.  
These are most different in their hinge regions between the heavy and 
light chains. IgG3 has the longest hinge region and is subsequently the 
most flexible protein. 
 
IgG4 production is regulated similarly to IgE and a suggested function for IgG4 is to 
compete for antigen binding with IgE and therefore reduce the intensity of an allergic 
reaction. These antibodies are functionally monovalent and thus cannot form immune 
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complexes which may be an important anti-inflammatory property. IgG4 has been 
reported as being a blocking/protective antibody (van der Giessen, Homan et al. 
1976). 
 
During formation of antibodies, subclass is generated by gene splicing. Somatic 
isotype subclass switching occurs in peripheral B cells where a cell can change 
production from IgG3 to 1 then to 2 then to 4 by sequentially splicing out more of the 
gene (Zeijlemaker 1996).This process is unidirectional and therefore continuing 
exposure to antigen may result in the accumulation of IgG4. It is not completely clear 
how this process is influenced but isotype switching to IgG4 has been shown to be 
dependent on IL4 (Spiegelberg 1989). This may explain why different IgG subclass 
populations predominate in active disease and disease in remission. 
 
The function of IgG is largely influenced by its ability to bind Fcγ receptors and this 
varies across the subclasses. IgG1 is the predominant class, it binds to neutrophils 
constitutively expressed Fc receptors, CD16 (FcγRIIIb) and CD32 (FcγRIIa) and after 
activation via CD64 (FcγRI). CD64 is the only receptor that can bind soluble IgG. 
IgG2 is binds via CD32. IgG3 can bind CD16, CD32 and CD64. IgG4 is a smaller 
protein and is generally thought to bind to neutrophils via CD64 only (Stitis 1991; 
Roitt 1996), although there is some contrary evidence emerging (Holland, Hewins et 
al. 2004). It has also been proposed that subclass activity may be influenced through 
the ratio of binding to inhibitory and activatory Fc receptors (Nimmerjahn and 
Ravetch 2005).  
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  IgG1 IgG2 IgG3 IgG4 
Binding to 
proteins 
(bacteria and 
viruses) 
++ +/- ++ +/- 
Binding to 
polysacchrides 
(bacterial cell 
wall) 
+ ++ - - 
Binding to 
allergens 
+ - - ++ 
Complement 
C1q binding 
++ + +++ - 
Complement 
alternative 
pathway  
binding 
++ + +++ - 
Fc receptor 
CD64 
++ - +++ + 
Fc receptor 
CD32 
++ + (dependent 
on isotype) 
+++ - 
Fc receptor 
CD16 
++ - ++ - 
 
Table 1: IgG subclasses.  
Binding abilities, complement activation and Fc Receptor binding. 
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2.2.3 IgG subclass and ANCA 
 
Neutrophils are activated by ANCA IgG which complexes antigenic targets PR3 or 
MPO with Fcγ receptors on the neutrophil surface, triggering signalling events leading 
to neutrophil activation (Ben-Smith, Dove et al. 2001). These ANCA are therefore 
referred to as PR3-ANCA IgG or MPO-ANCA IgG and can be detected by enzyme-
linked immunosorbent assay (ELISA). In addition, ANCA can also be detected by 
indirect immunofluorescence where a staining pattern is either seen in a perinuclear 
pattern (p-ANCA) or in a cytoplasmic pattern (c-ANCA). c-ANCA usually corresponds 
to PR3 directed ANCA and p-ANCA to MPO directed ANCA, although this is not 
always the case.   
 
ANCA directed against MPO and PR3 has been detected in all four IgG subclasses. 
In a retrospective study of all ANCA measured in patient sera in one centre, the 
ANCA were predominately IgG1 and IgG4 antibodies.  In MPO-ANCA, IgG2 was 
common and IgG3 scarce. In contrast, IgG3 was common in the PR3 group, and 
IgG2 rare (Segelmark and Wieslander 1993). This was supported in part by a study 
from our laboratory where IgG1 and IgG4 predominated in AAV, with MPO having 
specifically increased IgG1 predominance, and PR3, specifically IgG3 (Harper, 
Radford et al. 2001). In another study IgG3 was found to be reduced in the p-ANCA 
subset, and in c-ANCA IgG1 and IgG4 were the dominating subclasses. Despite high 
IgG4 activity, the sera containing c-ANCA were still able to activate complement 
(Mellbye, Mollnes et al. 1994). 
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ANCA subclass has been compared between active disease and remission (Table 2). 
The total IgG subclass divisions were similar to that in the normal population but the 
ANCA showed proportionally more IgG3 and less IgG2, which was more marked in p-
ANCA. In remission, the IgG3 fell and the IgG2 increased (Jayne, Weetman et al. 
1991). 
 
This was supported by a later study where an increased capacity to induce a 
respiratory burst was significantly related to increases in the relative amount of IgG3 
subclass of ANCA found in active disease (Mulder, Stegeman et al. 1995). Brouwer 
et al found IgG3 to be increased in renal limited AAV, but with overall predominance 
of IgG1 and IgG4, both in active and remission disease (Brouwer, Tervaert et al. 
1991). This increase in the IgG4 fraction was confirmed in a later study (Cambridge, 
Williams et al. 1994). This may be due to the chronicity of the disease with repeated 
antigen stimulation accumulating IgG4, as genes coding for the IgG4 are located at 
the most downstream switch site of the genes coding for immunoglobulin. Variation of 
ANCA subclass during active disease or remission may thereby influence 
pathogenicity. 
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Study Aims Conclusions 
Brouwer 
1991 
Is one ANCA subclass increased in 
renal limited AAV? 
Which subclasses predominate in 
AAV? 
IgG3 increased in renal limited 
AAV 
IgG1 IgG4 predominant in AAV 
Jayne 
1991 
Are ANCA subclasses same as 
normal IgG? 
Does one subclass increase in 
active disease or remission? 
ANCA IgG more IgG3, less IgG2 
especially in pANCA. 
In remission IgG3 fell and IgG2 
increased 
Cambridge 
1994 
Is IgG4 increased in AAV? IgG4 increased proportionally in 
ANCA compared to normal IgG 
Mellbye 
1994 
Which subclasses predominate in 
cANCA and pANCA patients?  
If IgG4 proportion high, can 
compliment still be activated? 
pANCA IgG3 reduced 
cANCA IgG1 and IgG4 dominant 
but still activate compliment 
Segelmark 
1993 
Which subclasses predominate in 
PR3 and MPO patients? 
MPO IgG2 common, IgG3 rare 
PR3 IgG3 common IgG2 rare 
Mulder 
1995 
Does subclass of ANCA affect the 
respiratory burst? 
In active disease more IgG3 and 
increased respiratory burst 
Harper 
2001 
Which subclasses predominate in 
vasculitis, and in PR3 and MPO 
patients? 
IgG1 and IgG4 predominant in 
AAV 
MPO increased IgG1 
PR3 increased IgG3 
Holland 
2004 
Does IgG4 activate neutrophils? IgG4 able to activate neutrophils 
 
Table 2: ANCA IgG subclass in vasculitis.  
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2.2.4 Glycosylation and galactosylation status 
 
As well as IgG subclass, glycosylation status of the immunoglobulin has been 
suggested to be important in disease pathogenesis. The structure of the IgG antibody 
Fc includes an oligosaccharide (Figure 2). Glycosylation is essential for IgG stability 
and Fc mediated effector function; removal of this oligosaccharide results in 
decreased activation of FcγR cell mediated cytotoxicity and complement activation 
(Jefferis, Lund et al. 1990; Jefferis, Lund et al. 1995; Jefferis, Lund et al. 1998). This 
is because the carbohydrate stabilises the molecule and confers on it the correct 
conformation to bind to the Fc receptor. Deglycosylation of the Fc molecule reduces 
binding to FcγRIIa, FcγRIIIb and to a lesser extent FcγRI.  
 
In addition to complete removal of this oligosaccharide, changes in its structure can 
alter the function of the IgG. In AAV disease states, it has been shown that there is a 
deficit in IgG galactosylation (i.e. the galactose residues on the side chains were 
missing from one or both side chains of the IgG) (Holland, Takada et al. 2002). A 
large proportion (57% in WG, 47% in MPO) of IgG in patients was agalactosylated 
(G0) whereas in controls the proportion of G0 IgG was 28%. The G0 glycoform of IgG 
has been shown to bind mannin binding lectin, activating complement and increasing 
uptake by macrophages and dendritic cells, thus conceivably contributing to 
autoimmunity (Dong, Storkus et al. 1999). Removing terminal acetylglucosamine and 
mannose sugars has been shown to cause conformational change which affects the 
interface of IgG Fc fragments and Fcγ receptors (Krapp, Mimura et al. 2003).  
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 Figure 2: IgG structure showing the carbohydrate moiety.  
The carbohydrate, in pink, is arrowed. The two light chains are green 
and yellow and the two heavy chains dark and light blue. 
 
2.3 Neutrophils 
2.3.1 Neutrophil function: superoxide and degranulation 
 
Neutrophils act as the first line of innate immune defence against invading micro-
organisms during infection and inflammation. There are two major effector functions 
in the neutrophil’s repertoire, a respiratory burst and the use of proteolytic enzymes 
(degranulation) (Abbas and Lichtman 2003). Although these reactions occur 
simultaneously, they are distinct from each other. Priming of the neutrophil precedes 
these reactions and during priming granules in the neutrophil cytoplasm move 
towards the cell surface in readiness to fuse with the plasma membrane. 
Simultaneously there is adhesion molecule up-regulation on the surface of the 
neutrophil. 
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The respiratory burst can occur both inside and outside the neutrophil. In the 
laboratory, chemiluminesense detects this reaction inside the cell, and cytochrome C 
detects the reaction outside the neutrophil. The respiratory burst proceeds in three 
parts:  
Oxygen burst:  2O2 (catalysed by NADPH) → 2O2-+NAP++H+ 
Dismutase reaction: 2O2+2H+ (catalysed by superoxide dismutase) → 2O-. 
(Superoxide) + H2O2 
Myeloperoxidase: H2O2+Cl-+H+ (catalysed by MPO) →HOCl (hydrochloric acid) + 
H2O. 
 
In vivo the toxicity of hydrochloric acid is converted to chloramines which damage 
microbes but not tissues (Weiss 1989). The respiratory burst is completed within 30 
to 40 minutes of activation. 
 
The respiratory burst happens simultaneously with neutrophil degranulation. 
Cytoplasmic granules fuse with the cell surface and release proteolytic enzymes such 
as PR3, elastase, collagenase and gelatinase, which cause extracellular matrix 
disruption. PR3 has multiple functions and is thought to be involved in the cell cycle, 
differentiation and death (Yang, Preston et al. 2001). It is a substrate for transcription 
factors such as nuclear factor-κB (Franzoso, Biswas et al. 1994) and activates 
cytokines such as TNFα and IL-1β by cleaving non-soluble pro-forms of these 
cytokines (Coeshott, Ohnemus et al. 1999). The proteolytic activity of PR3 is 
principally involved, but it is thought that PR3 can also have an effect on intracellular 
processes independent of proteolysis. 
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 The neutrophil has four types of granules (Faurschou and Borregaard 2003); 
secretory vesicles contain plasma proteins and receptors such as the β2 integrins; 
primary (azurophilic) granules contain MPO and serine proteases; secondary 
(specific) granules contain collagenase and lactoferrin and tertiary (gelatinase) 
granules contain enzymes such as the gelatinase, matrix metallopeptidase. The 
granules are released in order of activation, so that on minimal activation the 
secretory vesicles move to the surface of the neutrophil and release their contents. 
Tertiary and secondary granules can be induced to release their contents on further 
activation of the neutrophil. Primary granules require the neutrophil to be very 
activated before they are released. 
 
PR3 and MPO are very destructive and are limited in vivo by plasma anti-
proteinases. However in combination with chlorinated antioxidants the anti-proteinase 
shield can be destroyed. Therefore the combination of the two neutrophil reactions is 
tissue damaging (Weiss 1989). Degranulation occurs within 15 to 20 minutes. 
Proteinases are essential for neutrophils to kill bacteria. Mice deficient in proteases 
but normal in superoxide capacity and iodinating ability were unable to kill 
staphylococci or candida (Reeves, Lu et al. 2002). 
 
2.3.1.1 Proteinase 3 (PR3) 
 
Protease -3 is a serine protease located in the azurophilic granules of neutrophils, 
although it is also found in the specific granules and the secretory vesicles. It is 
stored as a mature active protein. It is synthesized as a pre-pro enzyme and 
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processed in four consecutive steps into the mature form of 222 amino acids, 29-
32kDa as three isoforms. Gene studies so far reveal that this protein is not very 
polymorphic and that polymorphisms in the gene are rare and do not seem to affect 
the structure at the catalytic site of the enzyme (van der Geld, Limburg et al. 2001). 
 
As well as storage is vesicles, PR3 is expressed on the membrane of neutrophils. 
The interaction of PR3 with the membrane is not entirely clear, but seems to be 
covalent and is not dependent on sialic acid residues or via a GPI-link (Witko-Sarsat, 
Cramer et al. 1999). There is evidence in vitro that PR3 can bind to EC and EC can 
internalise PR3 (Yang, Preston et al. 2001). 
 
Functionally PR3 is a degrading protease capable of killing phagocytosed microbes. 
This is independent of its enzymatic activity and is due to inhibition of molecular 
synthesis and oxygen metabolism of bacteria. Additionally some of the pro forms of 
the enzyme escape granular targeting and are secreted and may provide a negative 
feedback regulator for granulopoeisis (Skold, Rosberg et al. 1999). PR3 is involved in 
the growth and differentiation of granulocytes and monocytes. It is also implicated in 
neutrophil migration dependent on its enzymatic ability to degrade extracellular matrix 
proteins (Rao, Wehner et al. 1991). It is also implicated in the modulation of 
inflammation, degrading both TNFα (Leid, Ballieux et al. 1993) and C1 inhibitor (Leid, 
Ballieux et al. 1993). PR3 can also modulate the activity of platelets and endothelial 
cells (Renesto, Halbwachs-Mecarelli et al. 1994; Renesto, Si-Tahar et al. 1997) 
probably by cleavage and inactivation of protease activated receptors. PR3 can also 
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inhibit thrombin (Renesto, Si-Tahar et al. 1997) and neutrophil NADPH-oxidase (Tal, 
Sharabani et al. 1998), this latter is independent of its enzymatic activity. 
 
The natural inhibitors of PR3 are the serpins, and the principle one of this group is 
α1-antitrypsin (Rao, Wehner et al. 1991). PR3 is also inhibited by elafin in the skin 
(Wiedow, Luademann et al. 1991), and by α2-macroglobulin (Rao, Wehner et al. 
1991). Additionally, PR3 activity to large substrates such as elastin is partially 
inhibited by glycosaminoglycans (Fruh, Kostoulas et al. 1996). PR3 complexed to α1-
antitrypsin has been found in both WG patients and healthy controls, and deficiencies 
in α1-antitrypsin have been reported to be increased in WG (Esnault, Testa et al. 
1993).  
 
CD177 has been reported to co-localise with membrane bound PR3 on circulating 
neutrophils (Witko-Sarsat, Reuter et al.). A recent paper found that membrane 
expression of CD177 was increased on circulating neutrophils in AAV, but 
interestingly that primed neutrophils from CD177-negative individuals also express 
membrane PR3 and are susceptible to an anti-PR3 induced oxidative burst 
suggesting that a CD177 independent mechanism is also involved (Hu, Westra et al. 
2009). Binding partners other than CD177 for PR3 have yet to be explored. 
 
PR3 has variable surface expression between donors, and is increased in patients 
with AAV (Harper, Cockwell et al. 2001). This increased expression correlates with 
disease activity (Muller Kobold, Kallenberg et al. 1998) and is a stable phenomenon 
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within individuals. In addition there is an increase in apoptotic neutrophils expressing 
PR3 on their surface (Harper, Cockwell et al. 2001). 
 
2.3.1.2 Sites of binding of ANCA to PR3 
 
Anti-PR3 ANCA recognise more than one epitope on the PR3 molecule. Five 
epitopes have been identified, four of which are in or near the catalytic site of the 
enzyme (Griffith, Coulthart et al. 2001). In the development of the monoclonal anti-
PR3 antibody in our laboratory, the epitope on PR3 recognised by a mouse 
monoclonal antibody called 4A5 was used to create the variable region of the 
antibody. This epitope is recognised by more than 50% of patient ANCA and was 
therefore of direct pathological relevance (Colman, Hussain et al. 2007). 
 
The binding of ANCA to PR3 potentially crosslinks both the variable and the Fc 
regions of the antibody. This is controversial, but is supported by work from our group 
in signalling pathways (see section 2.3.3.3). Other molecules on the surface of 
neutrophils, such as CD15 do not result in crosslinking and downstream signalling in 
the same way (unpublished data). 
 
2.3.2 Fc receptor  
 
Activation of the neutrophil occurs when the Fc portion of the immunoglobulin 
attaches to the neutrophil surface Fc receptors. Some Fc receptors can activate 
signalling pathways in the neutrophil, whilst others can inhibit these pathways. 
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There is variation in the ratio of activatory FcγRIIa and inhibitory FcγRIIb receptors on 
the surface of neutrophils between healthy people. mRNA was measured in 50 white 
and 10 black healthy volunteers and ratios of activatory to inhibitory receptors fell into 
in four groups 1:1, 2:1, 3:1 and 4:1. This was associated with functional 
responsiveness of neutrophils to dimeric or aggregated IgG. Elastase release and 
up-regulation of CD11b was greater in the group with 4:1 ratio compared to the 2:1 
and 1:1 groups. The authors found a haplotype association in these groups (van 
Mirre, Breunis et al. 2006). 
 
Of the activating Fc receptors found on neutrophils, there are two constitutively 
expressed low affinity receptors, FcγRIIa (CD32) and FcγRIIIb (CD16), and one 
inducible high affinity receptor, FcγRI (CD64). FcγRIIa is a transmembrane protein 
with a tyrosine-based activation domain (ITAM) in its cytoplasmic region. FcγRIIIb is a 
glycosyl-phosphatidylinositol (GPI) anchored protein which is more highly expressed 
on neutrophils than FcγRIIa (van Mirre, Breunis et al. 2006). 
 
2.3.3 Neutrophils in AAV 
 
Neutrophils appear to be essential in vasculitis. In the elegant animal model 
described above (Xiao, Heeringa et al. 2005), when neutrophils were depleted, mice 
were completely protected against anti-MPO induced glomerulonephritis. 
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2.3.3.1 Fc involvement in AAV 
 
Fc involvement in ANCA induced neutrophil activation, is thought to be dependent on 
FcγRIIa (Mulder, Stegeman et al. 1995) and FcγRIIIb (Ben-Smith, Dove et al. 2001). 
However it has now been recognised that the neutrophils from patients with active 
vasculitis express high levels of FcγRI and this has been shown to be involved in 
superoxide production (Reumaux, Duthilleul et al. 2002). FcγRI is induced by 
interferon gamma (IFNγ) but not by TNFα.  
 
There is no association between vasculitis and polymorphisms of FcγRIIIb (Tse, 
Abadeh et al. 2000) or FcγRIIa (Tse, Abadeh et al. 1999). 
 
2.3.3.2 Apoptosis and superoxide in vasculitis 
 
Neutrophils from vasculitis patients become apoptotic more quickly than control 
neutrophils (Harper, Ren et al. 2000) and during apoptosis the target antigens for 
ANCA become expressed on the outer cell membrane (Gilligan, Bredy et al. 1996). 
These antigens, PR3 and MPO, are expressed more on neutrophils from patients 
with vasculitis than those from controls (Harper, Cockwell et al. 2001). In active 
vasculitis, there is an increase in circulating apoptotic neutrophils expressing PR3 
and MPO on their surface (Harper, Cockwell et al. 2001). Since ANCA can bind 
apoptotic neutrophils it is possible that this may affect neutrophil-endothelial cell 
interactions and the fate of apoptotic neutrophils within the vasculature. 
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The apoptosis of neutrophils in vasculitis may be dysregulated. Usually, neutrophils 
become apoptotic and are cleared by macrophages, inducing an anti-inflammatory 
response via appropriate cytokines. If neutrophils are not cleared by macrophages 
they undergo secondary necrosis which can induce a pro-inflammatory response. 
There is evidence in vasculitis that apoptosis is accelerated but externalisation of 
phosphatylserine is not, which may result in a reduced window of opportunity for 
macrophages to clear apoptotic neutrophils (Harper, Ren et al. 2000) 
 
Neutrophils from vasculitic patients in remission produce above normal levels of 
superoxide (Harper, Nuttall et al. 2002). 
 
2.3.3.3 ANCA causes distinct neutrophil signaling 
 
Increasing evidence suggests that the signalling cascades within the neutrophil 
activated by ANCA, are different from those activated by normal immune complexes. 
Normally, immune complexes cross link two Fc receptors (Figure 3) but ANCA may 
cause a different activation by cross linking via the Fc and Fab portions of the 
immunoglobulin simultaneously (Figure 3). This theory is controversial but supported 
by work from our laboratory (Williams, Ben-Smith et al. 2003; Williams and Savage 
2005). 
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 Figure 3: Conventional and alternative neutrophil signalling.  
Neutrophils are conventionally activated by immunoglobulin engaged 
to immune complexes linking with multiple Fc receptors on the 
neutrophil surface. The neutrophil is activated via a phospholipase C 
pathway. In the alternative activation model, ANCA engages an Fc 
receptor and either PR3 or MPO on the neutrophils surface 
simultaneously activating both the conventional pathway and a protein 
G pathway. 
 
In activation of the neutrophil by ANCA, as well as the normal Fc pathway resulting in 
tryrosine kinase, a separate pathway via Fab activates a G protein receptor coupled 
pathway. The Fab portion of the antibody binds the antigens MPO or PR3 on the 
neutrophil surface. This G protein signal is unusual and why this is activated by 
ANCA remains unknown. PR3 and MPO are both highly charged cationic proteins 
which may be why they insert into the anionic phospholipid bilayer of the neutrophil. 
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This charge may attract other molecules, or cause the PR3/MPO to localise in a 
particular sub compartment of the neutrophil membrane, thus leading to the unusual 
G protein signal.  
 
The Fc portion of the antibody binds the constitutively expressed FcγRIIa and 
FcγRIIIb receptors of the neutrophil, activates Syk kinase and phospholipase C, and 
mediates calcium release.  
 
Both the Fc and the Fab pathways must be engaged to cause a respiratory burst, 
that is, an intact antibody is required for activation of phosphoinositide 3-kinase and 
for full activation of the small GTPase, p21ras which is an important molecular switch 
point for a number of pathways. The FcR will not bind alone to FcγRIIa or FcγRIIIb as 
the affinity of the receptors is too low, it requires ligation of Fab simultaneously. Anti-
CD15 antibodies are also able to bind to neutrophils but these do not cause 
superoxide release. They have been reported to cause neutrophil adhesion (Forsyth, 
Simpson et al. 1989). 
 
The signalling pathways downstream of p21ras are not fully elucidated, but work from 
our laboratory suggests involvement of a number of small molecules which lead to 
both superoxide production and degranulation (unpublished data). 
 
Signalling within neutrophils may be dependent on lipid rafts. Lipid rafts are 
cholesterol enriched microdomains within cell membranes which contain 
sphingolipids (lipids derived from the aliphatic amino alcohol sphingosine) and 
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glycolipids (carbohydrate-attached lipids). Proteins associated with signalling are 
thought to associate with these rafts including tyrosine kinases of the src family and 
glycosylphosphatidylinositol (GPI)-anchored proteins (Brown and Rose 1992). 
Researchers have found that by disrupting lipid rafts signalling processes can be 
stopped (Petrie, Schnetkamp et al. 2000). This is supported by unpublished work 
from our lab where the disruption of neutrophil lipid rafts destroyed the neutrophil’s 
ability to produce superoxide. However the role of rafts remains controversial, they 
cannot be visualised directly and the proposed properties of them are not always 
supported by experimental evidence (Edidin 2003). 
 
In addition, the β2 integrin CD18 has been shown to be essential for initiation of 
signalling (Reumaux, de Boer et al. 2003) and intimates the need for further 
molecular interactions on the neutrophil cell surface. 
 
2.3.3.4 Degranulation in vasculitis 
 
The site of degranulation in vivo in vasculitis is not clear but is obviously important. 
Previous work in our laboratory (unpublished data) using the flow model 
demonstrated PR3 smears behind neutrophils suggesting they were degranulating 
on the endothelium. Degranulation would be likely to result in vascular damage. 
 
2.3.3.5 Variation in amount of PR3 and MPO on the surface of neutrophils 
 
PR3 and MPO are expressed on the surface of normal neutrophils after they have 
been ‘primed’ and are ready to undergo superoxide production and degranulation, for 
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example by exposure to TNFα. Preparation of neutrophils is thought to leave the 
neutrophils unprimed, but previous work in our laboratory using flow cytometry has 
demonstrated that MPO and PR3 expression is up-regulated on the surface of 
unprimed neutrophils (Hewins, Morgan et al. 2006).  
 
Patients with vasculitis have been found to have increased plasma concentrations of 
PR3 compared to healthy controls (Ohlsson, Wieslander et al. 2003) and also in 
vasculitis, greater amounts of PR3 and MPO were expressed on the surface of 
patients’ neutrophils versus control, when analysed by flow cytometry (Harper, 
Cockwell et al. 2001).  Vasculitis patients have also been found to have an increased 
number of membrane PR3 positive neutrophils (Witko-Sarsat, Lesavre et al. 1999) 
and these are associated with relapse (Rarok, Stegeman et al. 2002). In a recent 
study the role of these membrane PR3 positive neutrophils was investigated. TNFα 
and human anti-PR3 ANCA increased the amount of PR3 expressed on the 
neutrophil surface, thus providing an amplification loop where neutrophil activation by 
ANCA can lead to further expression of ANCA antigen (Brachemi, Mambole et al. 
2007). 
 
There have been reports of an association of AAV with a polymorphism in the PR3 
gene (Gencik, Meller et al. 2000), but this has not been substantiated in a further 
paper (Abdgawad, Hellmark et al. 2006).  
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2.4 Endothelial cells 
Endothelium forms the inner cell lining of blood vessels throughout the body and has 
many functions. It controls vasomotor tone, blood cell trafficking, coagulation and has 
a large role in immune function. Phenotypes of ECs change over time and according 
to the environment in which they exist and are therefore heterogeneous. It has been 
well established that chemokines and adhesion molecule expression differs between 
EC types and changes with the activation status of the endothelium (Lim, Garcia-
Cardena et al. 2003), i.e. endothelium in its resting state expresses little in the way of 
adhesion molecules but these are up-regulated when activated by cytokines such as 
TNFα.   
 
In vasculitis, the pulmonary and renal glomerular capillaries are particularly affected, 
and it is conceivable that ECs at these sites are more vulnerable to the effects of 
ANCA-neutrophil-EC interactions.  
 
There is now evidence that ECs are involved in the initiation and maintenance of 
inflammation. They constitutively express class I MHC, but not B7. They have been 
classified as semi-professional antigen presenting cells as they can partially activate 
T cells (Segal, Bihorac et al. 2002). 
 
Human umbilical vein ECs (HUVEC) have been widely used in in vitro experiments 
exploring EC function. They are easy to obtain, isolate and grow. Although HUVEC 
have been traditionally used to represent all EC function, in light of increasing 
evidence of diversity of function, this may no longer be acceptable practice. 
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 2.4.1 Evidence that endothelial cells have different properties 
 
Although some organelles such as Weibel-Palade bodies and fenestrae (transcellular 
pores, 70nm in diameter extending through the cell with a diaphragm across the 
opening) are typical of endothelium, these are not seen in every EC. Caveolae are 
70nm vesicles which are used in transcytosis, transporting molecules across the 
endothelium, these are not however specific to the endothelium. Their presence 
varies greatly throughout the body; they are common in capillaries in non-fenestrated 
endothelium.  
 
It is difficult to find a protein marker that is specific to the endothelium. CD-31 
(PECAM-1) is also expressed in monocyte, trophoblasts and leukocytes; vascular 
endothelial cadherin is also present in trophoblasts and foetal stem cells.  
 
2.4.1.1 Fenestrae 
 
We know from electron microscopy studies that there are variations in fenestrae and 
in the continuity of the basement membrane in EC. Continuous endothelium has a 
continuous basement membrane in contrast to discontinuous EC, seen in liver 
sinusoids. EC permeated with holes is called fenestraed endothelium and this can 
occur in continuous or discontinuous EC, and is seen in organs where filtration is 
required such as the glomerulus and some renal tubules.  
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Fenestrae are generated and maintained by VEGF (Eremina, Sood et al. 2003) and 
fenestrae can be induced in some EC which do not usually have fenestrae, such as 
skin and cremasteric capillaries (Roberts and Palade 1995). Functional differences 
such as permeability must be dependent on the presence of fenestrae, tight junctions 
and transcellular transport mechanisms which vary greatly between vascular beds. 
 
2.4.1.2 Fluid shear 
 
Shear stress is known to change the phenotype of EC and the expression of ICAM-1, 
VCAM-1 and E-selectin (Chiu, Lee et al. 2004). Grown under conditions of high fluid 
shear, neutrophils are subsequently less recruited in the EC flow model (Sheikh, 
Rainger et al. 2003). Shear stress varies throughout the vascular tree, from more 
than 1 Pascal in arteries, to 0.1 to 0.5 Pa (0.1Pa =1dyn/cm2) in post capillary venules 
such as the kidney.  
 
2.4.1.3 Chemokine and adhesion molecule expression 
 
Several publications have suggested that ECs from different species and locations 
differ in function.  Chemokines and adhesion molecules expression may differ 
between EC types; murine heart ECs exhibit high constitutive VCAM-1 expression 
while lung endothelia do not. TNFα up-regulated expression of adhesion molecules 
and chemokines on both cell types, but high levels of Regulation on Activation 
Normal T cell Expressed and Secreted (RANTES) was detected only in the heart 
endothelium (Lim, Garcia-Cardena et al. 2003). 
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Postcapillary venules are known to be ‘leaky’ and they have few tight junctions, high 
numbers of vesiculo-vacuolar organelles (VVOs) (which are probably formed from the 
fusion of caveolae) and increased expression of bradykinin, histamine and serotonin 
receptors which probably result in increased leakage of macromolecules through 
VVOs (Feng, Nagy et al. 1997). Cytokines such as TNFα have different effects on 
different ECs (Eriksson, Karlof et al. 2005). 
 
2.4.2 Microvascular versus macrovascular cells 
 
Macrovasular ECs such as HUVEC are conduit vessels whose function is to conduct 
blood from one area to another. Microvascular cells such as those found in the 
glomerulus are designed to allow for much more movement of cells across the 
endothelium into the tissue. Traditionally HUVEC have been used to represent ECs 
and have been presumed to act similarly to microvascular endothelium, there have 
been some studies which support this. McGinn et al (McGinn, Poronnik et al. 2004) 
found no morphological or immunohistological differences, both glomerular EC and 
HUVEC had a cobblestone appearance, stained positively for vWF and PECAM-1 
and negatively for antifibroblast surface antigen and anticytokeratin. Studying HUS, 
workers found that shiga toxin 1 or 2, stimulated the rapid secretion of unusually 
large vWF multimeric strings from HUVEC or from GEC (Nolasco, Turner et al. 
2005).Various ECs (HUVEC, dermal, aortic, pulmonary) were tested to determine 
their ability to form capillaries using a Matrigel-based support assay. Dermal and 
HUVEC were superior in their ability to develop capillary like structures but patterns 
of responsiveness were similar between the cell types. The authors therefore 
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concluded that it was justified to extrapolate from HUVEC to microvascular cells 
(Harvey, Welch et al. 2002). Some studies have also shown no differences between 
microvascular and macrovascular endothelium in terms of adhesion molecules. Brain 
microvascular cells were found to have similar adhesion molecules to HUVEC 
(Franzen, Duvefelt et al. 2003); comparing dermal microvascular cells to HUVEC, 
IL10 was found to induce similar amounts of E-selectin and IL-1β and TNFα were 
found to induce P-selectin in both types of EC (Vora, Romero et al. 1996).  
 
In contrast, others suggest that it is not satisfactory to extrapolate from HUVEC to 
microvascular endothelium. HUVEC was compared to saphenous vein EC and found 
to demonstrate significant functional differences in adhesion (Tan, Chan et al. 2004). 
A comparison of human umbilical arterial cells and HUVEC established different 
profiles for up-regulation of vascular adhesion molecule-1 (VCAM-1) where VCAM-1 
was more readily induced on the vein endothelium than the arterial (Kalogeris, Kevil 
et al. 1999). Auerbach (Auerbach, Alby et al. 1985) used cell cultures from multiple 
organ beds and reported that they expressed organ specific antigens. Glomerular EC 
(GEC), dermal EC and HUVEC were compared for expression of cell adhesion 
molecules (Murakami, Morioka et al. 2001). CD31, a molecule that can bind in a 
homotypic and heterotypic manner to link EC together, was constituently expressed 
on HUVEC, but levels were lower on GEC and dermal EC. The expression of CD31 
decreased in response to a combination of TNFα and IFNγ on all cell types. TNFα 
induced VCAM-1 on HUVEC and GEC but not on dermal EC, while IFNγ induced 
VCAM-1 only on HUVEC. E-selectin was induced on all three types of EC by TNFα 
but not by IFNγ. In a study pursuing the pathogenesis of HUS, certain ratios of 
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antifibrinolytic antigens were found to be antifibrinolytic in HUVEC but profibrinolytic 
in GEC (Louise and Obrig 1994). DNA microarray studies have found that there are 
differences between microvascular and macrovascular transcription (Chi, Chang et 
al. 2003). These studies suggested that GEC do not express the same adhesion cell 
profile as HUVEC and should therefore be studied independently to determine 
specific roles in inflammation. 
 
2.4.2.1 Glomerular endothelial cells 
 
In the glomerular microcirculation the capillary wall is particularly unique as it is 
permeable to water and small solutes, whilst remaining impermeable to 
macromolecules. This is a function of the three layers of the capillary wall; 
endothelium, glomerular basement membrane and podocyte. The glomerular EC is a 
specialized cell punctuated by multiple fenestrations, trans-cellular pores 60-80nm in 
diameter (Deen, Lazzara et al. 2001). These fenestrations have a glycocalyx which 
covers the fenestrae and probably contribute to the permeability barrier (Rostgaard 
and Qvortrup 1997). GEC are uniformly positive for CD31 (PECAM-1) and CD34, but 
not vWF (Jacquemin, Neyrinck et al. 2006). The GEC sit against a collagen-rich 
basement membrane; the opposing epithelial cell (the podocyte) is characterised by 
foot process slit diaphragms, and is the subject of intense research interest by virtue 
of its ability to alter the GEC phenotype. For example, deletion of podocyte VEGF 
results in loss of GEC barrier function (Eremina, Sood et al. 2003). The unique 
structure of the renal endothelium is likely to be part of the explanation as to why 
vasculitis targets the kidney and this is the subject of ongoing research. 
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The diameter of the capillaries in the glomerulus is small (10-20μm) (Shiraishi, Wang 
et al. 2003). Normal renal blood flow 0.22m/s in intrarenal vessels (Howes, Keilty et 
al. 1996). As the kidney receives 20% of cardiac output, GEC are exposed to high 
numbers of circulating cells. It is conceivable that this endothelial bed is 
physiologically protected from chronic inflammation, that inflammatory cells are less 
easily recruited to this EC surface than to other EC surfaces. The absence of selectin 
expression in the renal bed under normal conditions supports such a hypothesis 
(Savage, Brooks et al. 1997). 
 
2.4.3 Endothelial cell markers and markers of endothelial damage 
 
There are many papers in the literature exploring markers for EC damage. These 
include adhesion molecules such as selectins, cytokines, and other proteins released 
from the EC during damage, most commonly used is von Willebrand factor (vWF) but 
other proteins such as such as tissue plasmininogen activating factor and have been 
explored. Circulating ECs have recently also been discussed as markers of EC 
damage, particularly in AAV. 
 
2.4.3.1 CD31 
 
CD31 (cluster differentiation molecule 31) also known as platelet EC adhesion 
molecule (PECAM-1) is a member of the immunoglobulin superfamily. It is expressed 
in high concentration on vascular ECs and in lower levels on lymphocytes, 
monocytes and platelets. It binds in a homotypic and heterotypic manner to join EC 
together affecting the growth and morphology of EC (Fawcett, Buckley et al. 1995). 
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 2.4.3.2 Von Willebrand Factor (vWF) 
 
Von Willebrand Factor is a large multimeric glycoprotein produced in ECs in 
organelles called Weibel-Palade bodies. It has a primary function in haemostasis 
binding to collagen types I and III (van der Plas, Gomes et al. 2000).  vWF is 
released from EC in vasculitis when ECs are damaged and can be therefore used as 
a damage marker (Savage, Pottinger et al. 1991). vWF has been used extensively as 
a marker of EC cell damage in many other disease processes (e.g. sepsis, cardiac 
failure, haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome) and 
can be used quantifiably, where the amount of vWF released is proportional to the 
amount of EC damage.  
 
2.4.3.3 Circulating endothelial cells 
 
Large numbers of circulating EC are present in patients with active vasculitis when 
compared to non-ANCA associated glomerulonephritis and healthy controls, and 
these fall with treatment (Woywodt, Streiber et al. 2003). Circulating EC are thought 
to arise due to apoptosis and detachment from the basement membrane with release 
into the peripheral blood (Woywodt, Streiber et al. 2003). There is some debate from 
other studies as to the significance of these circulating EC, and it has been 
suggested that injured, shed cells do not account for all those found in the peripheral 
circulation (Holmen, Elsheikh et al. 2005). There may also be release of endothelial 
progenitor cells from the bone marrow in order to repopulate the denuded areas, and, 
indeed, these may offer therapeutic potential (Segal, Bihorac et al. 2002). In a recent 
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study, inflammatory EC were increased in patients with active disease compared with 
those in remission, and levels of these cells correlated with C-reactive protein and 
extent of organ involvement. They also found that patients with active disease had 
less endothelial progenitor cells, and that their proliferation and migration was 
inhibited by the circulating inflammatory EC (Holmen, Elsheikh et al. 2005). 
 
2.4.3.4 Endothelial Microparticles 
 
Loss of cellular phospholipid asymmetry when EC are damaged often causes 
shedding of lipid-symetric microvesicles from the EC surface and this may allow the 
cell to return to a resting state, that is, it is important in cell repair. These are less 
than 1 micron in diameter and may be useful in diagnosing states in which the 
endothelium is activated, and this has been used in Multiple Sclerosis (Larkin 2001). 
In AAV this has been used as a research tool and was found to correlate with 
disease activity (Brogan and Dillon 2004). 
 
2.5 Interaction of leukocytes, ANCA and endothelial cells 
2.5.1 Normal neutrophil adhesion cascade 
 
Passage of leukocytes from blood to underlying tissue is a process that involves 
attachment, rolling, arrest and transmigration (Figure 4). Rolling adhesion is 
supported by selectin adhesion molecules (expressed by leukocytes and cytokine-
activated ECs), which engage fast flowing cells from the circulation. E-selectin is 
highly restricted to ECs and is expressed in activated endothelium largely in post 
capillary venules. It is up-regulated by lipopolysacchride (LPS), and this varies 
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according to the organ (Yano, Liaw et al. 2006). Rolling adhesion is converted to firm 
adhesion by a second signal that results in conformational change of integrin 
molecules on the neutrophil surface, which bind to their ligands such as ICAM-1 on 
the endothelium. These ligands vary from organ to organ (Henninger, Panes et al. 
1997). The neutrophil then moves through the tissue towards chemoattractants. This 
transmigration process is poorly understood, but is thought to involve CD31, 
junctional adhesion molecules (JAM) (Aurrand-Lions, Johnson-Leger et al. 2001; 
Johnson-Leger, Aurrand-Lions et al. 2002; Woodfin, Reichel et al. 2007) and recent 
work suggests that CD99 may also be involved in a homophilic interaction between 
neutrophil CD99 and CD99 at the EC junction (Lou, Alcaide et al. 2007).  There have 
also been reports of leukocytes transmigrating through EC (Carman and Springer 
2004).  
 
Although this rolling-adhesion-transmigration cascade occurs in most inflamed 
tissues and in the high endothelial venules of lymphoid organs, the exact 
mechanisms of neutrophil emigration in inflamed glomeruli have not yet been 
established. For example, it may be that leukocyte rolling does not occur in glomeruli 
and that other mechanisms (e.g. direct capture using endothelial P-selectin or ICAM-
1) pertain in this tissue (Kuligowski, Kitching et al. 2006). In the lungs and liver 
neutrophils do not roll prior to adhering and rolling is probably not selectin dependent 
(Wong, Johnston et al. 1997). 
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It is also probable that neutrophil adhesion and transmigration are dysregulated in 
the presence of ANCA, with consequent “bystander” injury to EC (Radford, Savage et 
al. 2000; Radford, Luu et al. 2001).  
 
 
Figure 4: Neutrophil adhesion cascade.  
(a) Endothelium not stimulated with cytokine does not support 
neutrophil rolling. (b) Cytokines such as TNFα and IL-1β induce 
selectins on the neutrophil surface and their ligands on the endothelial 
surface. Chemokines which attract neutrophils are also induced on the 
endothelial surface. (c) The neutrophil engages via P-selectin 
glycoprotein ligand–1 (PSGL-1) on the neutrophil to P-selectin on the 
EC and the neutrophils rolls on the endothelial surface. (d) A second 
signal such as ANCA induces chemokines on the endothelial surface to 
bind specific leukocyte receptors, initiating inside-out signalling 
causing conformational change in neutrophil integrin molecules. Firm 
adhesion takes place as integrins bind to ligands such as intercellular 
adhesion molecule-1 (ICAM-1) (e) Transmigration via engagement of 
molecules such as junctional adhesion molecule-1 (JAM-1) allows the 
movement of the neutrophil into the tissues towards chemoattractants. 
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2.5.2 Lymphocyte capture onto EC 
 
VCAM-1 is used by peripheral blood lymphocytes for capture onto EC monolayers. 
Endothelial VCAM-1 can support capture from flow and rolling adhesion by 
interactions with lymphocyte α4β1 (VLA-4) integrin, and if the integrin is activated, 
the adhesion becomes stable and stationary. Lymphocytes can also bind 
CD11a/CD18 bind to endothelial ICAM-1 and this can also be used for stable 
adhesion and migration. The relative importance of ICAM-1 and VCAM-1 in stable 
adhesion and migration has not been well addressed in functional flow studies (Lalor, 
Clements et al. 1997). 
 
2.5.3 Adhesion molecules and chemokines 
 
2.5.3.1 P- selectin, E-selectin and L-selectin 
 
E-selectin was first identified in 1987 as a molecule which, when blocked, reduced 
the adhesiveness of polymononuclear leukocytes and HL-60 cells (a promyelocytic 
cell line) to human ECs. It was initially named endothelial leukocyte adhesion 
molecule-1 (ELAM-1) (Bevilacqua, Pober et al. 1987) and changed to E-selectin in 
1992. E-selectin was found to bind human neutrophils (Hession, Osborn et al. 1990) 
and eosinophils (Kyan-Aung, Haskard et al. 1991) on EC that had been activated by 
IL-1β, TNFα or LPS. This induction peaked at 5 hours and remained for 24 hours. 
Inhibition of leukocyte adhesion by blocking E-selectin was found to be additive with 
the addition of blockade of CD18 (Leeuwenberg, Jeunhomme et al. 1990).  
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Selectins are a family of cell adhesion molecules which are single chain 
transmembrane glycoproteins. In interacting with their ligands, the distal lectin-like 
domain of the selectin binds to carbohydrate groups presented on ligands on the 
leukocyte, which slows the cell and causes it to roll. 
 
Three selectin genes have been identified, L-selectin, constitutively expressed on all 
leucocytes and whose ligands are CD34 and GLYCAM-1; E-selectin expressed on 
activated ECs binding to its ligand (known to bind to sialyl Lewis X on 
polymorphonuclear leukocytes (Munro, Lo et al. 1992) and to cutaneous lymphocyte 
antigen on T cells (Rossiter, van Reijsen et al. 1994)), and P-selectin expressed on 
platelets and ECs which binds to P-selectin glycoprotein ligand-1 (PSGL-1) (Kevil 
and Bullard 1999). 
 
P-selectin is contained in Weibel-Palade bodies in platelets and in EC, along with 
vWF. Weibel-Palade bodies are not transcription controlled and can be recruited very 
quickly by histamine and thrombin and rapidly brought to the cell surface (Weller, 
Isenmann et al. 1992). The function of P-selectin is to capture leukocytes from flow 
onto the surface of ECs. 
 
E-selectin is not stored but undergoes de novo synthesis in response to TNFα and 
IL-1β over several hours (Savage, Brooks et al. 1997). There is some evidence that 
certain types of endothelium, such as dermal endothelium, may have constitutively 
expressed E-selectin (Chong, Murphy et al. 2004). E-selectin captures neutrophils, 
monocytes and some subsets of T cells. 
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 In normal renal tissue, P-selectin expression is absent. E-selectin expression is also 
absent but can be induced in cultured glomeruli by exposure to IL-1β, TNFα and 
Interferon-γ (Savage, Brooks et al. 1997).  
 
The significance of selectins in the diseased glomerulus is not clear. In acute 
glomerulonephritis, P-selectin can be detected in glomeruli but this observation is 
complicated by the fact that this is predominantly on platelets within the glomeruli (Li, 
Zhou et al. 1997). P-selectin mRNA signals have been observed on capillary or 
venous endothelium in the interstitium, but not in glomeruli (Segawa, Wada et al. 
1997).  
 
The absence of selectin molecule expression in the glomerulus has been proposed 
as a protective mechanism against the development of glomerulonephritis (Harari, 
Marshall et al. 2001). P-selectin up-regulation in the interstitium has been associated 
with interstitial fibrosis and tubular atrophy (Li, Zhou et al. 1997) and selectins are 
increased in diabetic nephropathy (Hirata, Shikata et al. 1998). When GBM antibody 
was injected into mice, P-selectin increased on GEC within 30 minutes resulting in 
neutrophil recruitment. This was not complement or platelet dependent (Tipping, 
Huang et al. 1994). In a lupus model in mice, increased E-selectin, P-selectin and 
VCAM-1 mRNA in glomeruli were observed during development of glomerular 
lesions, and related to the severity of lesions (Nakatani, Fujii et al. 2004).  
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In contrast to these studies, P-selectin deficient mice were shown to have more 
severe glomerular damage in a model of glomerulonephritis (Rosenkranz, Mendrick 
et al. 1999). Using chimeric mice, this group showed that P-selectin on the 
endothelium was predominately responsible for protection from exacerbating 
disease. They also found that P-selectin was not expressed in the endothelium of the 
glomerulus and concluded that the protective effect of P-selectin may be accounted 
for by shedding by non-renal ECs.  
 
P-selectin blockade made no difference in leukocyte adhesion in the glomerulus in 
the rat intravital model (Little, Pusey et al. 2005). 
 
2.5.3.2 β2 Integrins and ICAM-1 
 
As the neutrophil is engaging via ligands on its surface to selectins on the EC, 
chemokines bind specific leukocyte receptors, initiating inside-out signalling that 
brings about changes in the configuration of neutrophil integrin adhesion molecules.  
 
Integrins are cell surface receptors with α and β subunits. There are four principle 
adhesion proteins that are heterodimeric, consisting of a common β subunit non-
covalently attached to α subunits (CD18/CD11a-d).  The integrins expressed on 
neutrophils are the β2 integrins: CD11a/CD18 (leukocyte- function associated 
antigen-1: LFA-1) which binds to ICAM-1 on the endothelial surface and 
CD11b/CD18 (Mac-1) which binds to ICAM-1, fibrinogen and factor X. ICAM-1 is 
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expressed constituitively  and further upregulated by IL-1β and TNFα within 6 hours 
and lasts up to 72 hours (Mayadas and Cullere 2005).  
 
The importance of integrins in neutrophil mediated endothelial damage has been 
known for some time (von Asmuth, van der Linden et al. 1991). In a model of TNFα 
activated neutrophils on EC, blocking the CD18 beta chain consistently prevented 
neutrophil activation, blocking the CD11b alpha chain decreased adhesion of the 
neutrophils to EC but did not reduce EC detachment or hydrogen peroxide release 
(von Asmuth, van der Linden et al. 1991). The β2 integrins have been implicated in 
AAV where blocking them prevented leukocyte adherence (De Vriese, Endlich et al. 
1999). Polymorphisms in the CD18 gene may lead to increased adhesiveness of 
neutrophils in vasculitic patients (Meller, Jagiello et al. 2001). Single nucleotide 
polymorphisms were identified as having an association with MPO-ANCA vasculitis 
and these were proposed to have a dose dependent increase in adhesion of the 
neutrophil via CD18 facilitating degranulation and respiratory burst in these patients. 
 
In mice, integrins have also been suggested to be involved in the capture of 
neutrophils, rather than selectins. LFA-1 was reported to be involved in the 
adherence of neutrophils and Mac-1 in neutrophil crawling (Phillipson, Heit et al. 
2006). 
 
Engagement of leukocyte integrins also affects functional response of immunological 
cells via outside–in signalling and many of the processes are mediated by molecules 
used in the classical immunoreceptor signalling pathways. 
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 Intercellular adhesion molecule-1 (ICAM-1; CD54), a membrane glycoprotein, is an 
adhesion molecule which binds to the β2 integrins.  It is expressed on a variety of 
cells such as B and T lymphocytes, dendritic cells, macrophages, fibroblasts, 
keratinocytes and ECs. It is responsible for the conversion of rolling to stationary 
adhesion of neutrophils and is up-regulated by cytokines such as TNFα and IL-1β 
(Abbas and Lichtman 2003). 
 
2.5.3.3 VCAM-1 and VLA-4 (Very late antigen 4) 
 
Vascular adhesion molecule-1 (VCAM-1; CD106) is a cell surface sialoglycoprotein 
mediating leukocyte-EC adhesion and signal transduction. It is involved in the 
adhesion of lymphocytes, monocytes, eosinophils and basophils. It is expressed on 
ECs after stimulation by cytokines and is transcription up-regulated, being detectable 
after 8 hours and lasting for over 24 hours (Abbas and Lichtman 2003). VCAM-1 
binds via the β1 integrin VLA-4 (CD49dCD29). VCAM-1 mRNA and protein are 
induced via an NFκB dependent pathway (Zhou, Connell et al. 2007). Transfer of the 
protein to the cell surface after its manufacture is dependent on post translational 
modifications (Abe, Smith et al. 1999). These take place in the endoplasmic reticulum 
and the Golgi apparatus to convert the protein into a sialoglycoprotein by addition of 
various sugars and sialic acid. The sugars are added by a multitude of enzymes. The 
sialic acid, which is an α2,6-linked sialic acid is added by the enzyme Galβ1-
4GlcNAcα2,6-sialytransferase (ST6N), encoded by the ST6N gene (Abe, Smith et al. 
 46
1999). The addition of sialic acid may reduce the adhesiveness of the VCAM-1 
protein (Abe, Smith et al. 1999).  
 
VCAM-1 has reported to be seen in normal renal biopsies in Bowman’s capsular 
epithelium, proximal tubule and interstitial vascular endothelium (Pall, Howie et al. 
1996) and subsequently VCAM-1 has been reported to be expressed in Bowman’s 
capsule and proximal tubules in renal tissue, but was only seen weakly on glomerular 
EC after upregulation by TNFα and IL-4 in combination (Savage, Brooks et al. 1997). 
VCAM-1 has also been reported to be induced after a 6 hour exposure to IL-1β or 
TNFα on cultured human GEC (Park, Chang et al. 1998; Murakami, Morioka et al. 
2001). Also in cultured human GEC, TGF-β was demonstrated to blunt both TNFα 
induced VCAM-1 expression and IL1-β induced expression (Park, Yang et al. 2000) 
 
In animal models VCAM-1 mRNA was increased in the kidney after uretertic ligation 
and immunostaining was increased in the interstium but decreased in the glomeruli 
(Shappell, Mendoza et al. 2000). In a mouse model of lupus nephritis, expression of 
VCAM-1 correlated with the severity of disease (Nakatani, Fujii et al. 2004).  
 
In vasculitis, mouse GEC was exposed to a rabbit anti-recombinant mouse MPO 
antibody and this increased the expression of VCAM-1 implying that the MPO-ANCA 
induced activation of GEC directly (Nagao, Matsumura et al. 2007). In renal biopsies 
from patients with vasculitis, VCAM-1 was found in glomerular endocapillary cells and 
was associated with more severe lesions (Pall, Howie et al. 1996). In a subsequent 
study VCAM-1 was again found in vasculitis in human renal tissue (Arrizabalaga, 
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Sole et al. 2008) where abnormal VCAM-1 and ICAM-1 were seen in the tubules of 
more than 80% of patient samples and in the glomerular tuft in more than 60%. 
VCAM-1 was associated with leukocyte infiltration, suggesting that VLA-4 bearing 
leukocytes are contributing to glomerular injury. 
 
Very late antigen 4 (VLA-4) is a β1 integrin which binds to VCAM-1 (Abram and 
Lowell 2007), fibronectin and osteopontin (Khan, Allen et al. 2003) and is comprised 
of the α4β1 subunits. The intact 150 kDa α4 subunit can be cleaved into two non-
covalently associated fragments of 70 and 80kDa each. Cleavage of this subunit 
which is increased following T-cell activation has been suggested to change VLA-4 
functions (Teixido, Parker et al. 1992). VLA-4 has three distinct adhesion activities, it 
binds to a domain called CS-1 within the HepII region of fibronectin; it binds to 
VCAM-1 on the surface of activated ECs and it is involved in the induction of 
homotypic aggregation among mononuclear leukocytes and cell lines. It may also 
play a role in cytolytic T cell function. 
 
The role of VLA-4 in progressive renal injury was investigated in a rat model of 
nephrotoxic nephritis where VLA-4 was blocked. There was a reduction in 
albuminuria, a higher creatinine clearance and less renal scarring in the rats who 
received blocking antibody, and the authors concluded that VLA-4 mediated pro-
inflammatory and pro-fibrotic effects within the kidney (Khan, Allen et al. 2003). 
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2.5.3.4 Chemokines 
 
Chemokines are small proteins, released locally, which control leukocyte migration. 
They are largely homogeneous and have four conserved cysteines with two essential 
disulphide bonds. Chemokines are produced under pathological conditions by tissue 
cells and infiltrating leukocytes (Baggiolini 1998). The family of chemokines involved 
with neutrophil interaction are termed CXC and IL-8/CXCL8 is a member of this 
group. Chemokines bind neutrophils via seven transmembrane domain G-protein 
coupled receptors. Neutrophils have two receptors for IL-8/CXCL8, CXC chemokine 
receptor 1 and 2 (CXCR1 and CXCR2). CXCR1 is involved in superoxide production 
and CXCR2 with neutrophil migration (Lu, Garfield et al. 2006). Chemokines initiate 
inside-out signalling and cause a conformational change in neutrophil integrin 
molecules causing firm neutrophil binding. The roles of these chemokines in AAV 
have been explored in the flow model (Calderwood, Williams et al. 2005). 
 
2.5.4 Cytokines 
 
Cytokines (Table 3) are mediators and regulators of innate and adaptive immunity, 
and stimulators of haematopoiesis. Many immunologically active cells produce 
cytokines; macrophages secrete cytokines in response to LPS from bacteria and 
dsRNA from viruses and T cells produce cytokines in response to foreign antigen. 
Cytokines regulate lymphocyte populations by recruiting, activating and regulating 
leukocytes such as neutrophils. Additionally cytokines act on EC and leukocytes to 
stimulate inflammatory reactions to microbes. Cytokine receptors are transmembrane 
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proteins. Signalling pathways are activated by ligand-induced receptor clustering 
(Abbas and Lichtman 2003).  
 
Cytokine Size Cell source Biological effects Receptor 
TNFα 17kD 
51KD 
homotrimer 
Macrophages
T cells 
EC activation 
Neutrophil activation 
Hypothalamus (fever) 
Liver – acute phase protein 
production 
Muscle catabolism 
Apoptosis 
TNF-R 
IL-1β 17kD 
mature 
form 
33-kD 
precursors 
Macrophages 
EC  
some 
epithelial 
cells 
EC activation 
Hypothalamus (fever) 
Liver – acute phase protein 
production 
Thrombosis (removes 
anticoagulation factors from EC) 
2 
members 
of IgG 
super 
family 
 
Table 3: Cytokines relevant to this thesis 
 
2.5.4.1 TNF alpha (TNFα) 
 
TNFα is the principle mediator of the acute inflammatory response to gram-negative 
bacteria. The TNF family of proteins bind to the TNF receptor (TNF-R) which has 
conserved cysteine-rich extra-cellular domains. Activation of the receptor by ligand 
binding recruits intracellular cytoplasmic signalling molecules which can either induce 
inflammatory or apoptotic pathways. Specifically these cytoplasmic signalling 
molecules include TRADD (TNF receptor associated death domain), FADD (Fast-
associated death domain) or RIP (receptor interacting protein). TRADD binds directly 
to the TNF-R cytoplasmic domain and can then bind FADD and caspase-8 which 
results in apoptosis. Alternatively TRADD binds directly to TRAF-2 (TNF receptor 
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associated factor 2) forming a heterodimeric complex with RIP-1 leading to NFκB 
activation, gene transcription and inflammation (Wajant, Henkler et al. 2001). 
 
2.5.4.2 TNFα and IL-1β on EC 
 
On EC, TNFα and IL-1β upregulate the expression of adhesion molecules such as 
selectins, ICAM-1 and VCAM-1. After ligand binding, they both cause vasodilatation 
by production of prostacyclin (PGI2). EC and macrophages secrete chemokines in 
response to TNFα which result in leukocyte chemotaxis and recruitment. 
Mononuclear phagocytes are induced to secrete IL-1β. TNFα additionally induces 
apoptosis of some cell types (Abbas and Lichtman 2003). IL-1β causes production of 
nitric oxide and endothelin. 
 
Neutrophils do not interact with an endothelial monolayer that has not been activated, 
and in models, activation by TNFα has demonstrated increasing capture of 
neutrophils with increasing concentrations of TNFα (Bahra, Rainger et al. 1998). 
These captured neutrophils additionally demonstrated increasing static adhesion and 
migration at increasing doses of TNFα. The major change in adhesive behaviour was 
prevented by blockade of CD18, demonstrating the key role of β2 integrins. At low 
concentrations of TNFα, E-selectin was predominant in capturing cells from the 
circulation, while at high concentrations both E-selectin and P-selectin were 
important. Study of the kinetics of these steps suggested that although the rolling 
velocity of the cells was dependent on TNFα concentration, neither the rate at which 
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the cells became activated nor the time spent moving over, through and under the 
EC was strongly influenced by TNFα concentration (Luu, Rainger et al. 1999). 
 
TNFα and IL-1β levels are high in patients with AAV (Grau, Roux-Lombard et al. 
1989). TNFα has been investigated as a potential therapeutic target (Huugen, Xiao et 
al. 2005) and IL-1β has been found in glomeruli of AAV patients (Noronha, Kruger et 
al. 1993). These cytokines were therefore chosen for investigation in this thesis. 
 
EC can be treated with cytokines resulting in stimulation or activation. Stimulation 
results in the immediate release of substances already present in the cell, e.g. 
release of P-selectin and vWF by histamine. Activation results from transcriptional 
up-regulation and production of molecules such as ICAM-1 and VCAM-1, 12-24 
hours after treatment with cytokines such as TNFα.  
 
2.5.4.3 Hydrogen peroxide 
 
Hydrogen peroxide is not a cytokine but when EC are exposed to this chemical, a 
product of activated neutrophils, irreversible injury and death of EC may occur. At low 
concentrations of hydrogen peroxide EC is activated (Bradley, Johnson et al. 1993). 
Treatment with 50 to 100μmol/L of hydrogen peroxide has been shown to selectively 
increase expression of ICAM-1 and MHC class 1 but not E-selectin or VCAM. It is 
also thought that hydrogen peroxide inhibits TNFα induced gene expression 
(Bradley, Johnson et al. 1993). Sub-injurious concentrations of hydrogen peroxide 
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can therefore activate endothelium but not in the same way as inflammatory 
cytokines. 
 
2.5.5 EC and AAV 
 
In AAV the interaction of the neutrophil with the EC is thought to involve an activated 
endothelium whereby selectin receptors and chemokines are up-regulated attracting 
neutrophils on which E-selectin has been induced by TNFα. The neutrophil after 
rolling encounters a second signal causing integrins to bind molecules such as ICAM-
1 and resulting in firm adhesion. The neutrophil then transmigrates into the tissue, or 
degranulates at the endothelial surface resulting in inflammation. 
 
ANCA may be involved at several points in this process of leukocyte-endothelial 
interaction (Figure 4). Traditionally, it has been thought that ANCA activate 
neutrophils with resultant release of superoxide or proteases at the EC surface thus 
resulting in EC damage, although some studies have suggested that ANCA may 
interact directly with EC (Muller Kobold, van Wijk et al. 1999). We shall now examine 
the evidence for the effect of ANCA on various steps of leukocyte-endothelial 
interaction. 
 
2.5.5.1 The effects of serine proteases on EC 
 
Elastase and PR3 (but not MPO) have been shown to be potent inducers of EC 
apoptosis (Yang, Kettritz et al. 1996). These proteases are released following ANCA-
induced neutrophil degranulation. Yang et al have shown that PR3 and MPO are 
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internalised by EC, and that PR3 causes these cells to undergo apoptosis (Yang, 
Preston et al. 2001). This occurs via direct cleavage of p65 NF-κB, resulting in its 
diminished transcriptional activity, and suggests that PR3 and elastase have specific 
fundamental roles in EC responses during inflammation (Preston, Zarella et al. 2002). 
It has been suggested that, far from their role being one of simple degradation, 
proteases such as PR3 play a role in crosstalk between leukocytes and EC. As these 
proteases enter EC they can influence signalling pathways by intervening in caspase 
cascades and by activating pro-apoptotic signalling events (Pendergraft, Rudolph et 
al. 2004).  
 
In unpublished work from our laboratory, high concentration PR3 was, as above, 
found to damage EC after prolonged exposure. However, when EC were exposed to 
concentrations that did not affect EC integrity, PR3 activated the EC and caused it to 
support the adhesion of neutrophils. This emphasises the complex interplay between 
proteases and EC and hints at subtle mechanisms by which circulating ANCA may 
indirectly alter endothelium.  
 
2.5.5.2 Inhibition of respiratory burst and serine proteases by EC 
 
Neutrophils stimulated by ANCA in suspension undergo a respiratory burst 
(superoxide response) and release proteases such as PR3 (Falk, Terrell et al. 1990). 
However, Zhao and colleagues have suggested that EC can down-regulate the 
superoxide response of neutrophils by the suppression of NADPH oxidase activity 
(Zhao, Benard et al. 2003), suggesting that this ANCA-induced effect may actually be 
blunted at the endothelial surface. Subsequently, Zhao et al found that the adhesion-
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mediated suppression of the oxidase response could be restored to its previous rapid 
onset if the neutrophils had had prior exposure to cytokines and inflammatory 
mediators, such as TNFα (Zhao and Bokoch 2005). 
 
In order to evaluate potential mediators of endothelial injury in vasculitis, the factors 
controlling the neutrophil respiratory burst and endothelial release of vWF were 
explored (Lu, Garfield et al. 2006). These experiments compared neutrophil 
interaction with fMLP, normal IgG and ANCA, on both EC and P-selectin surfaces, 
measuring vWF release by ELISA and serine protease activity enzymatically. EC 
inhibited the superoxide release from those neutrophils stimulated with both fMLP 
and ANCA, a finding that was reversed by the addition of adenosine deaminase, 
which rapidly degrades adenosine. The authors concluded that adenosine was 
released from EC to inhibit the potentially deleterious effects of superoxide and that it 
was therefore unlikely that ANCA-induced neutrophil release of superoxide radicals 
resulted in EC injury in vivo. In line with the study described above by Zhao, TNFα 
activation of EC did reduce the level of inhibition but, overall, this was a very small 
effect. 
 
In these experiments, serine proteases were also released by ANCA during 
neutrophil–endothelial co-culture and thought to be mediating EC damage (as 
quantified by the release of vWF). Diisopropylflurorphosphate, a serine protease 
inhibitor, abolished this vWF release, indicating that EC damage in the context of 
circulating ANCA is likely to be mediated by serine proteases such as PR3 rather 
than superoxide. 
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 2.5.5.3 Direct effect of ANCA on EC 
 
ANCA may act directly on ECs and in the presence of EC the interaction of 
neutrophils and ANCA may be different to the action of neutrophils in suspension. 
ANCA from patients with AAV have been found to directly activate EC causing 
expression of E-selectin on the cell surface (Muller Kobold, van Wijk et al. 1999). 
However, these studies have not subsequently been confirmed, and indeed we were 
unable to reproduce this response (unpublished data). 
ANCA binding to EC via Fab portion 
 
Early studies found that TNFα and IL-1β induce PR3 expression in the cytoplasm of 
EC, and that this is translocated to the EC surface, thereby becoming accessible to 
ANCA (Mayet, Csernok et al. 1993). Affinity purified PR3-ANCA can bind to 
expressed PR3 and activate EC, an effect that can be blocked by co-incubation with 
purified PR3 (Mayet and Meyer zum Buschenfelde 1993; Sibelius, Hattar et al. 1998; 
De Bandt, Meyer et al. 1999). In addition, PR3 is present in serum (Henshaw, Malone 
et al. 1994) and thus could potentially bind to EC, complexing with ANCA. However, 
subsequent studies have not been able to find PR3 expression by cultured EC (King, 
Adu et al. 1995; Pendergraft, Alcorta et al. 2000). It may be that it is easily shed from 
EC during handling of these cells or that ANCA are interacting with PR3 that is bound 
to the EC, rather than the protease being manufactured endogenously within them.  
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The hypothesis that MPO-ANCA are capable of causing damage to glomerular EC 
(GEC) was tested by incubating mouse GEC with a polyclonal rabbit anti-
recombinant mouse MPO antibody (Nagao, Matsumura et al. 2007). These workers 
found that mRNA for ICAM-1, VCAM-1 and E-selectin were up-regulated by 12.5, 7.5 
and 10.5 fold respectively, although they did not report any endothelial damage and 
did not exclude an effect of lipopolysaccharide. The potential mechanisms of this EC 
activation are not clear as it has not been possible to demonstrate the presence of 
MPO on EC.  
ANCA binding to EC via Fc portion 
 
ANCA binding directly to the EC via its Fc portion would require that there were Fc 
receptors on glomerular cells. There are very few reports of this in the literature 
(Aarli, Matre et al. 1991), but Fc receptors are know to be present on liver EC (Muro, 
Shirasawa et al. 1993) and FcγR expression has been reported to be up-regulated 
on cytokine stimulated aortic EC (Pan, Kreisle et al. 1998). Based on work in our 
laboratory (unpublished) it appears unlikely that Fc receptors are present on GEC 
and, therefore, that ANCA would be interacting with GEC in this way. 
 
2.5.5.4 Does PR3-ANCA inhibit the enzymatic reaction of PR3? 
 
There have been some suggestions that PR3-ANCA might bind to and thereby inhibit 
the action of the enzyme PR3 (van der Geld, Tool et al. 2002). This appears to be 
dependent on the site at which the ANCA binds, and may therefore imply that that 
some PR3 specific ANCA may not be pathogenic. In results from our lab 
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(unpublished) the chimeric PR3-ANCA which is directed against PR3 does not inhibit 
the action of the enzyme. The chimeric PR3-ANCA binds at the 4A5 site on the PR3 
enzyme (the 4A5 site is defined as that region of the protein where a mouse anti-PR3 
antibody called 4A5 binds (Colman, Hussain et al. 2007)), thus implying that binding 
at this site does not inhibit the enzyme. 
 
2.5.5.5 Where does ANCA-induced neutrophil degranulation occur? 
 
It has been suggested that degranulation of neutrophils occurs within or at the wall of 
the blood vessel since ANCA and neutrophils interacting in the blood steam would be 
cleared rapidly by the reticuloendothelial system. As described above, neutrophils 
interact with selectins on the blood vessel wall in the presence of inflammatory 
mediators and roll on the surface of the EC layer. Under these circumstances, 
interaction with ANCA could cause the neutrophil to become abnormally activated, 
causing it to degranulate and move through the vessel wall. It is possible that EC 
injury occurs if the transmigrating cell is actively degranulating at the same time. 
Once in the tissue the neutrophils may undergo dysregulated (pro-inflammatory) 
apoptosis (Harper, Radford et al. 2001) and form a nidus for inflammation. There is 
evidence demonstrating neutrophil lysosomal enzymes binding to EC and basement 
membranes in renal biopsies of patients with AAV (Brouwer, Huitema et al. 1994). 
However, there is currently no firm evidence indicating at what stage ANCA binds to 
the neutrophil or where ANCA-induced degranulation actually occurs.  
 
If neutrophils were degranulating in the general circulation it would be likely that an 
increase in PR3 and other neutrophil components would be detected. This has been 
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reported in vasculitis, where disease controls had lower levels of PR3 (Ohlsson, 
Wieslander et al. 2003). Whether this is specific to vasculitis or a feature of 
inflammatory disease in general is, however, yet to be established. The effects of 
protease damage or activation must depend on the protease/anti-protease balance, 
and it is likely that only proteases present in the protected microenvironment between 
an adhering PMN and an EC would be able to do damage. A paper which looked at 
the interaction between elastase, protease-3 and their inhibition by α-1antitrypsin, 
found that α-1antitrypsin had a higher affinity for elastase, which was therefore 
neutralised more quickly than PR3. PR3 was therefore able to diffuse further and do 
more damage than elastase (Duranton and Bieth 2003) 
Transmigration of neutrophils in the glomerulus 
  
Neutrophils recruited to the glomerulus during inflammation may consequently have 
several fates. They may stay within the vasculature, degranulate here and cause 
local destruction to the vessel wall. Deformation and shape change could potentially 
result in clogging of the small capillaries. Alternatively they may migrate through the 
vessel wall, either into Bowman’s space, where they would form a component of the 
debris in the crescent, or into the mesangium where they would form a nidus for 
inflammation and further recruitment of inflammatory cells. They could then 
potentially migrate back into the circulation, or into the lymph system. There is so far 
no direct evidence for transmigration of neutrophils in AAV. Animal models have not 
visualised the kidney by direct intra-vital microscopy due to technical difficulties. 
Neutrophils are not usually found in kidney biopsies of patients with AAV, although in 
very early disease they are occasionally seen.  
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 The most compelling evidence that neutrophils migrate into Bowman’s capsule and 
are present in acute lesions in AAV, comes from the elegant animal model by Xiao et 
al, who demonstrated glomerular accumulation of neutrophils and macrophages 
(Xiao, Heeringa et al. 2005). There is no current direct evidence for transmigration of 
neutrophils, but in previous work in the flow model, rather than frustrating the 
migration of neutrophils, ANCA appeared to promote it (Radford, Luu et al. 2001). 
 
2.5.6 Anti-endothelial antibodies 
 
Anti-EC antibodies (AECA) have been documented (but not well characterised) in 
AAV (Table 4) and other diseases. Some workers suggest that AECA are pathogenic 
in AAV (Praprotnik, Rozman et al. 2000; Guilpain and Mouthon 2008), and may be 
associated with propylthiouracil induced AAV (Yu, Zhao et al. 2005). It has been 
proposed that AECA bind to EC in vasculitis and that these then activate the EC, as 
well as engaging neutrophils from the circulation via their Fc portion. AECA in 
vasculitis patients have been shown to induce IL-1β on EC (Carvalho, Savage et al. 
1999) and have also been shown to induce apoptosis (Bordron, Dueymes et al. 
1998), although this effect on apoptosis could not be replicated in our laboratory 
(Williams, Colman et al. 2005).  
 
Several studies support the concept of anti-endothelial antibody binding, including 
work from our laboratory (Savage, Pottinger et al. 1991; Del Papa, Guidali et al. 
1996; Muller Kobold, van Wijk et al. 1999), although the antigen(s) that these 
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antibodies are binding to remains unclear. Reports of the proportion of patients with 
AAV who have AECA vary in the literature from 20% to 80% (Savage, Pottinger et al. 
1991; Chan, Frampton et al. 1993; Varagunam, Nwosu et al. 1993; Holmen, Elsheikh 
et al. 2005; Yu, Zhao et al. 2005; Oostingh, Schlickum et al. 2007; Sebastian, Mahr 
et al. 2007) (Table 4). Recent work examining a large cohort of AAV patients found 
that disease activity did not correlate with the presence or the titre of AECA, and was 
only positive in 20% of patients (Sebastian, Mahr et al. 2007). However, a 
subsequent study reported a high incidence (71%) of antibodies against GEC and 
demonstrated that, when the same samples were tested against HUVEC (the 
substrate used in earlier studies), they were detected in only 7% of samples (Holmen, 
Elsheikh et al. 2005). AECA may be additive to ANCA in the injury to EC, and there is 
evidence that they augment neutrophil/EC adhesion (Florey, Johns et al. 2007). It 
may be that the presence of AECA is therefore important in AAV and, in view of this 
study, warrants further investigation. It is possible that AECA bind to ECs from 
different locations to a different extent (Praprotnik, Blank et al. 2001). AECA in large 
vessel diseases such as Takayasu’s arteritis bound to and activated HUVEC but not 
microvascular EC.  
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 Figure 5: Potential mechanisms of endothelial injury/activation in 
ANCA-associated vasculitis. 
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Reference Method of 
detection 
Study group AECA type and 
frequency 
Correlation with 
disease 
Savage, 1991 
(Savage, Pottinger 
et al. 1991) 
HUVEC 168 WG 59% IgG AECA 
68% IgM AECA 
Not investigated 
Varagunam, 1993 
(Varagunam, 
Nwosu et al. 
1993) 
HUVEC 43 MPA 
27 WG 
2% MPA 
19% WG 
Not investigated 
Chan, 1993 
(Chan, Frampton 
et al. 1993) 
Not defined 10 AVV 80% yes 
Holmen, 2004 
(Holmen, Elsheikh 
et al. 2005) 
HUVEC, 
HKEC 
and others 
10 WG 
5 MPA 
20 control 
WG: HUVEC 7% / 
HKEC 71% 
MPA: HUVEC 0% 
/ HKEC 60% 
Control: HUVEC 
1% / HKEC 5% 
yes 
Yu, 2005 (Yu, 
Zhao et al. 2005) 
HUVEC 11 PTU induced 
AAV 
91% yes 
Sebastian, 2007 
(Sebastian, Mahr 
et al. 2007) 
HUVEC 173 WG 20% no 
 
Table 4: Summary of Literature of anti-EC antibodies (AECA).  
HUVEC = human umbilical vein EC; HKEC = human kidney ECs; WG= 
Wegener’s Granulomatosis; MPA= microscopic polyangiitis; PTU = 
propylthiouracil; AAV = ANCA associated vasculitis 
 
2.5.7 Flow model of of leukocyte-endothelial cell interactions 
 
Detailed explanation of the flow model is undertaken below in methods. Briefly it is a 
system whereby adhesion molecules, platelets or EC can be coated on or grown 
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within glass capillaries and can be viewed directly whilst neutrophils or other 
leukocytes are flowed through. The effects of the addition of ANCA and other 
substances added into the system can then be observed. 
 
ANCA-neutrophil interactions have been studied previously in flow models using 
human platelets (Radford, Savage et al. 2000) and EC (Radford, Luu et al. 2001; 
Calderwood, Williams et al. 2005) as the adhesive substrate. In the platelet model, P-
selectin was presented by the platelet monolayer and neutrophils rolled continuously 
on it. When ANCA were introduced to the system, rolling was converted to stationary 
adhesion, which was accompanied by neutrophil shape change. Antibodies blocking 
the Fcγ receptor IIa (CD32) or the integrin CD11b completely inhibited ANCA-
mediated conversion. In the EC model, following activation of the EC by TNFα, 
neutrophils rolled on the surface of the monolayer and the subsequent addition of 
ANCA caused changes in shape and increased adhesion of neutrophils, with 
subsequent migration through the endothelial layer (Radford, Savage et al. 2000). 
 
The roles of the integrins CD11a/CD18 and CD11b/CD18, and the chemokine 
receptors CXCR1 and CXCR2 were investigated in the same model using highly 
activated endothelium (treated with TNFα 100units/ml, which induces firm adhesion 
of the neutrophil to the EC monolayer) and minimally activated endothelium (treated 
with 2 units/ml of TNFα, where neutrophils roll but need a further stimulus to stop) 
(Calderwood, Williams et al. 2005). CD11a/CD18, CD11b/CD18 and CXCR2 were 
important in the adhesion and migration of neutrophils on both highly and minimally 
activated endothelium, whereas CXCR1 had minimal effect. However, when the 
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endothelium was only minimally activated with TNFα, only CD11b/CD18 stabilized 
the adhesion caused by the addition of ANCA. This illustrates the importance that 
these specific integrins and chemokines have in the interaction of ANCA-induced 
neutrophils with EC.  
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3. HYPOTHESES OF THE PHD THESIS 
The hypotheses of this thesis are: 
 
• ANCA IgG of different subclasses vary in their ability to activate neutrophils 
and change their interaction with ECs. 
 
• The Fc receptor has a differential role when neutrophil interaction with ANCA 
IgG is compared to neutrophil interaction with IgG not containing ANCA 
 
• Glomerular ECs are targeted in AAV because of a distinct phenotype 
 
• It may not be relevant to use HUVEC as a substitute for GEC when 
investigating AAV. 
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4. MATERIALS AND METHODS 
4.1 Cell and reagent preparation 
4.1.1 Neutrophil Isolation 
 
Blood from healthy volunteers was collected into tubes containing EDTA 
anticoagulant (Sarstedt, Numbrecht, Germany). Neutrophils were isolated using a 
two step density gradient. Whole blood was layered over equal volumes of 
Histopaque-1077 and Histopaque-1119 (Sigma, UK) and centrifuged at 2500rpm for 
30 minutes. The middle neutrophil fraction was harvested and washed twice in 
phosphate buffered saline (PBS) (Invitrogen, UK)  with calcium and magnesium, 
which had bovine serum albumin (BSA) (Sigma, UK) added to a dilution of 7.5%. The 
neutrophils were then re-suspended in 1 ml of PBS/BSA, counted using a 
haemocytometer and then re-suspended to a concentration of 1 x 106 cells per ml in 
PBS/BSA.  
 
Neutrophils were not usually activated by their isolation, and if they were experiments 
were abandoned. It was relatively easy to assess whether neutrophils had been 
activated because when they were introduced into the flow model unstimulated by 
ANCA they appeared round and rolled on the EC surface or remained in the through 
flow. Activation of neutrophils resulted in shape change, they appeared ‘spiky’ and 
adhered quickly to the EC.  
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4.1.2 Peripheral blood lymphocyte isolation 
 
Peripheral blood lymphocytes were isolated in the same way as neutrophils except 
the top mononuclear cell fraction was harvested. After washing, the cells were plated 
into small petri-dishes and left at 37°C for 20 minutes allowing 
monocytes/macrophages to stick to the plastic. The rest of the cells were collected 
and re-suspended to a concentration of 1 x 106 cells per ml as above. 
 
4.1.3 Patient Immunoglobulin G isolation 
 
ANCA positive IgG was isolated from plasma exchange fluid taken from patients 
during the active phase of Wegener’s Granulomatosis or Microscopic Polyangiitis. 
Patients accorded with the Chapel Hill Consensus Conference definitions for 
vasculitis (Jennette, Falk et al. 1994) and all had severe disease (creatinine 
>500mmol/L or pulmonary haemorrhage), with evidence of renal vasculitis confirmed 
histologically by renal biopsy. PR3 or MPO-ANCA was confirmed in patients by 
indirect antigen specific ELISA and indirect immunofluorescence.   
 
Plasma exchange fluid was aliquoted into 50ml samples. In order to remove clotting 
factors it was heated to 37ºC with 1ml of 1 molar calcium chloride (Sigma, UK)  and 
the precipitant removed. The resultant serum was diluted 1:1 in PBS, 0.2μm filtered 
and passed manually through a 5ml volume HiTrap Protein G column (Amersham 
Biosciences, GE Healthcare, UK). 0.1molar glycine, pH 2.6 (Sigma, UK) was used to 
elute the IgG off the column and was neutralised with 1 ml of 1 molar Tris base 
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(Sigma, UK), pH 9.0. The sample was placed into pre boiled dialysis tubing (Medicell 
International Ltd.) (10-14kDa cut off) and dialysed in PBS at 4ºC overnight. The 
sample was then spun through a concentration column to approximately 1mL volume 
using vivaspin concentrators (Vivascience, Hannover, Germany) with a 10,000Da cut 
off, and stored at 4˚C for up to one month. 
 
The concentration of the eluted IgG was determined by spectroscopy. IgG samples 
were diluted 100x and transferred to a quartz cuvette. The absorbance was 
measured at 280nm using PBS buffer as a blank. The protein concentration of the 
samples was determined using the following equation (derived from the Beer 
Lambert law): A = ε x C x L (A = absorbance; ε = molar extinction coefficient; C = 
concentration; L = length of the light path.) The molar extinction coefficient for IgG at 
280nm is 1.43 and the light path of a 1ml cuvette is 1cm. Protein concentrations 
using this method are expressed in mg/ml.  
 
Normal control IgG was obtained from healthy volunteers. After consent blood was 
taken from a pool of at least 10 volunteers. The whole blood was then left to stand 
and separate, and the serum removed from the top of the sample. This was then 
combined into a pool and the serum processed as described above to isolate normal 
IgG.  
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4.1.4 Chimeric PR3-ANCA and control 
 
Chimeric PR3-ANCA subclasses 1, 3 and 4 were developed in our laboratory prior to 
the current work commencing. Mouse/human chimeric IgG1, IgG3 and IgG4 
monoclonal ANCA are directed against a single epitope on the PR3 molecule that is 
recognized by a mouse monoclonal antibody against human PR3, called 4A5 
(Colman, Hussain et al. 2007).  
 
Hybridoma cells (where fusion of a myeloma cell and normal cell line is produced that 
is capable of producing antibodies) expressing 4A5 were used to synthesize cDNA 
using a first strand cDNA synthesis kit. The mouse variable regions were amplified by 
PCR using 5' primers specific to the mouse variable region leader sequences and 3' 
primers specific to the mouse constant region. Fresh PCR products were cloned into 
sequencing vectors and transformed into E.coli. PCR screening was performed to 
select clones containing PCR products and plasmid DNA purified from positive 
clones. Automated sequencing was carried out and homology searches performed 
using BLAST software to confirm that mouse light and heavy chain variable regions 
had been amplified. The mouse light and heavy chain variable regions were 
subcloned into vectors containing the appropriate constant regions i.e. the IgG kappa 
chain or IgG1, IgG3 and IgG4 heavy chains. These were then co-transfected into 
CHOdhfr- cells. 
 
Clones which produced high levels of IgG and proliferated robustly were selected and 
expanded into a hollow fibre bioreactor (Goodall 1998). IgG1 and IgG4 were purified 
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from culture supernatant using Staphylococcal protein A (SpA) coated sepharose and 
IgG3 purified using Streptococcal protein G (SpG) coated sepharose. IgG production 
was verified by ELISA, SDS-PAGE and mass spectrometry. Microtitre plates coated 
with PR3 were used to confirm the specificity of antigen recognition. Surface plasmon 
resonance was performed to ascertain antibody affinity and avidity of the chimeric 
antibodies to PR3 in comparison with the 4A5 anti-PR3 mouse antibody. 
 
The chimeric PR3-ANCA were able to produce the distinct cytoplasmic staining 
pattern on ethanol-fixed neutrophils which is characteristic of patient-ANCA IgG using 
indirect-Immunofluorescence. They also recognised PR3 by ELISA and Western blot. 
Flow cytometry was used to confirm binding to PR3 expressed on the neutrophil cell 
surface. 
 
The chimeric PR3-ANCA were compared in experiments to chimeric anti-NP (nitro-
phenol) antibodies developed in the same way to the ANCA antigens (gift from Dr 
Margaret Goodall). Nitro-phenol is not found in the human body so is therefore an 
irrelevant antigen. In some experiments where difficulties with these controls were 
experienced, myeloma antigens of a particular subclass were used (gift from Dr 
Margaret Goodall). 
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4.1.5 Endothelial Cell culture 
 
4.1.5.1 Human umbilical vein endothelial cell (HUVEC) culture  
 
Umbilical cords were collected with informed consent. Using a sterile technique, the 
cords were canulated with glass canulae and washed with sterile PBS to remove 
blood clots. Collagenase (Sigma) at a concentration of 1mg/ml was injected into the 
cords and they were incubated at 37ºC for 15 minutes. The cords were then flushed 
with 30ml of sterile PBS, which was collected and centrifuged at 1500rpm for 5 
minutes. The pellet was then re-suspended in 4ml of medium 199 (Invitrogen, UK), 
which per 100ml contained 20ml of 20% heat inactivated foetal calf serum (FCS) 
(Sigma, UK), 10μl of hydrocortisone (Sigma, UK) 1μg/ml, 10μl of epidermal growth 
factor (Sigma, UK) 10μg/ml, 1ml of penicillin and streptomycin 100u/L (Sigma, UK) 
and 1ml of amphotericin 2.5μg/ml (Invitrogen, UK). 
 
The isolated cells were then placed in tissue culture flasks (25cm2; Falcoln, BD, 
UK/Ireland) which had been pre-coated with gelatin (Sigma, UK) and were cultured at 
37ºC in a humidified CO2 (5%) incubator. After 12 hours the medium was changed, 
and thereafter every 2-3 days until the cells reached a confluent monolayer. 
 
4.1.5.2 Conditionally immortalised glomerular endothelial cells (GEC1 and 2) culture  
 
Conditionally immortalized glomerular ECs containing a temperature sensitive 
transgene (simian virus 40 large tumour antigen and telomerase) have been 
developed by our collaborators (Satchell, Tasman et al. 2006), and were obtained 
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from Bristol University. Briefly, primary cell culture had been obtained from normal 
human kidney glomeruli that had been decapsulated by sieving. Cultures of these 
cells were infected with retrovirus containing supernatants from two packaging cell 
lines. The first, PA317 produced viral particles containing an SV40LT antigen gene 
containing both tsA58 and U19 mutations. This rendered the cells temperature 
sensitive. The second, from the packaging line TEFLY-A, produced viral particles 
containing hTERT, rendering the cells immortal at temperatures of 33 ºC. Cells 
transduced with the SV40LT construct were selected and placed at 33ºC. After 
reaching confluence cells also transduced with hTERT were selected with 
hygromycin.  
 
They were cultured in tissue culture flasks (75cm2, Falcoln, BD, UK/Ireland) in EBM-2 
medium (Clonectics, Cambrex, UK). Exact concentrations of added reagents were 
unknown as the medium came in a kit, but it contained EC based medium, human 
fibroblast growth factor-B, hydrocortisone, endothelial growth factor vascular human 
recombinant, epidermal growth factor human recombinant in buffered BSA saline 
solution, recombinant long R insulin-like growth factor-1 in aqueous solution, ascorbic 
acid, gentamicin sulphate, amphotericin-B and foetal bovine serum. 
 
When confluent (2-3 days) the cells were removed with trypsin (Sigma, UK) and 
EDTA (Sigma, UK), split into thirds and reseeded. Before use in experiments, the 
cells were grown at 37ºC for at least 30 hours to allow the SV40LT mutant to be fully 
arrested.  
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During this research two cell lines were tested, both from our collaborators in Bristol. 
 
4.1.5.3 Primary glomerular endothelial cells (PGEC) culture 
 
Primary cells were obtained from TSC Cellworks, UK, at passage 1. The company 
state that the EC are obtained by dissecting human kidney tissue and then pushing 
the tissue through a steel mesh to obtain glomeruli. The glomeruli are then enzyme 
treated and purified from primary culture using the CD31 marker.  
 
They were grown in the EBM2 medium (as above) in tissue culture flasks (25cm2 or 
75cm2, Falcoln, BD, UK/Ireland) with pre-coating of human fibronectin (Sigma, UK) 
and placed in a humidified CO2 (5%) incubator. They were grown to confluence 
before either splitting into 3 flasks or using in experiments. The medium was changed 
every 2-3 days. These became confluent in 4- 5 days. 
 
4.1.5.4 Freezing endothelial cells 
 
Trypsin and EDTA were used to remove cells from the flasks and they were then 
spun down into a pellet, to which was added 1ml of FCS with 20% DMSO (Sigma, 
UK). These were then placed in a cryovial and snap frozen. 
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4.2 Flow model methods 
4.2.1 Preparation of microslides and testing with platelets 
 
Glass microslides (rectangular cross section 0.3x3mm; length 50mm, Camlab, 
Cambridge, UK) were cleaned with nitric acid, washed in water and then in acetone 
and coated with 4% 3-aminopropyltriethoxysilane (APES) (Sigma, UK). They were 
then dried and autoclaved. A layer of platelets was used to check the even coating of 
the APES on two slides. 
 
4.2.2 Coating microslides with P-selectin or immunoglobulin 
 
Microslides previously coated with APES were coated with P-selectin (R&D Systems, 
UK) made up to the required concentration by dilution in PBS. 55μl of P-selectin 
solution was pipetted into the glass microslide and then incubated for 2 hours at 
37ºC. Any uncoated APES on the slide was then blocked with 1% albumin (Sigma, 
UK) and re-incubated for a further 2 hours. 
 
IgG coating was achieved by diluting pure human IgG (Binding Site, UK) in PBS, to 
the desired concentration (50-400μg/ml). This was pipetted into glass microslides as 
above and incubated for 1 hour at 37ºC, and APES was blocked as above. 
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4.2.3 Transfer of endothelial cells into microslides 
 
The EC were grown to confluence and using sterile techniques were removed with 
trypsin and EDTA 0.2%. The trypsin action was stopped with medium and the cells 
spun at 1600rpm for 5 minutes. The pellet was re-suspended in 0.4mls of medium 
and drawn up into APES coated microslides in 60μl aliquots. Six slides were 
prepared in this way and then incubated for one hour at 37ºC allowing adherence 
and spreading of the ECs. The slides were then placed in a modified Petri dish full of 
medium (made at Birmingham University) and the slides were connected via rubber 
tubing to a pump which exchanged medium through the slides every hour. The 
endothelium was cultured in this system for 24 hours allowing formation of an 
endothelial monolayer. 
 
4.2.4 Flow model set up 
 
Flow experiments were performed in an enclosed Perspex chamber (made in house) 
at 37ºC (Figure 6). A microslide containing either a monolayer of ECs or coated with 
P-selectin was glued to a glass microscope slide, mounted on a phase-contrast 
microscope and viewed both in real time and recorded on video. One end of the 
microscope slide was attached via silicon rubber tubing to a syringe pump allowing 
control of the rate of flow across the microslide surface (usually 0.382mls/min 
resulting in 0.1Pa wall shear stress). The other end of the microslide was connected 
by silicon rubber tubing to an electronic valve (Lee Products, Gerards Cross, UK), 
which allowed switching between a reservoir of wash buffer (50ml PBS with calcium 
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and magnesium/1ml bovine serum albumin (BSA)) and a reservoir containing 
neutrophil or PBMC suspension and then subsequently any treatments used. 
 
Once the microslide was inserted into the flow system, wash buffer was perfused to 
remove debris or cytokine remaining after treatment. Flow was then switched to the 
neutrophil/PBMC suspension and this was perfused for 4 minutes, followed by a 
washout of 1 minute. Video microscope recordings were then made in 4 fields along 
the centre of the microslide in the direction of flow. Treatment was then commenced, 
depending on the experiment, and further video recordings made in the same way as 
the first, usually at 2 minute intervals and up to 14 minutes after the initial perfusion of 
neutrophils. 
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 Figure 6: The flow model.  
All flow experiments are performed in a Perspex box at 37ºC. The 
microslide, mounted on a glass microscope slide is attached to a pump 
and to the cell reservoir and fluid wash buffers. Events in the slide can 
be viewed through the microscope, recorded on video and analysed on 
the computer. 
Video recordings were subjected to computer aided analysis off-line. Sequences of 
images were digitized and analysed using Image Pro-Plus software 
(MediaCybernetics, USA). Two populations of cells were counted on P-selectin: 
those rolling, which maintained their round shape and rolled on the surface and those 
exhibiting stable adhesion on the P-selectin surface and demonstrating shape 
change (Figure 7). On ECs, in addition to these populations there was another 
population of neutrophils which had migrated underneath the endothelial monolayer 
and were phase dark (Figure 7).  
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 For each time point in the experiment, four fields had been captured and the cells in 
each field were counted in each population. In excel, averages were calculated for 
each time point and converted to neutrophils/PBMC per square mm per 106 cells 
perfused. In addition, percentage of each population was calculated, allowing 
expression of the relative levels of interaction (rolling, stationary-adhered and 
transmigrated). 
 
On P-selectin to calculate the rolling velocity of cells, ten cells in one field were 
selected and start and end locations of these cells used to calculate the distance 
travelled in the 6 seconds of the sequence. An average was taken for the ten cells in 
the field.  
 
Figure 7: Neutrophil appearance.  
In the flow model neutrophils rolling on a P-selectin surface appear 
round and white (first panel). After treatment with fMLP or ANCA the 
neutrophils firmly adhere and undergo shape change (second panel). 
On an activated EC monolayer (third panel) neutrophils roll (blue 
arrow), firmly adhere (red arrow) or transmigrate behind the endothelial 
layer (green arrow) 
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4.2.5 Treatment protocols 
 
4.2.5.1 Cytokine, histamine and hydrogen peroxide 
 
Confluent EC in microslides were treated with cytokines for four hours prior to flow 
assays. TNFα (concentrations between 2units/ml and 1000units/ml) (NIBSC, UK) or 
IL-1β (R&D systems, UK) (concentrations of 5 x 10-9 g/ml and 5 x 10-10 g/ml) were 
pipetted into the microslides, incubated for 1 hour, and the process repeated each 
hour for 4 hours. Histamine (Sigma, UK) was used to treat the EC for 20 minutes at 
100μmolar and 10μmolar. In other experiments histamine was also infused with the 
neutrophils to allow for a continuous treatment of the EC. Hydrogen peroxide (H2O2) 
(Sigma, UK) was used at a concentration of 100μMolar for up to 1 hour to upregulate 
selectins on the EC. Any extension to this time resulted in damage to the ECs.  
 
4.2.5.2 fMLP (N-formyl-methionyleucylphenylalanine) 
 
fMLP (Sigma, UK) was added to the system, after 4 minutes of inflow of neutrophils 
and 1 minute of wash, at a concentration of 1x 10-7 molar and 4mls was infused over 
the rolling neutrophils. 
 
4.2.5.3 Human ANCA 
 
In P-selectin experiments, ANCA IgG or normal IgG at 200μg/ml (a concentration 
previously shown to give an optimal response (Radford, Savage et al. 2000)), diluted 
in PSA/BSA was added to the flow assay after 4 minutes perfusion of neutrophils and 
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1 minute of wash out. The IgG infusion was continued for up to 8 minutes. This 
allowed observation of events before and after the addition of ANCA. In HUVEC 
experiments, ANCA IgG or normal IgG at  200μg/ml was added to neutrophils just 
before perfusion over ECs for 4 minutes. The bolus of cells was then washed out with 
PBS/BSA.  ANCA or normal IgG at 200μg/ml was then perfused over the 
endothelium for up to 8 minutes.  
 
4.2.5.4 Chimeric PR3-ANCA 
 
The same protocols as above were used for chimeric PR3-ANCA and controls (anti 
NP) but these were used at concentrations of 60μg/ml for IgG1 and IgG4 and 
48μg/ml for IgG3 so that there was equivalent molar quantities. These concentrations 
had previously been shown to give an optimal response in the flow model 
(unpublished data).  
 
4.2.6 Experiment design for flow experiments 
 
4.2.6.1 P-selectin titration 
 
Microslides were coated with P-selectin (R&D Systems, UK) at 0, 0.5, 1, 2, 5μg/ml. 
For each microslide, neutrophils were perfused for 4 minutes. After 1 minute of wash, 
4 video microscope recordings each of 15 seconds were made along the centre line 
of the slide. The concentrations were tested in different orders in each experiment. 
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4.2.6.2 fMLP on P-selectin 
 
Microslides were coated with P-selectin at a concentration of 2μg/ml. Neutrophils 
were perfused for four minutes over the slide and video recordings taken as 
described above. fMLP was then added to the treatment chamber and perfused over 
the cells for 2 minutes. Four further microscope video recordings were then taken 
(Figure 8). 
 
Figure 8: Experimental design for flow experiments with fMLP. 
Video recordings were taken before and after fMLP was perfused over 
rolling neutrophils. 
 
4.2.6.3 Immunoglobulin coating 
 
All experiments were repeated at least 3 times. IgG1 (Binding Site, UK) was coated 
in increasing concentrations (50μg/ml, 100 μg/ml, 200 μg/ml and 400 μg/ml) on 4 
microslides; neutrophils were flowed across for 4 minutes and video recordings taken 
at 5 and 10 minutes.  
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In the next experiments, subclasses IgG1-4 were coated at 100 μg/ml (the optimum 
concentration found in the gradient experiments) and neutrophils flowed across as 
before, video recordings were taken at 5 and 10 minutes. These experiments were 
then repeated using neutrophils which had been treated with anti-CD32 (clone IV.3 
01470) (StemCell Technologies, France) or anti-CD16 blocking antibodies (clone 
3G8) (BD biosciences, UK) both used at 10μg/ml for 30 minutes. 
 
In the final experiments, on IgG3 coated surfaces, neutrophil were observed which 
had been treated with anti-CD18 at 10μg/ml for 30 minutes (clone 6.5E, gift from Dr 
M Robinson, Celltech, UK); both anti-CD32 and anti-CD16 together, both at 10μg/ml 
for 30 minutes;  or with BAPTA-AM at 100mMolar for 30 minutes (Sigma, UK).  
BAPTA-AM was suspended in DMSO (Sigma, UK) and washed off after treatment. 
For the control, DMSO alone was used. For the other antibodies isotype control 
(mouse IgG1 isotype control) (Sigma, UK) was used as a control at 20μg/ml. 
 
4.2.6.4 Patient  and chimeric ANCA on P-selectin 
 
Six microslides were coated with P-selectin at a concentration of 2μg/ml. Neutrophils 
were perfused for four minutes over the slide and video recordings taken. Previously 
isolated patient ANCA at 200μg/ml was added to the treatment chamber and 
perfused through the microslide continuously for the remainder of the experiment. 
Video microscope recordings were taken in four episodes every 2 minutes until 14 
minutes (Figure 9). The process was repeated for 4 different patient ANCA, normal 
IgG and no IgG; the whole experiment was repeated at least 3 times. In experiments 
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using chimeric PR3-ANCA the same protocol was used, and PR3-ANCA IgG1, 3 and 
4 and control chimeric NP for each subclass were perfused. Antibodies of subclass 
IgG1 and IgG4 were used at 60μg/ml (previously found to be a useful working 
concentration (Lu, Garfield et al. 2006) and IgG3 at 48μg/ml so that they were 
equivalent in molarity.  
 
Figure 9: Experimental design for flow experiments with ANCA.  
On a P-selectin surface at 2μg/ml neutrophils were perfused for four 
minutes. ANCA was perfused over the rolling neutrophils. Video was 
taken at 6 minutes, before neutrophils had been exposed to ANCA, and 
then at 2 minute intervals until 14 minutes 
 
4.2.6.5 Blockade of CD32 and CD16 after chimeric ANCA on P-selectin 
 
Experiments were undertaken to explore the role of CD32 and CD16 on neutrophils 
in the situation of exposure to ANCA. These experiments were limited by reagent as 
the chimeric ANCA were limited. The experiments on P-selectin were repeated but 
only two time points taken, immediately pre-ANCA and 2 minutes after exposure to 
ANCA. Neutrophils which had previously been treated with isotype control antibody 
(mouse IgG1 isotype control, Sigma, UK), or anti-CD32 (as above) or anti-CD16 (as 
above) were flowed across the slide and events recorded. Chimeric ANCA of 
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subclasses IgG1, 3 or 4 was then flowed over the slide and cell adhesion and 
behaviour recorded. 
 
4.2.6.6 Endothelial cell cytokine titration 
 
EC were grown in a monolayer in 5 microslides. These were treated with cytokines. 
For TNFα experiments, concentrations of 0, 1, 5, 10, 100u/ml for HUVEC, primary 
GEC and GEC2; 0, 100, 1000u/ml for GEC1 were applied for 4 hours. For IL-1β 
concentrations of 5 x 10-10g/ml and 5 x 10-9g/ml were applied for 4 hours. For H2O2, 1 
millimolar was applied for 1 hour. Neutrophils were perfused for four minutes, 
followed by a 1 minute wash out. Video recordings were taken at 5 and 7 minutes. 
The process was repeated for each concentration and the order varied for each 
experiment repeat. 
 
4.2.6.7  Patient and chimeric ANCA on HUVEC 
 
Six microslides with a monolayer of ECs were treated with 100u/ml of TNFα in 3 
experiments and 2u/ml in 3 separate experiments. In contrast to experiments on P-
selectin, neutrophils were treated with ANCA or normal IgG (200μg/ml) just before 
they were perfused and in addition, ANCA or normal IgG was continuously perfused 
for the rest of the experiment. This was because previous published work had 
established these protocols were effective (Radford, Luu et al. 2001). Video 
microscope recordings were taken at 5 minutes and at 2 minute intervals thereafter to 
14 minutes. The same protocol was used with chimeric PR3-ANCA IgG1, 3 and 4 at 
concentrations as in the P-selectin experiments. 
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4.2.6.8 Flow experiments for EC comparisons 
 
Initial experiments compared HUVEC growing in normal medium as described above 
or EBM2, previously used for glomerular cells as described above. Experiments were 
then performed in flow stimulating the HUVEC with 100 or 2units TNFα for 4 hours 
and comparing neutrophil capture and behaviour as described above. 
 
In experiments using neutrophils, three EC types, HUVEC, PGEC and GEC2 were 
compared. In separate experiments, these were treated with 100units or 2units/ml 
TNFα or 5 x10-9 or 5 x 10-10g/L Il-1β for 4 hours, or 1 milimolar H2O2 for 1 hour and 
neutrophils flowed across. Video recordings were made at 5 minutes and 10 minutes 
and the capture and behaviour of neutrophils on the EC observed. The same 
protocol was used for experiments with PBL, where PGEC and HUVEC only were 
compared, EC were stimulated with TNFα at 100units/ml for 24 hours. 
 
In blocking experiments using PBL, VCAM-1 was blocked on the EC by injecting 
microslides with anti-VCAM-1 antibodies (both ligands were blocked: 4B2 to domain 
1 (R&D Systems, UK) and GH12 to domain 4 (a gift from Dr Roy Lobb). Both 
antibodies were used at 10μg/ml for 30 minutes. Isotype control (mouse IgG1 isotype 
control, Sigma, UK) was used as a control at 20μg/ml. In other experiments VLA-4 
was blocked (MAX68P, a gift from Dr M Robinson at Celltech) on neutrophils by 
incubating the neutrophils with the blocking antibody at 10μg/ml for 30 minutes prior 
to perfusion into the flow model. Data for cell behaviour was collected as previously. 
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Initial experiments with GEC1 also examined the influence of human ANCA on 
neutrophil behaviour. In these experiments GEC1 were compared with HUVEC. 
GEC1 were stimulated with 1000units/ml of TNFα and HUVEC with 2units/ml. 
Human ANCA was added to neutrophils before perfusion, as described above, and 
data collected for capture and behaviour of neutrophils. 
 
4.2.6.9 Endotoxin testing and removal 
 
During the course of the flow experiments there were considerable problems when 
investigating the effects of chimeric ANCA on neutrophils on EC because control anti-
NP antibodies appeared to activate neutrophils. After changing the control, and 
investigating the use of other myeloma controls with minimal success, all antibodies 
were tested for endotoxin using an E-toxate kit (Sigma, UK).  
 
The multiple test vial and endotoxin standards were re-constituted with endotoxin free 
water. Two tubes of each sample to be tested were prepared. E-toxate working 
solution was added to one sample tube and to the standards. The other sample tube 
had endotoxin added to it, to check for the presence of E-toxate inhibitor. The 
samples were positive for endotoxin if after 1 hour, left undisturbed, a hard gel had 
formed in the bottom of the test tube 
 
All samples were contaminated with endotoxin. This was removed by either perfusing 
the antibodies through an endotoxin removal column where packed beads coated 
with polymixin B columns (Detoxi-Gel affinityPak prepacked columns, Pierce, UK); or 
by spinning in Handee centrifuge columns (Pierce, UK) with polymixin beads (Pierce, 
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UK): 1ml of beads (50% suspension) to 250μl antibody at 10,000G for 5 minutes. The 
samples were retested to check that all endotoxin had been removed. 
 
4.2.7 Statistical analysis and graphical representation of flow experiments 
 
The number of cells per mm2 per 106 perfused was used to study capture of total 
numbers of cells. In order to study the behaviour of the cells, the percentage of cells 
rolling, stationary-adhered and, in endothelial experiments, those migrated across the 
endothelium was calculated as a proportion of the whole captured population. This 
data is graphically represented throughout the thesis. 
 
This data was entered into Excel as numbers of cells calculated for each field. Four 
fields were averaged for each time point, and cells per mm2 per 106 perfused and 
percentages were calculated. Data was transferred to Prism (GraphPad Prism 
version 3.00 for Windows, GraphPad Software, San Diego California, USA) for graph 
construction. In concentration titration experiments, the cell number and percentage 
were plotted against concentration, and in comparison of antibodies, against time 
after exposure to antibodies. All experiments were repeated at least three times, and 
the standard error of the mean (SEM) calculated for each data point and plotted as 
error bars. Results from the flow experiments were represented in three separate 
ways. P-selectin experiments, where neutrophils were in contact with a P-selectin 
surface could either stop and adhere or roll. Graphs were created for these 
experiments with the percentage of cells that were rolling throughout the time course 
of the experiment (the remaining cells were obviously therefore static).  
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 Results from experiments where ECs were used were represented in two ways. 
Firstly the total numbers of cells captured were graphed, which allows interpretation 
of the potency of the ECs to capture neutrophils or PBL from flow. Secondly the 
behaviour of the captured neutrophils/PBL was represented by the percentage of 
cells captured that were rolling, statically adhered or migrated across the ECs layer. 
By representing these as percentages of the total captured cells a comparison can 
then be made directly between treatments on the behaviour of the captured 
neutrophils, even if different total numbers of cells had been captured. The graphs 
are either plotted over time or for simplicity of comparison of treatments, at one time 
point, and the percentage of rolling cells (blue), static cells (red) and migrated cells 
(yellow) are represented. Error bars (SEM) for these experiments are plotted at each 
time point. 
 
For statistical analysis, data were transferred to Minitab (Minitab Inc., Version 13.0, 
USA). Analysis of variance (ANOVA) was used to look at differences between 
treatments, in relation to the treatments themselves, variation over time or 
concentrations, and the variability between experiments. ANOVA was performed by 
the general linear model allowing for a 2-way ANOVA where experiment number and 
treatment number were used for paired data. In order to compare which treatments 
were significant, a post ANOVA Dunnett test was performed. In unpaired tests, a 
one-way ANOVA used treatment number alone. 
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4.3 Superoxide assay 
Superoxide anion production was determined by the superoxide dismutase (SOD) 
inhibitable reduction of ferricytochrome c. Neutrophils were suspended to 2x106 
cells/ml and primed with cytochalasin B (2.5μg/ml, Sigma) for 5 minutes and then 
TNFα (2ng/ml NIBS, London, UK) for 15 minutes at 37ºC. PMN were stimulated with 
200μg/ml of IgG. 
 
These were then added to a reaction mixture containing cytochrome c (75μM, Sigma) 
and agonist, with or without SOD (150 units, Sigma). The wells without SOD were 
repeated in triplicate and averaged. The OD at 550nM was then taken for the wells 
with and without SOD and the difference calculated, to establish the change in OD. 
Thus delta A = (absorbance at time x – absorbance at time 0) – (absorbance in the 
presence of SOD at time x – SOD at time 0). 
 
The molar extinction coefficient for ferricytochrome c is 21.1 x 10-3M and the light 
path is 0.6cm for a final volume of 250 μl. In order to calculate production of 
superoxide the following is applied: change in SOD wells – change in non SOD wells/ 
12.66 x 1000. 
 
4.4 Microscopy: phase contrast and electron microscopy 
ECs were grown in monolayers as described above on glass microslides. They were 
viewed and photographed under phase contrast microscopy with the equipment used 
for the flow model. 
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 Both transmission electron microscopy (EM) and scanning electron microscopy was 
performed during the course of this work in order to look for fenestrations. The cells 
were grown in monolayers in plastic six well plates (Falcoln, BD, UK/Ireland) and 
were cultured in medium containing different concentrations of VEGF. Medium either 
contained no VEGF, the ‘normal’ amount which was provided in the EMB2 medium 
pack (10μg/ml) or high concentrations of VEGF (100μg/ml). 
 
Preparation of samples, and help with operating the microscopes were performed by 
our colleagues in the Electron Microscopy laboratories. 
 
For transmission EM, cells were fixed in 2.5% glutaraldehyde (Agar Scientific Ltd., 
UK) in 0.1 molar phosphate buffer (Agar Scientific Ltd., UK) and then post fixed in 1% 
osmium teroxide (Agar Scientific Ltd., UK), dehydrated through an ethanol series 
(Agar Scientific Ltd., UK) and embedded in Mollenhauer resin (Agar Scientific Ltd., 
UK). They were cut by the EM laboratory and transmission electron microscopy was 
performed on a Jeol 1200EX TEM electron microscope. The images from these 
techniques were not satisfactory, so we went on to perform scanning EM. 
 
For scanning EM, cells were fixed, dehydrated and dried as above. They were then 
critically point dried in a Polaron Critical point drier and mounted on stubs. They were 
sputter coated with platinum in an Emscope SC500 sputter coater and examined in a 
Philips XL-30 FEG ESEM microscope in high vacuum mode. 
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4.5 Flow cytometry 
4.5.1 Fow cytometry for surface markers and adhesion molecules on endothelial 
cells 
 
ECs were grown to confluence as above and either left untreated or treated with 
TNFα for 4 hours if testing for E-selectin, vWF, CD31, CD16, CD32; 12 hours if 
testing for ICAM-1 and 24 hours when testing for VCAM-1. ECs were removed by 
treatment with EDTA at 4ºC for 45 minutes followed by scraping, washed and 
centrifuged at 1600rpm for 5 minutes and resuspended in PBS with 
calcium/magnesium. The cells were then counted and diluted to 106 per ml. 100μl of 
cells were added to each flow cytometry tube (12mm x 75mm 5ml round bottom 
polystyrene tubes, Falcoln, BD, UK/Ireland). For detection of vWF, cells were 
permeabilsed and fixed using Fixperm solution (Invitrogen, UK). 
 
All primary and conjugated antibodies (negative control, mouse IgG1κ murine 
myeloma (Sigma, UK); monoclonal mouse anti-human CD31 (Dako UK Ltd); 
monoclonal mouse anti-human vWF (Dako UK Ltd); monoclonal mouse anti-human 
E-selectin (R&D systems, UK) monoclonal mouse anti-human ICAM-1 (abcam, USA); 
monoclonal mouse anti-human VCAM (R&D systems, UK); monoclonal mouse anti-
human CD64 (Dako UK Ltd.)) at 1:50 and conjugated antibodies (monoclonal mouse 
anti-human CD16 (Dako UK Ltd.) and negative control mouse IgG2a (BD, 
UK/Ireland)) were added to each tube and left for 15 minutes at room temperature. 
2mls of PBS was added and the cells were centrifuged, supernatants discarded and 
the cells resuspended by vortex. Cells treated with conjugated antibodies were fixed 
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in 100ml of 2% paraformaldehyde (PFA, Sigma, UK) in PBS, and stored. Secondary 
antibody (anti-mouse immunoglobulins-FITC (Dako UK Ltd.) was added at 1:10 
incubated for 15 minutes in the dark, washed and fixed. 
 
Samples were acquired on a FACScalibur flow cytometer using cell quest software 
(Becton Dickson, Oxford, UK) with 1 x104 cells acquired per tube. Forward and side 
scatter gating excluded dead cells. List mode data was analysed using WinDMI 
software. Antibody staining was quantified by measuring geometric mean 
fluorescence. 
 
4.6 Immunocytochemistry and immunohistochemistry 
4.6.1 Immunocytochemistry for vWF; CD31; E selectin: VCAM-1 on EC 
 
4.6.1.1 Cell smears 
 
Confluent ECs were removed from flasks with trypsin, spun to a pellet and re-
suspended in 1 ml of PBS. Using a transfer pipette, a drop of this suspension was 
placed onto a microscope slide and sucked back off, and this was repeated so that 
there were two circles of cell suspension on the slide. The slides were then left to 
completely dry out and were then fixed in fresh dehydrated acetone (VWR) at minus 
20ºC for 20 minutes. After drying, a paraffin wax pen mark was drawn around each 
circle of cells. The slides were then washed in Tris buffered saline (TBS). 
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In a humid chamber, the primary antibodies, mouse anti-human CD31, mouse anti-
human vWF, and mouse monoclonal IgG isotype control (all from Dako UK Ltd.) at 
1:25 in TBS, were added to each slide for 1 hour followed by secondary antibody, 
rabbit anti-mouse FITC conjugated 1:25 in TBS (Dako UK Ltd.) for 1 hour in the dark.  
The slides were then rewashed, and citifluor (Citifluor Ltd., UK) was dropped over the 
circle of cells and covered with a coverslip. These were then viewed under a 
fluorescent microscope (Nikon Eclipse E600). Cells were viewed at X100 
(MRH01902 CFI Plan Fluor 100X objective oil N.A. 1.3 W.D. 0.2mm spring loaded, 
stopper) in oil immersion, at room temperature, using Nikon digital camera DXM1200 
and Nikon NIS elements acquisition software (Nikon, Kanagawa, Japan). All images 
were processed using Photoshop Elements 6.0 (Adobe, CA, USA), the sharpness of 
the images was adjusted and lens blur removed. Each image was adjusted to the 
same settings.  
 
4.6.1.2 Whole monolayer staining 
 
Since the images resulting from the above method were criticised as they did not 
demonstrate stained EC monolayers, further studies were untaken and these 
explored more adhesion molecules. ECs were grown to confluence on glass 
coverslips in 12 well plates and treated with TNFα for the appropriate time for each of 
the adhesion molecules (as above). The coverslips were washed in cold PBS in the 
wells. Primary antibodies were added (negative control, mouse IgG1κ murine 
myeloma at 1:20 (Sigma, UK); monoclonal mouse anti-human CD31 at 1:20 (Dako 
UK Ltd.); monoclonal mouse anti-human vWF at 1:25 (Dako UK Ltd.); monoclonal 
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mouse anti-human E-selectin at 1:100 (R&D systems, UK); monoclonal mouse anti-
human VCAM at 1:100 (R&D systems, UK)) and left for 1 hour at room temperature. 
After washing, secondary antibody, rabbit anti-mouse immunoglobulins-FITC 
conjugated (Dako UK Ltd.) was added at 1:25 and left for 1 hour in the dark at room 
temperature. The cell layer was fixed with 2% PFA with 4% sucrose for 15 minutes.  
4',6-diamidino-2-phenylindole (DAPI) (Sigma, UK) was diluted 1:50 in PBS and put 
onto the cell layer for 5 minutes. The coverslips were then washed, carefully removed 
from the wells and placed on microscope slides. A drop of Citifluor (Citifluor Ltd, UK) 
was placed on each coverslip, covered with a further coverslip and secured with clear 
nail varnish. The slides were then viewed with a fluorescent microscope as described 
above, and the images processed as above.  
 
4.6.2 Immunohistochemistry for VCAM-1 in kidney biopsy 
 
Sections of renal tissue previously obtained by workers in the laboratory, mounted on 
glass microscope slides and preserved in paraffin, were treated to remove the 
paraffin and rehydrate the sections. This was achieved by emersion for 5 minutes 
each in Xylene (BD chemicals, UK/Ireland) and then in an ethanol series (BD 
chemicals, UK/Ireland) from 100%; 90%; 80% and then running water. 
 
Antigen retrieval was performed by microwaving the samples for 20 minutes in a 
10mM citrate buffer (see appendix). After cooling and washing in running water for 10 
minutes, a PAP pen was used to draw around each sample creating a well. Blocking 
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in 0.3% hydrogen peroxide (Sigma, UK) in methanol (BD chemicals, UK/Ireland) was 
performed for 30 minutes. 
 
After washing thrice with gentle agitation in tris buffered saline (TBS) (see appendix) 
the samples were blocked with 20% donkey serum (Sigma, UK) and then incubated 
with primary antibody (goat anti-human polyclonal anti-VCAM-1 (R&D, UK)) diluted to 
4μg/ml (1:300) in TBS, overnight at 4ºC. 
 
After washing the samples were incubated with secondary antibody (donkey anti-goat 
immunoglobulins; Santacruz Inc., USA) at 1:100, rewashed and developed cautiously 
with 33 diaminobenzidine (DAB) (Sigma, UK) and washed for 10 minutes. 
Counterstaining was achieved with haemotoxylin (Sigma, UK) following which the 
samples were mounted using immunomount (Thermo Scientific, USA) and viewed 
with a Nikon ES400 Eclipse microscope as above. Data was collected using NIS 
Elements version 3, F package software. Images were processed as above. 
 
4.7 Enzyme linked immunosorbant assay (ELISA) 
4.7.1 Cell ELISA for E-selectin, ICAM-1 and VCAM-1 on EC 
 
96 well plates (BD Falcoln, UK/Ireland) were coated with gelatin or fibronectin and 
EC seeded 4 x 104 cells per well and incubated overnight in a humidified CO2 (5%) 
incubator at 37ºC. EC were stimulated with 100units/ml of TNFα or 5 x 10-9g/ml IL-1β, 
for 4 hours for E-selectin; 12 hours for ICAM-1 and 24 hours for VCAM-1. In other 
experiments, hydrogen peroxide at 1 millimolar for 1 hour was used to induce 
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selectins. The cells were fixed with 2% paraformaldehyde (Sigma, UIK) with 4% 
sucrose in PBS for 10 minutes. Endogenous peroxidase was inhibited by 0.1% 
hydrogen peroxidase (Sigma, UK) in methanol (Fisher Scientific, UK) and then 
blocked with 10% marvel and 5% sheep serum (Dako UK Ltd.) to prevent non-
specific binding of antibodies to cells for 1 hour. 
 
Primary antibodies, monoclonal mouse anti-human human E-selectin (R&D systems, 
UK); monoclonal mouse anti-human ICAM (abcam, USA); monoclonal mouse anti-
human VCAM (R&D systems, UK) were used at 1:1000 for one hour. Secondary 
antibody, anti-mouse IgG (from sheep), horse radish peroxidase (HRP) linked 
(Invitrogen, UK) 1:1000 was applied in all wells for one hour. The substrate 3,3´,5,5´-
tetramethylbenzidine (TMB) (Calbiochem, Merk, UK) was then added. The colour 
changed quickly and stop solution was added after 5 minutes. The absorbance was 
then read at an OD of 450nm.  
 
Wells were treated with secondary antibody alone as a negative control, or with 
primary antibodies either in normal PBS or made up in PBS or 0.1% triton to 
permeablised EC. 
 
The student’s T test was used to compare results (Minitab version 13.0, State 
College, PA). 
 
EC were washed and 0.1% crystal violet applied for 10 minutes. After rewashing, the 
cells were solubilised with 1% triton (BDH chemicals, VWR, USA) and left overnight 
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in humid conditions. The absorbance was then read at 550nm. The results of each 
well were then compared by the students T test to establish that there were the same 
number of cells in each well. 
 
4.8 Western blotting 
EC were grown to confluence, treated with 100units/ml TNFα for 24 hours, removed 
with EDTA and trypsin, centrifuged and re-suspended in lysis buffer with protease 
inhibitors (see appendix) and left for 15 minutes on ice. Samples were then 
centrifuged for 10 minutes at 1500rpm, and the supernatants collected and frozen. 
When all samples had been collected, they were defrosted, 22μl of non-reducing 
loading buffer (see appendix) was added to each 100μl of sample, and for reduced 
samples 20μl of betamercaptoethanol (Sigma, UK) was added and the sample boiled 
for 5 minutes. 
 
Glass and aluminium plates, comb, spacers and holders were cleaned with alcohol, 
and the plate holder was sealed with grease and assembled. Water was used to 
check the seal. The resolving gel (see appendix) was poured (10% for VCAM: 90-
110kDa), left to set for 30 minutes and overlaid with methanol to prevent drying. This 
was then removed, the stacking gel (see appendix) poured on, the comb inserted, 
and the gel left for 15 minutes. The gel tank was assembled, running buffer put into 
the plates, and the gel loaded with 15μl of samples. The unit was set to 60 mVolts 
and 60 mAmps and run for 20 minutes, after which the voltage was increase to 
120mV and run for approximately 1 hour until the dye front dropped off the gel. 
Nitrocellulose membrane (low fluorescence PVDF membrane, Amersham 
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Biosciences, UK) was cut and soaked in methanol for 5 minutes. Filter paper was cut 
and soaked in buffer, and stacked with 3 papers, then the membrane and then 3 
further filter papers. The gel was removed from the glass plates, the resolving gel cut 
off, the separating gel peeled off, washed and stacked on the semi-dry unit on the 
filter paper and transferred at 37.8mAmps for 1 hour. Blocking was achieved with 5% 
marvel in TBS (see appendix) at room temperature for 2 hours. Primary antibody 
(murine anti-human VCAM-1, R&D Systems, UK) was diluted1:1000 in 5% 
marvel/TBT-T (see appendix) and incubated at 4°C overnight with agitation. 
 
After washing, the blot was incubated with secondary antibody at 1:5000 (donkey 
anti-goat IgG HRP linked, Santa Cruz Biotecnology Inc, USA) in blocking buffer for 1 
hour at room temperature with agitation. The substrate ECL (E.coli lysate, Pierce, 
USA) was diluted 1:1, incubated for 5 minutes, drained and wrapped in Saran wrap 
(VWR, UK). The membrane and photographic paper were then placed into a cassette 
and left for 5 minutes, developed and fixed. 
 
4.9 RNA Arrays 
RNA arrays were performed by our colleagues in the RNA extraction laboratories. 
 
Microaaray printing was performed by 70-mer oligos consisting of the Human 
Genome Array Ready Oligo Set (AROS) v4.0 were supplied by Operon. These were 
stored in a lyophilized form at -800C. 
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They were then resuspended at a concentration of 40μM in 3xSSC and left to re-
suspend overnight at 40C. The re-suspended oligos were then spotted onto 
UltraGAPS coated slides using a Microgrid TAS II arrayer (BioRobotics) at 70% 
humidity. After spotting the arrays were stabilised and immobilised using a UV cross-
linker and stored in a desiccated chamber at -800C. 
 
For RNA extraction, aliquots of no more than 5 x 106 cells were isolated and 
resuspended in 200µl of buffer (as supplied in the RNEasy Mini kit, Qiagen, UK) and 
RNA extraction performed with the kit. After extraction, RNA was treated to remove 
any contaminating DNA (DNase I kit, Ambion, USA) and the yield quantitated with 
spectrophotometry (Eppendorf Biophotometer) at 260nm wavelength.  
 
Reverse transcription PCR of the RNA was achieved by adding 1-5μg of RNA to 1μl 
oligo(dT)12-18 primer (Invitrogen, UK), and making the mixture up to 17μl with de-
ionised water. After heating to 650C for 10 minutes, and ice cooled, 8μl of 1st strand 
buffer, 4μl 0.1M DTT, 2μl Superscript II 200U/μl (all from Superscript II RNase H 
Reverse Transcriptase kit, Invitrogen), 8μl 10mM dNTPs (made up from 100mM PCR 
Grade dNTP Set, Invitrogen) and 1μl de-ionised water were added. The reaction was 
then kept at 420C for 2 hours. The cDNA synthesized was extracted using Macherey-
Nagel PCR Purification Kit, but the final elution step was performed using 35μl water 
rather than the supplied elution buffer. The eluted cDNA was quantitated by 
spectrophotometry, tested for purity by gel electrophoresis and stored at -200C. 
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Cy3-dCTP and Cy5-dCTP labelling was performed using 500ng of sample cDNA. 
This was added to 20µl random primer mix (Bioprime Labelling Kit, Invitrogen), made 
up to 43µl with deionised water, heated to 940C for 5mins and ice cooled. The 
following were then added: 1.2µl 10mM dATP; 1.2µl dTTP; 1.2µl dGTP; 0.72µl dCTP 
(all made up from 100mM dNTP Set PCR Grade, Invitrogen, UK); 0.68µl water; 1µl of 
either Cy3 dCTP (Amersham Biosciences,UK) or Cy5 dCTP (Amersham 
Biosciences, UK); 1µl 40U/µl Klenow enzyme (Bioprime Labelling Kit, Invitrogen, 
UK). The reaction was then kept at 370C for 8 hours. 
 
The labelled cDNA was purified by means of Macherey-Nagel PCR Purification Kit as 
before and  measured for pmols of labelled product by spectrophotometry 
(Pharmacia Biotech Ultrospec 2100 pro) at 550nm (Cy3-dCTP) or 650nm (Cy5-
dCTP). pmol yield was calculated by the following: Cy3 = Abs550 x 50µl/0.15 and 
Cy5 = Abs 650 x 50µl/0.25.  
 
Array hybridisation was performed. Arrays were initially prepared by a pre-soak using 
Corning Pronto Microarray Hybridisation Kit (Corning, USA) for 20 minutes at 420C, 
followed by three washes in de-ionised water. The slides (UltraGAPS coated slides, 
Corning, USA) were then pre-hybridised (2.5ml 20 x SSC; 0.25ml 20% SDS; 50μl 
100mg/μl Fraction V BSA; made up to 50ml with distilled water) for 2 hours at 420C. 
Labelled cDNA for test and reference samples were taken (equal pmol), added 
together, concentrated with Microcon YM-30 concentration columns (Millipore, USA) 
and eluted in a final volume of 30µl water. 50µl of labelled cDNA mix was then made 
up following the instructions for the UltraGAPS coated slides, using 5µg PolyA DNA 
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and 8µg Cot1 DNA as nucleic acid-blockers and formamide. The 30µl labelled probe 
was added and the mix denatured at 950C for 5 minutes. The pre-hybridised slide 
was dipped in water, and then spun to dry. It was then placed into a corning 
hybridisation chamber (Corning, USA) and the preparation instructions for the 
chamber followed. The probe mix was placed on the slide surface and a Lifter Slip 
(VWR, USA) applied. The hybridisation chamber, wrapped in a damp paper towel 
and foil was heated in a hybridisation oven at 420C for 16-20 hours. 
 
After hybridisation the coverslip was removed by immersing array in 2 x SSC and 
0.1% SDS at 420C. It was washed in the same solution at 420C for 5 minutes, then at 
room temperature for 5 minutes (0.2x SSC), then four times in 0.05 x SSC and finally 
spun dry. The arrays were then scanned using a Perkin Elmer ScanArray Gx and 
ScanArray Express Software.  
 
Microarray analysis was performed. Slide scans were processed first using 
ScanArray Express. A prepared GAL file was used to annotate the slide image and 
the intensity data extracted and exported as a gpr file. The results files were then 
uploaded into the GEPAS analysis software for normalization. First within slide 
normalisation was performed using print-tip normalisation with background 
subtraction. This was then followed by slide scale normalisation between slides. Data 
for the normalised data was then exported to TMEV, allowing us to perform SAM 
analysis, hierarchical clustering, and PCA. 
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5. OPTIMIZATION OF MODELS 
5.1 Early experiments: setting up the systems 
5.1.1 P-selectin titration: adhesion and rolling velocity 
 
5.1.1.1 Adhesion and behaviour 
 
A titration of concentration was performed using concentrations of P-selectin 0, 0.5, 
1, 2 and 5μg/ml. The total numbers of neutrophils captured was between 300 and 
600 cells per mm2 of slide per 106 neutrophils perfused (Figure 10). No neutrophils 
were captured when no P-selectin had been applied to the slide, and increasing 
numbers of neutrophils were captured as the concentration of P-selectin increased 
between 0.5 and 2 μg/ml. Thereafter there was no increase in numbers of cells 
captured when the concentration of P-selectin was increased to 5μg/ml.  
 
The behaviour of the captured cells, as illustrated (Figure 10) which presents the data 
of rolling cells as a percentage, demonstrates that the number of rolling cells fell 
between 0.5μg/ml and 1μg/ml and then levelled off with between 50 and 60% of cells 
rolling when the concentration of P-selectin was between 1 and 5μg/ml. 
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Figure 10: Neutrophil adhesion and behaviour on increasing 
concentrations of P-selectin.  
In the flow model microslides were coated with P-selectin in increasing 
doses. Left hand panel: The numbers of neutrophils captured increased 
between 0.5 and 2.0μg/ml and thereafter did not increase. No 
neutrophils were captured on slides with no P-selectin coating. Right 
hand panel: behaviour of captured neutrophils: The percentage of 
captured neutrophils which roll decreases between 0.5 and 1.0μg/ml of 
P-selectin and thereafter does not change. There is no significant 
variability by ANOVA. The wall shear stress was 0.1Pa. n=10. 
 
An analysis of variance (ANOVA) performed for this data demonstrated that there 
was no significant difference between different concentrations of P-selectin for 
capture or rolling of the neutrophils. There was no significant variability between 
experiments.  
 
In summary, neutrophils are captured on P-selectin. There is an insignificant increase 
in the number of neutrophils captured with increasing concentrations of P-selectin 
and at concentrations of P-selectin between 1 and 5μg/ml about half of these cells 
roll. 
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5.1.1.2  Rolling velocity 
 
In the P-selectin titration, the rolling velocity of moving cells was calculated, and fell 
as the concentration of P-selectin increased (Figure 11). 
 
Figure 11: Rolling velocity of neutrophils on increasing concentrations 
of P-selectin. 
Rolling velocity of captured neutrophils decreased as the concentration 
of P-selectin increased (p=<0.001 by ANOVA). The wall shear stress 
was 0.1Pa. (n=3). 
 
In the analysis of variance for these experiments (n=3) the concentration was highly 
significant in determining the velocity of these cells (p=<0.001). Variation between 
experiments was insignificant. 
 
In contrast to the capture and rolling behaviour of neutrophils overall, the 
concentration of P-selectin is thus important in the speed at which neutrophils roll. In 
subsequent experiments with P-selectin concentrations of 2μg/ml of P-selectin were 
therefore used. 
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 5.1.2 fMLP on P-selectin 
 
fMLP when perfused over rolling neutrophils caused any rolling cells to stop rolling, 
firmly adhere and undergo dramatic shape change. In three experiments the mean 
number of cells rolling before fMLP, were, 38%, 70% and 87% respectively and these 
converted to 0%, 3.85% and 0% after fMLP was added. 
 
5.1.3 HUVEC TNFα titration: Adhesion and behaviour 
 
In the next set of experiments HUVEC were used, grown in monolayers on glass 
microslides. The HUVEC were stimulated with increasing doses of the inflammatory 
cytokine TNFα and the number of neutrophils captured and the behaviour these 
neutrophils exhibited was recorded. TNFα was used in concentrations of 0, 1, 5, 10 
and 100μg/ml in 12 experiments. 
 
The total number of cells and their behaviour was recorded 7 minutes after neutrophil 
inflow. The total number of adherent cells (rolling, stable-adhered and transmigrated) 
increased with the concentration of TNFα (p=0.004). In these experiments there was 
some neutrophil adhesion at 0units of TNFα. This unexpected result may be due to 
the fact that some neutrophils were activated. These were early preparations of 
neutrophils and poor handling may have activated the cells. In later experiments 
there was no significant adhesion of neutrophils if the endothelium had not been 
activated with cytokines, and this is in line with previous published work. Activated 
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neutrophils will bind promiscuously to any albumin exposed by breaks in the 
endothelial monolayer. 
 
The behaviour of these cells was not the same at all concentrations of TNFα (Figure 
12). At very high concentrations of TNFα (100u/ml) there was less rolling, and more 
migration. These differences were significant by ANOVA (rolling cells p=0.034 and 
migrating cells p=0.011).  
Figure 12: Neutrophil capture on HUVEC with increasing 
TNFα concentration. 
Neutrophils were flowed over a monolayer of HUVEC using the flow 
model. Left hand panel: With increasing concentrations of 
TNFα, increasing numbers of neutrophils were captured, this was 
significant by ANOVA (p=0.004). Right hand panel: Behaviour of 
neutrophils with increasing concentrations of TNFα. There is a 
significant increase in migration of neutrophils at high concentrations 
of TNFα (p=0.011). Wall shear stress was 0.1Pa (n=5). 
 
5.2 Patient ANCA 
5.2.1 Specifics of patient ANCA 
 
The specifics of the patient ANCA used in the experiments are as follows (Table 5). 
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Immunoglobulin subclass total IgG (g/L/ (%)) Patient 
sample 
Disease 
Type 
Immunofluorescence MPO 
titre 
(U/ml) 
PR3 
titre 
(U/ml) 
 
IgG1 
 
IgG2 
 
IgG3 
 
IgG4 
220115 MPA pANCA 103 1.9 18.08 
(69%) 
6.91 
(26%) 
0.93 
(3.6%) 
0.06 
(0.7%) 
220084 WG cANCA 4.17 83.7 7.39 
(65%) 
2.62 
(23%) 
0.57 
(5%) 
0.85 
(7%) 
220028 MPA pANCA 140 4.7 10.12 
(68%) 
2.88 
(19%) 
0.71 
(6.2%) 
1.12 
(10%) 
220054 MPA pANCA >100 2.07 5.23 
(37%) 
6.96 
(49%) 
1.34 
(10%) 
0.54 
(4%) 
Normal 
IgG 
    60.3 
(71.5%) 
19.4 
(31.0%) 
5.0 
(8.4%) 
0.7 
(4.2%) 
Table 5:  Properties of patient ANCA used in experiments.  
IgG= immunoglobulin; MPA= microscopic polyangiitis; WG= Wegener’s 
Granulomatosis; cANCA = cytoplasmic anti-neutrophil cytoplasm-
antibody; pANCA perinuclear anti-neutrophil cytoplasm-antibody; U/ml 
= units per millimetre; g/L = grams per litre 
 
5.2.2 Superoxide and patient ANCA 
 
Neutrophils produce superoxide as part of their repertoire of defence against 
pathogens. Normal IgG caused neutrophils to undergo a small amount of superoxide 
production. In the presence of some patient ANCA, superoxide production was 
greater than control but there is variability between patient ANCA. Patients 220028, 
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220054 and 220084 had large superoxide responses which were significant by 
ANOVA (all p=<0.001) (Figure 13). Patient 220115 ANCA did not produce a 
superoxide response that was significantly larger than control. fMLP consistently 
causes neutrophils to undergo a large superoxide response. 
 
 
Figure 13: Superoxide production by neutrophils in the presence of 
normal IgG or patient ANCA.  
Superoxide anion production was determined by the superoxide 
dismutase inhibitable reduction of ferricytochrome c. Neutrophils were 
suspended to 2x106 cells/ml and primed with cytochalasin B (2.5μg/ml) 
for 5 minutes and then TNFα (2ng/ml) for 15 minutes at 37ºC. PMN were 
stimulated with 200μg/ml of IgG. Significant levels of superoxide over 
control were produced by three of the four patient ANCA (p=<0.001 by 
ANOVA). All superoxide production represented over time up to 120 
minutes. (n=5) 
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5.2.3 P-selectin with patient ANCA 
 
Having tested the ability of the selected patient ANCA to cause superoxide 
production by neutrophils, we then proceeded to functional studies using the flow 
model. In the first experiments, a simple model was used, where glass microslides 
were coated with P-selectin and neutrophils flowed across. ANCA or control normal 
IgG was perfused across the neutrophils after 4 minutes of neutrophil inflow. One set 
of neutrophils was left untreated. The total number of neutrophils captured onto the 
P-selectin surface did not differ between treatments (Figure 14). When the behaviour 
of the neutrophils was studied, the neutrophils which had not been exposed to any 
treatment continued to roll (grey line Figure 14 right hand panel). Normal IgG (control 
in black) caused approximately half of the neutrophils to stop rolling by 8 minutes and 
this was compared to the four patient ANCA (220028, 220054, 220115, 220084) by 
two way ANOVA. There was a significant difference between normal IgG and patient 
220084 (p=0.004), patient 220115 and patient 220028 (p=<0.001 in both) where the 
ANCA stopped cells rolling more than normal IgG. There was no significant 
difference in comparing patient 220054 with normal IgG. 
 
In analysing of all the data together (n=3) there is a significant effect of time 
(p=<0.001) and between antibodies (p=<0.001), but there is no significant variability 
between experiments.  
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Figure 14: Influence of patient ANCA on neutrophils on P-selectin at 
2μg/ml.  
In the flow model, four different patient ANCA at 200μg/ml, were 
compared against control IgG at 200μg/ml and no IgG. In the left hand 
panel there is no significant difference in the total number of 
neutrophils captured between the treatments. In the right hand panel, 
behaviour of the captured neutrophils is shown as a percentage of 
adhered cells that are rolling. With no treatment, neutrophils continue 
to roll. When treated with normal IgG half the neutrophils stop rolling. 
When treated with patient ANCA, significantly more neutrophils stop 
rolling than with control normal IgG (patient 220084 p=0.004; 220028 
and 220115 both p=<0.001). One patient ANCA, 220054 did not stop 
neutrophils more than control. Wall shear stress 0.1Pa (n=3). 
 
5.2.4 HUVEC with patient ANCA 
 
In the next set of experiments we used ECs which enable the study of more complex 
interactions. Rather than just selectins being presented to the neutrophil, other 
molecules now influence the interactions such as integrin/ICAM-1, chemokine and 
cytokine receptors. For these flow experiments data was collected at 2 minute time 
points over 15 minutes. All of this data was used in ANOVA analysis but for clarity the 
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graphs presented here are of the final time point (15 minutes after the inflow of 
neutrophils. 
 
Experiments on HUVEC with patient ANCA were performed on HUVEC treated with 
high levels of TNFα (100units/ml) and low levels (2units/ml).  
 
5.2.4.1 Patient ANCA on HUVEC treated with TNFα 100 units: Adhesion and 
behaviour 
 
In initial experiments using highly activated endothelium, there was no significant 
difference in the total numbers of neutrophils captured when treated with no antibody, 
normal IgG or any of the four patient ANCA (Figure 15). Additionally, there was no 
significant difference in the number of neutrophils captured over time. 
 
The behaviour of the neutrophils changed dependent on the antibody they were 
exposed to (Figure 15). The data is presented for behaviour (i.e. rolling, stationary 
adhered, migrated) as percentages of total neutrophils captured. No antibody or 
normal IgG causes approximately half of the adherent cells to roll, 25% to adhere 
firmly and a small proportion to migrate across the endothelial layer, which increases 
over time. 
 
In these experiments, in contrast to the P-selectin experiments above, neutrophils 
were pre-treated with ANCA and therefore the effects can be seen immediately. The 
treatments were significantly different from each other when analysed together 
(p=<0.001).  
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 When the patients ANCA were compared against normal antibody, ANCA isolated 
from patient 220054 and 220084 were similar to the controls. ANCA from patients 
220028 and 220115 caused more cells to stop rolling when compared to normal IgG 
(220028 p=<0.001; 220115 p=0.024). Migration was not significantly different 
between any of the treatments.  
Figure 15: Neutrophil adhesion and behaviour on HUVEC treated with 
100units/ml TNFα.  
In the flow model there was no significant difference in the number of 
neutrophils captured from flow between each treatment.  Behaviour of 
neutrophils varied between treatments. The proportion of rolling cells 
(blue) static cells (red) and migrated cells (yellow) are shown. With no 
treatment or normal IgG approximately half the cells roll. Exposure to 
patient ANCA 220115 (p=0.028) or 220028 (p=<0.001) resulted in a 
significant decrease in the proportion of neutrophils rolling. Wall shear 
stress 0.1Pa (n=3). 
 
5.2.4.2 Patient ANCA on HUVEC treated with TNFα 2units: Adhesion and behaviour 
 
When EC were treated with low levels of TNFα, in contrast to the situation on highly 
activated endothelium, there was a variation in the number of neutrophils captured 
depending on treatment (Figure 16). When neutrophils were untreated low numbers 
of neutrophils were captured (50-150), normal IgG captured about 250 neutrophils. 
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Two of the patient ANCA captured between 300 and 500 neutrophils, significantly 
higher than normal IgG control (patient 220115, p= <0.001; patient 220084, p= 
0.042), two patient ANCA did not capture neutrophils more than controls (220054, 
220028). 
 
The behaviour of neutrophils captured differed between the control normal IgG and 
patient ANCA for all four patients (Figure 16). HUVEC treated with TNFα 2u/ml 
supported rolling of neutrophils. Addition of normal IgG or patient ANCA converted 
rolling to static adhesion. Additionally ANCA IgG compared to normal IgG caused 
changes in behaviour, namely less rolling (patient 220115, 220028 and 220084 
p=<0.001; 220054, p=0.001) and more migration in all four patient samples (220115, 
p=0.035; 220028, p=0.017; 220084, p=0.012; 220054, p=0.049). 
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Figure 16: Neutrophil adhesion and behaviour on HUVEC treated with 
2units/ml of TNFα.  
In the flow model when pre-treated with no antibody, normal IgG or four 
different patient ANCA (all at 200μg/ml), neutrophils exposed to two 
patients’ ANCA adhered more to the endothelium than those exposed 
to normal IgG (220115 p= <0.001; 220084 p= 0.042). Two patient ANCA 
(220054; 220028) behaved similarly to control. Behaviour of neutrophils 
varied between treatments. The proportion of rolling cells (blue) static 
cells (red) and migrated cells (yellow) are shown. Exposure to patient 
ANCA causes less rolling (patient 220115, 220028 and 220084 p=<0.001; 
220054 p=0.001) and more migration (220115 p=0.035; 220028 p=0.017; 
220084 p=0.012; 220054 p=0.049) than exposure to normal IgG. Wall 
shear stress 0.1Pa (n=5). 
 
5.3 Testing controls to explore why they activate 
 
We had considerable problems with early flow experiments as our control sera 
activated neutrophils and although differences between the ANCA activated 
neutrophils and controls were established the differences were not as great as 
expected. Normal IgG was not known to activate neutrophils and in previous flow 
experiments this had not been a problem (Radford, Savage et al. 2000). The problem 
was particularly marked when we began experiments using chimeric PR3-ANCA of 
the IgG3 subclass. We therefore undertook experiments to investigate this problem. 
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5.3.1 Testing controls for endotoxin 
 
Samples of immunoglobulin were tested for the presence of endotoxin by ELISA and 
found to have endotoxin present. This was removed using endotoxin removal beads. 
The samples with and without endotoxin were then run in the flow model.  
 
Endotoxin altered the behavior of neutrophils (Figure 17). This is seen in alteration of 
rolling and static behaviours, but is only seen when the system is partially stimulated. 
Thus the endotoxin presence makes a significant difference to the behavior of 
neutrophils treated with normal IgG. Normal IgG does not have a great effect on 
neutrophils, most remain rolling. However when the normal IgG had endotoxin in it 
there was a conversion to static adhesion (p=<0.001) with less rolling (p=<0.001). 
Migration was not significantly altered. Furthermore, if endotoxin was added to the 
already contaminated normal IgG, the effect was even more marked with significant 
increases in static neutrophils (p=<0.001) and decreases in those rolling (p=0.001). 
 
If the system is already highly stimulated (e.g. with ANCA) the effect on the 
neutrophils is much less marked due to the fact that they are already mostly static 
without the additional stimulus of endotoxin. The only significant difference in 
behaviour in this experiment was when further endotoxin was added to already 
contaminated ANCA which significantly decreased the rolling behavior (p=0.041). 
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 Figure 17: Effect of endotoxin in flow.  
Normal IgG or ANCA was prepared and endotoxin was detected in both 
samples. Neutrophils were treated with either the original samples of 
normal IgG or ANCA, or samples where the endotoxin had been 
removed, or samples where endotoxin had been added. Neutrophils 
were flowed over HUVEC and data taken at 2 minute intervals. Data 
shown at 15 minutes as percentage of total adhered cells rolling (blue); 
static (red) and migrated (yellow). There were significant differences in 
behaviour after each treatment but this is more noticeable in the normal 
IgG samples. ET= endotoxin. n=1 
 
5.4 Discussion 
 
5.4.1 P-selectin titration: adhesion and rolling velocity 
 
Neutrophils were captured on P-selectin and between a concentration of 1μg/ml and 
5μg/ml there was no significant change in the numbers of cells captured or the 
behaviour, that is the proportion of the neutrophils rolling as opposed to stationary. 
The velocity of the neutrophils that were rolling decreased as the concentration of the 
P-selectin increased. For further experiments 2μg/ml of P-selectin was used as at 
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this concentration the neutrophils adhered adequately and rolled at a speed which 
allowed for sensitivity in treatments 
 
5.4.2 fMLP on P-selectin 
 
fMLP is a powerful stimulant which stopped neutrophils rolling on P-selectin and 
caused firm adherence. This was accompanied by a change in shape of the cells. 
The addition of fMLP caused consistent reduction in rolling. This has been observed 
previously (Rainger, Rowley et al. 1998). 
 
5.4.3 HUVEC TNFα titration 
 
When HUVEC were treated with increasing concentrations of TNFα total binding 
increased. At high doses (100units/ml) of TNFα there was increased neutrophil 
migration across the endothelial monolayer. This is consistent with previous results in 
our laboratory. In further experiments using HUVEC, highly activated endothelium 
was represented by 100units/ml of TNFα, and minimally activated endothelium by 
2units/ml of TNFα.  
 
5.4.4 Patient ANCA 
 
Four patient ANCA were studied in these experiments; three of them specific for 
MPO and one for PR3. Clinical presentation of the patients were similar, all had 
severe disease and renal failure requiring immunosuppression and plasma 
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exchange. ANCA was obtained for these experiments from plasma exchange fluid by 
isolating the whole IgG fraction. The same concentration of IgG was used in each 
experiment, but the proportion of the IgG which is ANCA was unknown. This may 
explain some of the differences in how active the ANCA were in the various 
experiments, although it is interesting that all the patient ANCA were more active 
than control in at least one of the assays (Table 6). The proportion of total IgG which 
is actually ANCA is small; probably less than 10μg/ml, but this is likely to vary from 
patient to patient. It is difficult to quantify the amount of ANCA in patient serum. 
Immunofluorescence is subjective, and by ELISA quantification may not be accurate 
or comparable between patients, if there is variation in affinity of ANCA for the 
antigen both within, as well as between, patients. 
 
 220115 220084 220028 220054 
Superoxide - + + + 
P-selectin adhesion assay: behaviour ++ + ++ - 
HUVEC adhesion assay: behaviour 
(100units/ml TNFα) 
+ - + - 
HUVEC adhesion assay: behaviour 
(2units/ml TNFα) 
+ + + + 
 
Table 6: Summary of patient ANCA activity.  
In the assays tested the different patient ANCA influenced neutrophil 
behaviour differently, with all ANCA activating neutrophils in at least 
one assay. 
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5.4.5 Superoxide with patient ANCA 
 
Superoxide is produced by neutrophils in the respiratory burst and requires the 
neutrophils to be primed prior to a second stimulus. Patient ANCA provides a 
secondary stimulus for superoxide production and is variable between different 
patient samples, but is generally higher than the superoxide response elicited by 
normal IgG. Of the four patient ANCA tested, three caused more superoxide 
production than control IgG. This variation in response may be due to varying 
pathogenicity of patient ANCA, perhaps dependent on subclass or epitope specificity 
or on actual concentration of ANCA. 
 
Superoxide experiments were performed with neutrophils in the absence of IgG 
Figure 13) and did not elicit a superoxide response. Control IgG from ‘normal’ donors 
does elicit a minimal superoxide response, this has been noticed in previous work in 
our laboratory, and reasons why this may occur is discussed further in section 5.4.6. 
 
5.4.6 P-selectin studies with patient ANCA 
 
Neutrophils rolled on P-selectin as established in the P-selectin titration, and 2μg/ml 
was chosen as a concentration where the cells were rolling at a suitable velocity. 
When normal IgG control was perfused over the neutrophils, a proportion stopped 
rolling when compared to experiments where no antibody was used. This non-
specific response has been noted previously, but is unexplained, as with IgG isolated 
from normal people as opposed to those with vasculitic disease, one would not 
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expect neutrophil activation. Although all IgG preparations were assiduously 
microfuged to precipitate immune complexes, low levels of immune complex 
formation cannot be excluded which could activate the neutrophils. It is likely in these 
early experiments that the reason for this activation was contamination by 
lipopolysaccharide (LPS), as this was found to be a problem with later controls (see 
5.3.1). This was not however explored in the early experiments. 
.  
Three of the patient ANCA stopped the cells from rolling more than the control IgG 
and this reached significance and one patient ANCA did not significantly reduce 
rolling. This variation in response of neutrophils to different ANCA in the flow model 
has been previously noted, and currently remains unexplained; these differences in 
response are discussed below and are currently being pursued by other workers in 
our group. 
 
Of the ANCA that did have an effect on the neutrophils, two ANCA were very 
dramatic and reduced rolling quickly with a sustained effect at 8 min. Patient 220084 
seemed not to be as potent or as rapid at causing an effect despite very destructive 
clinical disease. 
 
5.4.7 HUVEC studies with patient ANCA 
 
When patient ANCA was studied on highly activated HUVEC there was no difference 
in the numbers of cells captured on the endothelium when comparing normal IgG 
with patient ANCA. In contrast to P-selectin, the neutrophils were pre-treated with 
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ANCA so that changes over time were not seen, and the neutrophils were affected by 
the treatment throughout the course of the experiment (data over time not shown). 
The reason for this decision was historic: although ideally experiments would be 
performed adding the ANCA into the system as in the P-selectin model so that 
changes could be seen during the experiment, this had not worked well in previous 
studies with HUVEC in the flow model (Radford, Luu et al. 2001). Greater changes in 
neutrophil behaviour were seen when ANCA was added to the neutrophils before the 
experiment: this method was therefore used in these experiments. 
 
When the endothelium was treated with 100units of TNFα, two of the patient ANCA 
(220115 and 220028) stopped the cells rolling more than the control, and these 
reached significance. Migration was not affected. 
 
HUVEC that has been pre-treated with 100units of TNFα is highly activated and is 
probably already capturing and activating neutrophils to a maximum amount, so 
against this background, it may be hard to see any additional effects of a moderate 
activating influence such as with ANCA. These studies were therefore repeated using 
minimally activated endothelium. 
 
In studies where the HUVEC were treated with TNFα at 2u/ml greater differences 
were seen between patient ANCA and normal IgG. The neutrophils rolled less and 
migrated more in the presence of ANCA. Of note the difference between untreated 
neutrophils, which roll on a minimally activated endothelium, and those treated with 
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normal IgG, was more obvious, and normal IgG can be seen to influence the 
neutrophils causing more to statically adhere, but not to migrate. 
 
It can be seen therefore that patient ANCA is able to alter the behaviour of 
neutrophils on P-selectin and on HUVEC and that there is a variation in the degree of 
affect. Although pooling all the patient data was discussed, there is an obvious 
variation between different patient ANCA, and thus repeats were done for each 
patient.  
 
5.4.8 Patient ANCA subclasses 
 
The relative proportions of each subclass within these ANCA varied greatly. Patient 
220115 was the only ANCA where the proportions of IgG were similar to those of 
normal IgG. Patients 220084 and 220028 had increased proportions of IgG4. It is 
thought that in chronic disease because of the process of somatic isotype switching 
(see 2.2.2), IgG4 can accumulate. Although all these ANCA were isolated from 
patients who were presenting for the first time and who had active disease, it is well 
know that patients may have long standing chronic, low level disease prior to 
presentation. Patient ANCA 220054 is the most unusual as it has a reduced 
proportion of IgG1 and increased proportions of IgG2 and 3 compared to normal IgG.  
 
In the superoxide experiments the patients 220028 and 220054 who have significant 
superoxide responses also have higher proportions of IgG3. The respiratory burst 
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has been reported to be increased in patients with higher proportions of IgG3, as 
discussed above. 
 
In the flow experiments, patient 220084 and 220028 caused neutrophil adhesion in 
both highly and minimally activated systems, but all four ANCA stopped neutrophils 
more than control in the minimally activated system. It is interesting that patient 
220054 has a higher proportion of IgG2 which is thought to have very little 
pathogenic activity. 
 
Comparison of the actions of patient ANCA due to the proportions of different 
subclasses is obviously limited with small patient numbers and these experiments 
were not designed to fully explore these differences. Important to note is the fact that 
the concentrations of the ANCA are not the same so it is difficult to speculate as to 
whether the differences seen are a subclass effect or simply due to the concentration 
of total ANCA. 
 
5.4.9 Summary of studies with patient ANCA 
 
Patient ANCA is polyclonal and thus directed against multiple different epitopes on 
the PR3 and MPO molecules. ANCA directed against certain epitopes may be more 
potent than other epitopes. In addition, IgG ANCA is known to vary in subclass 
fraction, which may influence its pathogenesis. It is difficult to conclude very much 
from a sample of just four patient ANCA but it is interesting to note that the ANCA 
which had the least effect in the flow model had a different subclass profile to the 
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other three ANCA with a greater proportion of IgG2. Again this is total IgG however 
and may not reflect the relative proportions of each subclass of ANCA. The cause of 
the functional variability between ANCA preparations from different patients is the 
subject of ongoing studies in the laboratory and appears to be dependent on the 
neutrophil donor as well as on the ANCA. 
 
These points are addressed in part by the use of standardised ANCA, which are of 
known subclass, are monoclonal, directed against a single epitope and can be used 
in exact concentrations, and to address this chimeric PR3-ANCA had been 
developed by workers in our laboratory. 
 
After these experiments had been performed to set up systems and explore previous 
work in this area, studies were undertaken using chimeric PR3-ANCA. In the flow 
studies a minimally activated endothelium (TNFα 2units/ml) was used as this had 
been found to be the most useful method of studying differences between ANCA in 
these initial experiments.  
 
5.4.10 Endotoxin effects on neutrophils in flow 
 
In order for lipopolysacchride (LPS) to activate immunologically active cells, it is 
bound to CD14 on monocytes and macrophages, which then become responsive. 
CD14 can be shed by macrophages and taken up by other cells, such as neutrophils, 
which can then confer LPS responsiveness to them. Conceivably this process could 
take place during the neutrophil preparation so that the neutrophils become 
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responsive to LPS without the need for serum in the system to supply CD14 (Chaby 
2004). In addition, it has been reported that L selectin (CD62L) on neutrophils can 
bind LPS and trigger signalling (Malhotra and Bird 1997).  
 
Endotoxin removal or addition had a significant effect on the behaviour of the 
neutrophils in the flow model, especially concerning the normal IgG control, where 
the presence of endotoxin reduced rolling and increased static adhesion. This affect 
was not so marked when the system was highly stimulated, such as in the presence 
of ANCA and may explain why there was considerable difficulty with controls in some 
experiments. 
 
The effect of endotoxin was important in systems which were not already fully 
stimulated. Therefore when studying the various effects of cytokines on EC, systems 
which are stimulated with high concentrations of TNFα or IL-1β were already fully 
stimulated and caused neutrophils to stop rolling whether or not endotoxin is present. 
Endotoxin therefore became much more important in systems with low 
concentrations of cytokines stimulating EC, and masked subtle differences in 
behaviour on these cells. Once this was established, for further experiments in flow 
using normal IgG or ANCA, endotoxin was routinely removed. 
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6. INTERACTIONS OF IMMUNOGLOBULIN AND NEUTROPHILS: 
NORMAL IGG VERSUS ANCA AND THE EFFECT OF IGG 
SUBTYPE 
 
Having established systems and models for the study of neutrophils and their 
interactions with ECs we wished to proceed to answer the question ‘How is the 
interaction of neutrophils with normal IgG in a conventional situation different from the 
interaction of neutrophils with ANCA?’ Conventionally, neutrophils bind to 
immunoglobulin via their Fc receptors (FcR). Neutrophils have three activatory Fc 
receptors; two constitutive, CD32 and CD16 and one inducible CD64. CD64 is the 
only receptor that can bind to soluable IgG. ANCA are predominantly IgG and are 
found in all four human IgG subclasses. Several papers have discussed the 
importance of IgG subclass in vasculitis. IgG3 has been proposed to be more 
pathogenic than the other subclasses in AAV (Mulder, Stegeman et al. 1995), to fall 
in remission (Jayne, Weetman et al. 1991) or to predominate in renal limited AAV 
(Brouwer, Tervaert et al. 1991) and IgG3 has been reported to be predominant in 
PR3-ANCA patients (Segelmark and Wieslander 1993; Harper, Radford et al. 2001). 
However these findings are contradicted by other studies where IgG1 and IgG4 were 
dominant in patients with cANCA (largely PR3-ANCA) (Mellbye, Mollnes et al. 1994) 
or overall in AAV (Brouwer, Tervaert et al. 1991; Harper, Radford et al. 2001). In 
consequence it is not clear from the published studies which subclasses of ANCA 
predominate or which are the most pathogenic. Clinical studies, although informative, 
are not functional or mechanistic and since no clear picture emerged from these 
studies regarding pathogenicity based on ANCA subclass, we wished explore these 
questions in the laboratory. 
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 Binding of IgG to FcR allows downstream signalling and activation of the neutrophil. 
Opsonisation of antigen with IgG allows recognition, binding and phagocytosis by 
neutrophils. FcR require cross-linking of more than one receptor to induce neutrophil 
activation (Ben-Smith, Dove et al. 2001). ANCA, in contrast to normal IgG can bind to 
neutrophils via the Fab portion of the antibody to either PR3 or MPO. We have 
previously postulated that simultaneous binding via the Fc receptor may cross link 
these receptors resulting in abnormal downstream signalling pathways and activation 
of the neutrophil, evidence for this has previously been published from our laboratory 
(Williams, Ben-Smith et al. 2003). 
 
During formation of antibodies, subclass is generated by gene splicing. Somatic 
isotype subclass switching occurs in peripheral B cells where a cell can change 
production from IgG3 to 1, then to 2, then to 4 by sequentially splicing out more of the 
gene (Zeijlemaker 1996).This process is unidirectional and therefore continuing 
exposure to antigen may result in the accumulation of IgG4. It is not completely clear 
how this process is influenced but isotype switching to IgG4 has been shown to be 
dependent on interleukin-4 (Spiegelberg 1989). There is some evidence to support 
the accumulation of IgG4 in AAV (Cambridge, Williams et al. 1994). If IgG4 was less 
pathogenic over time the disease might reduce in severity. In anti-glomerular 
basement membrane (GBM) disease recurrence of IgG4 anti-GBM antibody after 
treatment and remission did not cause disease relapse, but IgG1 recurrence did 
(Bowman, Ambrus et al. 1987). Although anecdotally in AAV, patients do remain in 
sustained remission after years of active disease, this is not a consistent disease 
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pattern, and relapses are common. Presumably factors that are triggering relapse, 
such as infection, may cause new antibody production, perhaps against new antigen 
epitopes. 
 
One proposed aspect of the pathology of AAV is that ANCA activates neutrophils and 
causes adherence to vessel walls, damaging the vessel. In order for neutrophils to be 
captured onto an EC surface, the neutrophil is engaged via selectin molecules 
enabling rolling on the EC. Provided an activating stimulus, such as ANCA, is passed 
to the neutrophils, stable, static adhesion is mediated through neutrophil integrins 
(CD18/CD11a and CD18/CD11b) binding to endothelial intracellular adhesion 
molecule-1 (ICAM-1) (Dustin, Rothlein et al. 1986). Transendothelial migration can 
then take place via a series of molecules such as junctional adhesion molecules 
(JAM) (Woodfin, Reichel et al. 2007). 
 
Our hypothesis based on the above was that ANCA IgG subclasses have different 
potencies and subsequently different pathogenic effects; moreover that these may be 
activated through different Fc receptors. Therefore we used purified IgG subclasses 
in a flow model to establish the interaction of the neutrophil with normal IgG and 
subsequently looked at the interactions of the neutrophil with ANCA on P-selectin 
and EC surfaces. 
 
Previous studies have used immobilised IgG to capture neutrophils, and explored the 
roles of Fc receptors and integrins, but they did not look at the effects of IgG subclass 
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(D'Arrigo, Candal-Couto et al. 1995; Sheikh and Nash 1996; Coxon, Cullere et al. 
2001). 
 
6.1 Studies of normal IgG interacting with neutrophils 
In order to look at normal IgG and neutrophil interaction we set up studies in flow 
where microslides were coated with pure human IgG of subclasses 1-4 and 
neutrophils flowed across. These experiments explored neutrophils binding to IgG 
under conditions of flow, where capture is likely to involve neutrophil FcR interacting 
with IgG Fc presented on a solid-phase support. 
 
6.1.1 Concentration gradient of IgG1 
 
In the first experiments we explored the concentration of IgG needed to cover the 
surface to allow adequate neutrophil capture after 5 minutes of neutrophil inflow. 
Using concentrations of 50, 100, 200 and 400μg/ml, neutrophil binding increased 
(Figure 18 left hand panel). Great variability was noted between donors, but this was 
not further explored. In the three initial experiments, binding onto the IgG1 surface 
was relatively low, but it was decided that 100μg/ml would be adequate to capture 
enough neutrophils for study and this concentration was therefore used for all further 
coating experiments. Neutrophil behaviour was similar at all concentrations (Figure 
18 right hand panel).  
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Figure 18: Concentration curve of IgG1 neutrophil capture and 
behaviour.  
Using the flow model, neutrophils were flowed over different 
concentrations of coated IgG1. Left hand panel: capture increased 
slightly between 50-200μg/ml and was greater on 400μg/ml. Numbers of 
neutrophils captured was low. Right hand panel: Neutrophil behaviour 
was similar at each concentration, most of the neutrophils spread on 
the IgG1 surface. Wall shear stress 0.05kPa. n=3. 
 
In these experiments as with others in this thesis great variability was noted between 
neutrophil donors in terms of neutrophil behaviour in the flow model. Some donors 
were more ‘sticky’ to surfaces than others, and the experiments were fairly consistent 
within donors. For this reason, experiments were repeated using at least three 
different donors, and this accounts for the variation in numbers between experiments, 
where three ‘sticky’ donors were used for one experiment and three ‘non-sticky’ for 
another. Within sets of experiments, e.g. testing each subclass, the same donor was 
used for each subclass, and at least three donors were used. The phenomenon of 
donor variation which was noted during this thesis was not further explored here, but 
subsequently ongoing work has begun in our laboratory to explore this phenomenon 
which may clearly have disease implications. 
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6.1.2 Comparison of IgG subclasses 1-4 
 
Using concentrations of 100μg/ml for all antibody coating, the four subclasses were 
then compared. Neutrophils bound avidly to IgG3, less to IgG1 and minimally to IgG2 
and IgG4 (Figure 19). The number of neutrophils captured onto these surfaces was 
increased over the initial experiments because there was variability between donors 
with some donor neutrophils being more ‘sticky’ than others.  
 
The numbers of neutrophils captured onto these surfaces were significantly different 
from each other (IgG1 versus IgG2 p=0.004; IgG1 versus IgG3 p=<0.001; IgG1 
versus IgG4 p=0.032; IgG2 versus IgG3 p=<0.001; IgG3 versus IgG4 p=<0.001) 
except IgG2 and IgG4. Once captured onto the immunoglobulin surface the 
neutrophils behaved similarly, changing from bright spheres to a phase-dark spread 
morphology with extended pseudopodia stretching across the surface (Figure 20). 
Movement appeared to be random on the surface which was uniformly covered with 
IgG. There was no difference in the behavioural pattern exhibited by the neutrophils 
on the different IgG subclass surfaces with most neutrophils spreading on the surface 
(Figure 19 right hand panel). 
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 Figure 19 Binding of neutrophils to IgG surfaces of subclasses IgG1-4.  
Using the flow model, neutrophils were flowed over IgG surfaces; the 
number of neutrophils captured and their behaviour, whether round or 
spread observed. Left hand panel: IgG3 avidly captures neutrophils, 
IgG1 captures to a lesser extent (IgG3 versus IgG1 p=<0.001) and IgG2 
and 4 capture only minimally. Right hand panel: Behaviour is similar in 
the four subclasses. Most of the neutrophils spread. Wall shear stress = 
0.05Pa; n=3. 
 
 
 
Figure 20: Behaviour of neutrophils on an IgG surface.  
In the left hand panel neutrophils are adhered but round and unspread. 
In the right hand panel neutrophils have spread out and appear dark 
with extended psuedophilia. 
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6.1.3 Blockade of CD32 and CD16 on neutrophils on normal IgG 
 
To establish which Fc receptors were important for the interaction of the various 
subclasses with neutrophils, blockade of the two constitutively expressed Fc 
receptors on the neutrophil surface was undertaken. Neutrophil behaviour was 
studied after adding antibodies to block CD32 and CD16 (Figure 21). On coated IgG3 
both antibodies reduced neutrophil binding significantly compared to control antibody 
(CD32 p=<0.001; CD16 p=<0.001), but anti-CD16 was more effective than anti-
CD32. On coated IgG1 and IgG2, the antibodies again inhibited adhesion, but now 
anti-CD32 was more effective than anti-CD16. Only blockade of CD32 reached 
significance (IgG1 p=0.039; IgG2 p=0.018). IgG4 supported such minimal capture 
that no effect of antibodies could be reliably observed. On IgG3, since there was 
residual capture after blockade of either receptor, both receptors were blocked 
together and this completely abrogated neutrophil capture (95%+/-3%; data not 
shown). Blockade of Fc receptors also changed the behaviour of the neutrophils 
once captured. Much less spreading was seen, especially with blockade of CD32 
(Figure 22), with 70 -100% of adherent neutrophils remaining spherical. 
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 Figure 21 Neutrophil adhesion on IgG surfaces 1-4 after blockade of 
CD32 and CD16. 
Using the flow model, neutrophils were flowed across the IgG surface 
after blockade of CD32 or CD16. Either blocking antibody reduced 
neutrophil spreading on the surface, but CD32 was more important in 
IgG1 (p=0.039 compared to control) and 2 (p=0.018 compared to 
control) and CD16 more important in IgG3 (p=<0.001 compared to 
control). There was no significant difference on IgG4 as binding was 
very minimal prior to blocking. Wall shear stress =0.05Pa; n=3. 
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Figure 22: Neutrophil behaviour on IgG surfaces after FcR blockade.  
Using the flow model neutrophil behaviour after blockade of CD32 and 
CD16 was observed. With no FcR blockade most of the neutrophils 
spread (red bars first panel). Blockade of CD32 results in most of the 
neutrophils remaining unspread (blue bars, second panel). Blockade of 
CD16 results in a reduction in spreading compared to no block, but it is 
not as dramatic as CD32 (third panel). Behaviour was similar in all 
experiments across the subclasses. Wall shear stress 0.05kPa. n=3. 
 
6.1.4 Blockade of CD18 and treatment with BAPTA-AM 
 
To explore the role of the integrin CD18 on the coated IgG3 surface, the neutrophils 
were treated with anti-CD18 (Figure 23). This did not reduce neutrophil binding to the 
IgG3 but it did change neutrophil spreading (p=<0.001). Thus, integrin molecules 
were not involved in capture but were important in subsequent behaviour of the 
‘activated’ cells. 
 
Finally in this set of experiments we wished to see if the binding of neutrophils to 
coated IgG via Fc receptors was a purely mechanical process or whether signalling 
of the neutrophil was important in binding. We therefore inhibited calcium signalling of 
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the neutrophil using BAPTA-AM which chelates intracellular calcium. This reduced 
the ability of the neutrophil to bind to the surface (p=<0.001) (Figure 23 left hand 
panel) and in addition reduced the ability of bound neutrophils to spread (p=0.001) 
(Figure 23 right hand panel). Thus, while FcR-IgG interaction directly captured 
flowing neutrophils, it also transduced a signal which stabilised adhesion through β2-
integrins. 
 
Figure 23: Blockade of CD18 and neutrophil calcium signalling 
inactivation. 
 
Neutrophil adhesion and behaviour on IgG3 coated surface after 
blockade of CD18 and inactivation of neutrophil calcium signalling with 
BAPTA-AM. Left hand panel: Blockade of CD18 did not reduce binding; 
calcium signalling inactivation of the neutrophil by BAPTA-AM reduced 
neutrophil binding (p=<0.001 compared to control). Right hand panel: 
Blocking CD18 reduced the number of neutrophils which spread 
(p=0.001 compared to control). Use of BAPTA-AM reduced neutrophil 
spreading (p=<0.001). Wall shear stress = 0.05Pa; n=3. 
 
6.2 Chimeric PR3-ANCA  
In previous studies and in preliminary work for this thesis, it has been demonstrated 
that IgG isolated from patients with AAV can activate neutrophils causing a 
superoxide response, and can increase adhesion and migration of neutrophils on 
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ECs in flow. Human ANCA is difficult to isolate in a pure form and use of the IgG 
fraction containing ANCA means that the quantity of ANCA is unknown. Human 
ANCA is directed against many epitopes on the PR3 molecule, but 50% of human 
ANCA is directed against an epitope recognised by the mouse antibody 4A5.  
Workers in our laboratory previously developed a chimeric mouse/human anti-PR3 
ANCA directed against this epitope in order that we could study the interactions of 
ANCA and neutrophils with a known concentration of ANCA and of known subclass. 
IgG1, 3 and 4 were developed. 
 
6.3 Superoxide and IgG1, 3 and 4 chimeric PR3-ANCA 
We firstly established that superoxide was produced by neutrophils in the presence of 
the chimeric ANCA. We compared superoxide responses produced by neutrophils in 
the presence of chimeric PR3-ANCA to those in the presence of chimeric NP control.  
We expected that IgG1 and IgG3 PR3 ANCA would activate the neutrophil to 
produce superoxide (both p=<0.001 by ANOVA compared to control), but we 
additionally found that IgG4 elicited a superoxide response (p=0.012) (Figure 24).  
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 Figure 24: Superoxide production by neutrophils exposed to chimeric 
PR3-ANCA.  
Superoxide anion production was determined by the superoxide 
dismutase inhibitable reduction of ferricytochrome c. Neutrophils were 
suspended to 2x106 cells/ml and primed with cytochalasin B (2.5μg/ml) 
for 5 minutes and then TNFα (2ng/ml) for 15 minutes at 37ºC. 
Neutrophils were stimulated with 60μg/ml of IgG1 and 4 and 48μg/ml of 
IgG3. Significant levels of superoxide over control IgG NP were 
produced by the three chimeric PR3-ANCA (p=<0.001 for IgG1 and 3; 
p=0.012 for IgG4 by ANOVA). All superoxide production represented 
over time up to 120 minutes. (n=4) 
 
Superoxide experiments which had been performed with patient ANCA (section 
5.4.5) had included negative controls where no IgG was used to stimulate the 
neutrophil and no superoxide response was seen here. In experiments where IgG 
control was used a small amount of superoxide is elicited, and the reasons for this 
are discussed previously (section 5.4.6). 
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6.4 Effect of fluid phase chimeric PR3-ANCA IgG on neutrophils 
rolling on P-selectin  
Using the flow model with P-selectin coated microslides we explored the effects of 
ANCA IgG of different subclasses on neutrophils already rolling on P-selectin in 
microslides. 
 
Typically, activation of such rolling neutrophils causes them to become stably 
adherent and migrate on the surface (e.g., Sheikh and Nash, 1996; Rainger et al., 
1997).  Here, soluble ANCA IgG is believed to bind to target PR3 antigen and then 
cross-link to FcR to transduce an intra-cellular signal [12]. 
 
For the total neutrophils captured, when all three PR3-ANCA (IgG1, 3 and 4) were 
compared together there was no statistical difference between the total number of 
neutrophils captured and this was also true for each PR3-ANCA individually 
compared to each other (Figure 25). 
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 Figure 25: Neutrophils captured onto a P-selectin surface after 
exposure to chimeric anti-PR3 ANCA. 
Using the flow model neutrophil adhesion to a P-selectin surface 
(2μg/ml) did not significantly vary after exposure to chimeric anti-PR3 
ANCA or control anti-NP, nor did it vary over time. Wall shear stress = 
0.1Pa; n=3 
 
Behaviour of the neutrophils on the P-selectin surface did however vary with antibody 
exposure. IgG1 NP control was compared with chimeric IgG1 PR3-ANCA (n=3). 
Under the influence of IgG1 PR3-ANCA neutrophils adhered to the P-selectin 
surface, and by 4 minutes less than 5% of the neutrophils were rolling. When treated 
with control NP the neutrophils continued to roll (Figure 26). By ANOVA there was 
significance in variation over time (p=0.035) and the differences between the 
treatments were highly significant (p=<0.001). The variations between experiments 
did not reach significance. 
 
The comparison of  IgG3 control NP versus PR3-ANCA (n=3) also demonstrated that 
by 4 minutes the number of rolling cells after exposure to PR3-ANCA had fallen to 
less than 5%, the control antibody did not stop the cells (p=0.005) (Figure 26). 
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Change in cell behaviour over time was significant in these experiments (p=0.048) 
and when analysed separately, change over time was significant for IgG3 PR3-ANCA 
but not for control NP. There was no significant difference between experiments. 
 
In the comparison between IgG4 PR3-ANCA and control NP, PR3-ANCA stopped the 
neutrophils rolling more than the control (p=0.01). By 8 minutes 35% of the 
neutrophils exposed to ANCA were rolling, whereas 70% of the control neutrophils 
continued to roll (Figure 26). The behaviour of the neutrophils over time varied 
significantly with PR3-ANCA (p=0.031), but not with the control. 
Figure 26: Neutrophils on P-selectin with chimeric PR3-ANCA. 
Neutrophils are converted to static adhesion on a P-selectin surface 
after exposure to chimeric PR3-ANCA. Using the flow model, 
neutrophils were flowed across a P-selectin surface (2μg/ml). 
Neutrophils roll on this surface but with the addition of chimeric anti- 
PR3-ANCA of subclasses 1 and 3 the neutrophils stopped rolling and 
adhered to the surface (IgG1 p=0.026; IgG3 p=<0.001); treatment with 
control NP did not alter rolling. IgG4 chimeric PR3-ANCA also had this 
effect (p=0.01) but it was of lesser magnitude. Wall shear stress = 0.1Pa; 
n=3 
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In a comparison of all three subclasses together, there was no difference in the 
influence of IgG1 and IgG3 PR3-ANCA on neutrophils in this system (Figure 27). 
Time was significant (p=<0.001). IgG4 stopped the cells rolling less quickly than the 
other two subclasses and a greater proportion of cells remained rolling (both 
p=<0.001).  
 
 
Figure 27: Comparison of PR3-ANCA IgG subclass on P-selectin. 
IgG1 and 3 PR3-ANCA stop neutrophils rolling on a P-selectin surface 
more than IgG4 PR3-ANCA. Using the flow model, neutrophils were 
flowed across a P-selectin surface (2μg/ml). IgG4 chimeric PR3-ANCA 
stops neutrophils rolling to a lesser extent than IgG1 or IgG3. (IgG3 
compared to IgG4 p=0.001, IgG1 compared to IgG4 p=0.014). Wall shear 
stress = 0.1Pa; n=3 
 
6.5 Blockade of CD16 and CD32 on ANCA-stimulated neutrophils 
Experiments were undertaken to explore the role of CD32 and CD16 on neutrophils 
in the situation of exposure to ANCA. These experiments were limited by reagent as 
the chimeric ANCA were limited. The experiments on P-selectin were repeated but 
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only two time points taken, immediately pre-ANCA and 2 minutes after exposure to 
ANCA. Neutrophils which had previously been treated with isotype control antibody, 
or anti-CD32 or anti-CD16 were flowed across the slide and events recorded. 
Chimeric ANCA of subclasses IgG1, 3 or 4 was then flowed over the slide and cell 
adhesion and behaviour recorded. 
 
We explored the role of CD16 and CD32 in the activation of neutrophils rolling on P-
selectin after exposure to the different subclasses of chimeric ANCA. Blockade of 
CD16 significantly reduced the effect of IgG1 ANCA on the neutrophils (p=0.03), that 
is, the neutrophil activation induced by ANCA which changed behaviour from rolling 
to static adhesion was reduced, and the neutrophils continued to roll after CD16 was 
blocked. For IgG3 PR3-ANCA, blockade of either CD16 (p=0.012) or CD32 (p=0.017) 
reduced the effect of the ANCA, allowing neutrophils to continue to roll even when 
ANCA was present (Figure 28). The influence of Fc receptor blockade on IgG4 was 
difficult to comment on since the numbers of neutrophils stopping with ANCA were 
low, but the blockade of either receptor did revert the rolling proportion of cells back 
to baseline. In summary, both IgG1 and IgG3 ANCA potently activated rolling 
neutrophils as judged by conversion to stable adhesion, whereas IgG4 ANCA was 
weakly effective.  In all cases, response to ANCA was reduced by blockade of FcR 
CD16 or CD32, suggesting both receptors may have a role in signal transduction. 
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Figure 28: Blockade of CD32 and CD16 on ANCA-stimulated 
neutrophils. 
After exposure to IgG1 chimeric PR3-ANCA, CD16 prevented ANCA 
stopping neutrophils more than control (p=0.028) and CD32 showed a 
trend. IgG3 chimeric PR3-ANCA was prevented from stopping 
neutrophils more than control by both CD16 (p=0.017) and CD32 
(p=0.012). IgG4 chimeric PR3-ANCA was not blocked by either CD16 or 
CD32, although these again showed a trend. All experiments performed 
on P-selectin. Exposure to chimeric PR3-ANCA for 2 minutes, n=3. 
 
6.6 IgG1, IgG3 and IgG4 PR3-ANCA with neutrophils on HUVEC 
Following experiments with chimeric PR3-ANCA on P-selectin surfaces we 
proceeded to experiments on HUVEC in order to study the more complex interactions 
including integrin/ICAM-1, chemokine and cytokine influenced receptor activation. 
 
Neutrophils were mixed with chimeric PR3-ANCA or controls just prior to perfusion 
into the flow model and this meant that in contrast to the P-selectin experiments there 
was no change over time as the ANCA were introduced, all recorded events occurred 
after the addition of the ANCA or its control. Although recordings were taken at 
multiple time points, for clarity only one time point (5 minutes after neutrophil inflow) 
is presented in these graphs. The EC had been activated with a low level of TNFα 
(2units/ml).  Preliminary data was obtained comparing each chimeric PR3-ANCA to 
its control alone (data not shown). Multiple experiments were performed to obtain 
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clear comparative data and in initial experiments there were considerable problems 
with controls activating the neutrophils, particularly concerning the IgG3 antibody 
(data not shown). After using several different controls we explored the possibility of 
contamination by endotoxin, and all the samples were cleaned using endotoxin 
binding columns (see chapter 5.3). This alleviated the problem of controls activating 
the neutrophils and the final data presented here was a direct comparison of the 
three chimeric PR3-ANCA and their chimeric NP controls. 
 
All three PR3-ANCA IgG subclasses tended to induce greater numbers of neutrophils 
to bind to the cytokine-activated EC surface compared to their equivalent subclass 
control antibodies (Figure 29).  
Figure 29: Neutrophils binding to and behaviour on human umbilical 
vein ECs.  
Using the flow model neutrophils were flowed across human umbilical 
vein ECs which had been stimulated with TNFα at 2units/ml. Left hand 
panel: IgG1, 3 and 4 PR3-ANCA captured neutrophils efficiently and 
IgG4 captured neutrophils more than its control (p=0.048). Right hand 
panel: IgG3 PR3-ANCA efficiently stopped neutrophils from rolling 
compared to control (p=<0.001); IgG1 stopped neutrophils but to a 
lesser extent (p=0.036 compared to control) and IgG4 stopped 
neutrophils but this was not significantly different to its control. Data 
shown at 5 minutes after inflow. Wall shear stress = 0.1Pa; n=3 
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 IgG3 PR3-ANCA was very potent in altering the behaviour of the captured 
neutrophils, causing 94% of neutrophils to stop rolling and convert to static adhesion, 
facilitating transmigration, and this behaviour was different to control antibody (29% 
neutrophils became static after exposure to the control antibody; p=<0.001) (Figure 
29 right hand panel). The same was true of IgG1 PR3-ANCA but the affect was less 
potent (58% of neutrophils converted to static adhesion compared to 21% with 
control antibody; p=0.036). IgG4 PR3-ANCA also tended to convert rolling to static 
adhesion (35% of neutrophils converted to static adhesion with anti-PR3 ANCA IgG4 
compared to 17% of neutrophils with control IgG), but this change in behaviour did 
not reach statistical significance (Figure 29). In general ANCA therefore increased 
overall binding and tended to stabilise adhesion. 
 
In these flow experiments and in the preceding experiments on P-selectin, it should 
be noted that controls and chimeric PR3 ANCA were compared directly and 
neutrophils with no IgG were not included in these experiments. This was due to the 
fact that only 6 slides could be used in each experiment and these were the 3 
subclasses, each with anti-PR3 and its control. Previous experiments had indicated 
that neutrophils with no IgG behave similarly to control IgG (section 5.2.4.1). 
 
6.7 Discussion 
This study was based on the premise that the interaction of a PR3-specific 
autoimmune immunoglobulin in AVV with the neutrophil is unique and is the 
pathogenic basis of the disease. In order to compare interactions of IgG with 
 147
neutrophils we examined neutrophils interacting with IgG that did not contain ANCA, 
and compared this to neutrophil interactions with ANCA IgG. Thus, normal IgG 
coated on a continuous presenting surface that would mimic presentation of Fc 
portions of fixed immune complexes was compared with control or ANCA IgG, 
presented in the fluid phase to flowing neutrophils, mimicking the situation in disease. 
 
6.7.1 Experiments using normal IgG 
 
In this study, freshly isolated neutrophils that had not been activated, bound to IgG 
presented on fixed surfaces and this interaction followed the conventional knowledge 
that neutrophils will interact avidly with IgG3, and with IgG1 and minimally or not at all 
with IgG2 and IgG4 (Jefferis and Kumararatne 1990) although we found increased 
binding to IgG3. Capture of neutrophils onto IgG surfaces has been demonstrated 
previously (Skilbeck, Lu et al. 2006). Greater capture of neutrophils by IgG3 may 
reflect the enhanced flexibility of the larger IgG3 molecule. It is unlikely that the 
enhanced neutrophil binding to IgG3 was due to a higher concentration of this 
subclass on the glass APES-coated slide as the antibodies were coated in equal 
molarity rather than equal concentrations which would disadvantage the larger IgG3 
molecules. The differential between the antibodies is interesting particularly since in 
disease states, IgG3 autoantibodies have proposed to be more pathogenic (Mulder, 
Stegeman et al. 1995).  
 
Having established that flowing neutrophils could be captured well by IgG3 and IgG1 
Fc, the specific neutrophil receptors supporting this were investigated using blocking 
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antibody. The relative roles that CD32 and CD16 play in individual subclass binding 
to neutrophils may be useful in the manipulation of disease states and in order to 
look at this we performed blocking studies. Blocking studies have been performed 
previously in this model using mixed immunoglobulin, and CD16 blockade was found 
to be of the greatest importance while CD32 also had a significant but lesser effect 
(Skilbeck, Lu et al. 2006). We looked at the roles of the constitutive receptors CD32 
and CD16 in neutrophil adhesion in flow conditions, and found that while all 
subclasses are affected by blocking these, there is a differential importance in the 
receptors. Blocking either receptor reduced binding in all four subclasses and 
blocking both receptors abolished neutrophil binding. The importance of these 
receptors varied however, with CD16 being more important in IgG3-mediated 
adhesion under flow and CD32 more important for IgG1 and 2 mediated adhesion. In 
the previous study in flow (Skilbeck, Lu et al. 2006), the importance of CD16 over 
CD32 could therefore be explained by the presence of greater proportions of IgG3 
subclass over IgG1. In addition, another study found that binding of subclasses on 
neutrophils to CD32 was highest with IgG3, then IgG1 and 2 and then IgG4. This was 
dependent however on allotypic form (Parren, Warmerdam et al. 1992). The present 
study has directly compared the relative importance of CD32 and CD16 for neutrophil 
adherence to IgG subclasses under flow conditions and has clearly shown that CD16 
is more important for IgG3 mediated adhesion, while CD32 is more important for 
IgG1 and 2 mediated adhesion. Interestingly, in a previous study that examined 
soluble immune complex binding to neutrophils via CD16 and CD32, granule release 
by neutrophils was induced by all four IgG subclasses in the presence of 
complement, but in the absence of complement, only IgG1 and IgG3 were 
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functionally active. Granule release by binding of IgG3 immune complexes was 
mediated predominantly by CD16, whereas IgG1 immune complexes induced 
specific granule release by CD32, suggesting similar engagement of Fc receptors by 
IgG subclasses for granule release as was observed for capture and adhesion of 
neutrophils from flow  (Voice and Lachmann 1997).  
 
We next looked at the role of CD18 in neutrophil stabilisation and adhesion. CD18 
was important in allowing the neutrophils to spread. CD18 is the common chain 
within the neutrophil β2 integrin molecules comprising CD11a/CD18, which binds to 
ICAM-1 on the endothelial surface, and CD11b/CD18, which binds to ICAM-1, 
fibrinogen and factor X (Mayadas and Cullere 2005). Change in conformation of 
integrins on neutrophils requires inside-out signalling (Abram and Lowell 2007). In 
our experiments, blocking the integrin prevented the neutrophils from spreading on 
the IgG surface. This finding is supported by previous published work (Skilbeck, Lu et 
al. 2006). There are two possible explanations for this result, the first is that the Fc 
receptor ligation induces activation of the integrin which binds to a ligand (albumin in 
this case (Zhu, Subbaraman et al. 2000)) and outside-in signalling results in 
neutrophil spreading. The second is that the Fc receptor ligation itself causes the 
neutrophil to spread whilst simultaneously activating CD18 which is required to 
adhere to the surface.  
 
When the neutrophil signalling was inhibited by chelating the intracellular calcium 
with BAPTA-AM, binding and spreading was reduced. The CD18 blocking studies 
indicate that spreading requires signalling within the neutrophil, but binding too is 
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clearly a metabolically active process and not simply mechanical; signalling is 
required to stabilise adhesion. 
 
6.7.2 Studies with chimeric anti-PR3 chimeric ANCA 
 
After establishing that solid-phase normal human immunoglobulin IgG subclasses 
differentially recruit neutrophils from flow by engagement with their constitutive CD16 
and CD32, we wished to compare this with chimeric ANCA IgG subclasses. The 
ANCA IgG had to be present in the fluid phase to enable antibody Fab and Fc 
portions to concurrently engage with neutrophil antigen and with Fc receptors 
(Williams, Ben-Smith et al. 2003). The question was whether with this added 
complexity, neutrophil responses differed from that observed following cross-linking 
of neutrophil Fc receptors alone. In order to study subclass effects we used chimeric 
antibodies developed in our laboratory that were all directed against the same 
epitope of PR3 on the neutrophil surface. 
 
All three anti-PR3 chimeric antibodies elicited a superoxide response. We wished to 
take the functional studies further and therefore used the flow model. 
 
Initially we flowed neutrophils over a P-selectin surface as we have used previously 
((Colman, Hussain et al. 2007) and Hussain et al in press). We verified that most of 
the captured neutrophils roll on this surface but with the addition of a second signal 
such as ANCA IgG, the rolling is converted to static adhesion. This was true of IgG1 
and IgG3 anti-PR3 ANCA (Colman, Hussain et al. 2007) but also was seen with PR3-
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ANCA IgG4 (Hussain et al in press) although to a lesser extent. IgG4 have been 
thought to be a benign blocking antibodies, and not to engage neutrophils via CD32 
or CD16 (Stitis 1991; Roitt 1996; Heijnen and van de Winkel 1997), although more 
recent evidence suggests that this is simplistic and multiple parameters determine Fc 
binding and the functional outcome (Greenwood, Clark et al. 1993; Voice and 
Lachmann 1997). In addition IgG4 does not always behave as a conventional 
antibody which should be considered when comparing the IgG subclasses: 
polyclonal IgG4 antibodies are functional monovalent, but monoclonal IgG4 are not; 
IgG4 lacks the normal covalent interaction between the heavy chains and also 
bispecific antibodies can be found in plasma (Aalberse and Schuurman 2002). In our 
study, flow cytometric analysis demonstrated that CD64 was not present on the 
surface of freshly isolated neutrophils (data not shown), therefore PR3-ANCA IgG4 
must be able to engage the constitutively expressed receptors. Indeed, previous 
studies confirmed that chimeric PR3-ANCA IgG4 stimulation of superoxide release 
and neutrophil degranulation can be blocked by antibodies to CD16 or CD32 in a 
manner partly dependent on the functional output, while deglycosylated PR3-ANCA 
IgG4, which cannot bind these receptors, is ineffective (Hussain et al in press). 
 
We then went on to study the effects of blocking CD16 and CD32 on chimeric PR3-
ANCA stimulated neutrophils. Both Fc receptors appeared to play a role when ANCA 
transduced an activation signal, with a hint that CD16 may have a more important 
role. Receptor usage for neutrophil capture from flow may be different from that in 
ANCA induced activation signalling. Neutrophils stopping on IgG coated surfaces 
may arise from activation of integrins, or simply from the ability of the Fc receptor 
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ligation to hold the neutrophil still. Our results with BAPTA-AM and CD18 blockade 
suggest that signalling is involved, so it may be that CD32 is more important for 
capture, and from the ANCA experiments, that CD16 is more important for neutrophil 
activation and subsequent conversion from rolling to static adhesion. 
 
P-selectin is a simpler stratum for rolling neutrophils than endothelium where 
chemokines and adhesion molecules may alter responses. Thus, neutrophils that had 
been exposed to PR3- ANCA IgG subclasses, or control antibodies, were flowed over 
cytokine-activated HUVEC and neutrophil adhesion and behaviour observed. We 
suggest from these experiments that ANCA will stabilise binding of neutrophils and 
markedly change the behaviour of the neutrophils on the endothelial surface. The 
potency of ANCA IgG subclasses paralleled the findings on normal IgG, thus, the 
IgG3 subclass was most potent at inducing the neutrophils to become static, prior to 
migration, with IgG1 also being effective but to a lesser degree. These findings match 
the initial findings on P-selectin but, importantly, show that they also occur on a more 
physiological substratum that is more indicative of what may occur in the 
microcirculation. Again, there is the implication that IgG3 is a more pathogenic 
subclass in AAV (Mulder, Stegeman et al. 1995), and that IgG4 may not be as inert 
as previously considered, although pathogenic outcome will depend on the overall 
composition of the ANCA IgG subclasses between individuals.  
 
The addition of anti-PR3 ANCA therefore activates the neutrophil and causes capture 
onto an endothelial surface, but it also changes the behaviour of activated 
neutrophils from rolling to adhesion and migration across the EC monolayers. We 
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have previously studied signalling pathways in the neutrophil and believe that 
simultaneously stimulating the neutrophil via the Fc and Fab portions of the 
immunoglobulin cross-links these receptors and causes aberrant downstream 
signalling resulting in inappropriate activation of the neutrophil (Williams, Ben-Smith 
et al. 2003). IgG1 and IgG3 seem to be strongly activating and even IgG4 seems to 
be activatory in this situation albeit weakly. We postulate this is due to different 
signalling strengths with recruitment of large mats causing increasingly strong signals 
until neutrophil activation takes place.  
 
An argument such as this regarding cross-linking of receptors raises the question of 
whether cross-linking can occur with other epitopes on the neutrophil surface. We 
have previously tested this in our laboratory with CD15 (unpublished) and found no 
increased neutrophil stimulation. Blocking antibodies to CD32  and CD16 could also 
induce cross-linking but this was checked in previous studies in our laboratory and 
blocking antibodies alone or in combination did not stimulate the release of 
superoxide from neutrophils (Hussain in press) leading us to conclude that there was 
no cross-linking of the receptors in these experiments. Cross-linking therefore seems 
to be a unique feature of ANCA induced neutrophil stimulation. 
 
In previous work we have demonstrated that IgG1 and IgG3 PR3-ANCA induce 
superoxide release, degranulation and IL8 production. IgG1 was more potent in 
degranulation and IgG3 more potent in IL-8 production (Colman, Hussain et al. 
2007). We have also demonstrated that IgG4 anti-PR3 was able to induce 
superoxide in the same magnitude as IgG1, and degranulation was also similar, but 
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IgG4 anti-PR3 ANCA did not induce IL-8 (Hussain in press). In these studies we 
investigated the roles of CD32 and CD16 (Table 7) and demonstrated that 
superoxide production by neutrophils when stimulated with IgG1 and IgG4 PR3-
ANCA was prevented by blocking CD32 but not CD16. Degranulation by IgG1 and 
IgG4 PR3-ANCA was also prevented by blocking CD32 but this time antibodies to 
CD16 also blocked the IgG1 PR3-ANCA response. IL-8 release in contrast required 
CD16.  
 
 IgG1 IgG3 IgG4 
Superoxide production + 
 
CD32 dependent 
+ + 
 
CD32 dependent 
Degranulation ++ 
 
CD32 dependent 
+ 
 
CD16 dependent 
++ 
 
CD32 dependent 
IL-8 production + 
 
CD16 dependent 
++ 
 
CD16 dependent 
- 
 
CD16 dependent 
Static adhesion + 
 
+  
Adhesion in flow ++ 
 
CD16 dependent 
+++ 
 
CD16/CD32 
dependent 
+ 
 
Table 7: Summary of chimeric ANCA action on neutrophils dependent 
on IgG subclass and Fc receptor engagement 
 
In the current studies in the flow model we studied the effects of blocking CD16 and 
CD32 on chimeric PR3-ANCA stimulated neutrophils on adhesion. Blocking CD16 
reduced activation of neutrophils by IgG1 and IgG3 PR3-ANCA, but CD32 was only 
affective with IgG3 PR3-ANCA. Neutrophils stimulated with IgG4 PR3-ANCA were 
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not influenced by CD32 or CD16 blockade, but the experiments were looking at early 
time points and in the previous experiments, IgG4 does not have an affect on 
neutrophils until later time points.  It is interesting that CD32 was influential on IgG1 
mediated neutrophil adhesion in initial experiments, but when IgG1 PR3-ANCA was 
involved, CD16 was more important. In IgG3 initially CD16 was more important, but 
both CD32 and CD16 had a significant effect on the ANCA-stimulated neutrophils. 
Previous studies in our laboratory with polyclonal patient IgG showed that the pro-
adhesive effects of polyclonal human ANCA IgG, a mixture of all subclasses, in the 
P-selectin flow assay is particularly sensitive to inhibition of CD32 (Radford, Savage 
et al. 2000).  
 
As regards the relative influence of Fc receptors in AVV, there seems therefore to be 
a differential effect depending on the neutrophil function. CD32 was important in 
superoxide production by IgG1 and 3 PR3-ANCA and in degranulation, CD16 
influenced degranulation by IgG1, and IL-8 production. Neutrophil adhesion 
appeared to be influenced by CD16, although IgG3 was also affected by CD32. 
These findings are novel, and may be useful in designing therapeutic targets. 
 
Chimeric and patient ANCA are different in that patient ANCA is polyclonal and 
therefore able to bind multiple antigenic targets on the PR3 molecule leading to 
clustering of antigen and Fc receptors to form large mats. We believe that this would 
be likely to amplify rather than alter the responses that we have observed. 
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In conclusion, these experiments showed that binding of neutrophils to IgG coated 
surfaces differs by IgG subclass and that Fc receptor blockade disrupts binding; 
CD32 is particularly important. Binding is an active process and requires signalling, 
and spreading on the IgG surface requires integrins. PR3-ANCA stabilises binding 
and activates neutrophils resulting in static adhesion, IgG3 is particularly potent and 
Fc receptor blockade disrupts the activation seen by ANCA. Exploration to target 
particular IgG subclasses, or Fc receptors may be useful in designing therapeutic 
intervention for AAV. 
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7. COMPARISON OF UMBILICAL VEIN AND GLOMERULAR 
ENDOTHELIAL CELL TYPES 
 
Kidney disease is an increasing problem and the number of people commencing 
dialysis is rising. There is an urgent need to address preventative strategies in 
nephrology and the key to many renal diseases may lie with the EC.  Literature 
regarding adhesion studies in renal endothelium is sparse and these studies aim to 
address this. In health, the renal circulation, due to its role in detoxification is supplied 
by 20% of the cardiac output. It is crucially important that leukocyte activation and 
recruitment does not take place within the kidney in a non-inflammatory environment. 
Renal capillaries are of a diameter of 10-20nm (Shiraishi, Wang et al. 2003) and 
require compression of leukocytes for them to pass through. If adhesion molecules 
were easily up-regulated this would result in clogging of glomerular capillaries with 
leukocytes and it may be that the glomerular EC has specific protective measures, 
such as reduced expression of adhesion molecules, to ensure recruitment of 
leukocytes is restricted to highly inflammatory conditions. In disease, disruption of 
such protection may explain specific targeting of the renal bed. The aim of this part of 
the thesis was to compare renal ECs with the standard comparator, human umbilical 
vein ECs (HUVEC) to establish any difference in adhesion molecule expression and 
functional ability in flow. 
 
ECs are heterogeneous, changing their phenotype over time and according to the 
environment in which they exist. Endothelium may fluctuate between a resting and an 
activated state in response to inflammatory mediators, so that adhesion and other 
molecules can be up-regulated when EC are activated by cytokines such as TNFα 
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(Cotran and Pober 1990). Indeed, chemokines and adhesion molecule expression 
can differ between EC types as well as with changes of the activation status of the 
endothelium (Lim, Garcia-Cardena et al. 2003).  
 
In the glomerular microcirculation the endothelium is particularly unique as it is 
permeable to water and small solutes, whilst remaining impermeable to 
macromolecules. Glomerular ECs are punctuated by multiple fenestrations, trans-
cellular pores 60-80nm in diameter (Deen, Lazzara et al. 2001). These fenestrations 
have a glycocalyx that covers the fenestrae and probably contributes to the 
permeability barrier (Rostgaard and Qvortrup 1997). 
 
Traditionally HUVEC have been used to model microvascular EC and have been 
presumed to behave similarly and although some studies have concluded similarities 
between ECs others have suggested that extrapolation from one to the other is not 
satisfactory, as discussed in the introduction. 
 
This chapter explores studies in which we aimed to compare three types of EC: 
HUVEC obtained from primary culture within our institution, primary glomerular ECs 
(PGEC) and conditionally immortalized glomerular ECs containing a temperature 
sensitive transgene (called GEC2 here).  We compared the cells by microscopy and 
presence of fenestrations. We then characterised them for the expression of CD31 
and vWF; explored functional differences by determining the expression profiles of 
the cytokine-modulated adhesion molecules, E-selectin, ICAM-1 and VCAM-1, and 
by comparing their performance under conditions of flow for capture of neutrophils 
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and peripheral blood lymphocytes. We performed RNA arrays to compare the gene 
profile of the three EC types. 
 
Cytokines were used to stimulate the endothelium to ascertain if these induced 
different patterns of behaviour dependent on the EC type. The cytokines chosen 
were TNFα and IL-1β which are both up-regulated in AAV, as discussed in the 
introduction. In order to induce selectins on the ECs, hydrogen peroxide was also 
used to treat the EC as this is known to induce selectins by up-regulation of 
histamine (Okayama, Coe et al. 1999). This can only be used for a short time as it is 
rapidly toxic to endothelium. In AAV the superoxide response produces hydrogen 
peroxide.  
 
The comparisons in this chapter were complicated by the use of two different 
transformed (immortalised) glomerular cell lines. The first line (GEC1) was tested in 
flow initially and then tested in E-selectin ELISA and found to not express E-selectin. 
A second cell line (GEC2) was then tested, and comparisons made between this, 
primary GEC and HUVEC. All of these data are presented below. 
 
7.1 Appearance of endothelial cells 
7.1.1 Phase contrast microscopy 
 
The 4 different cell types were grown in culture flasks and then transferred to glass 
slides. The monolayers of the cell types looked similar under phase contrast 
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microscopy, the cells grew in a single layer and were small, homogeneous and 
‘cobblestone’ in appearance. 
 
 
Figure 30: Phase contrast microscopy of ECs growing in monolayers. 
Clockwise from left: HUVEC, immortalised glomerular cell lines GEC1, 
GEC2 and primary glomerular cells. All cells were grown in EBM-2 
medium at 37°C. The immortalised lines were cultured at the permissive 
temperature (33°C) initially. Magnification x20, cells grown on glass 
slides. 
 
7.1.2 Electron microscopy 
 
HUVEC, PGEC and GEC2 were examined by electron microscopy (EM). We wished 
to see if the glomerular cells had fenestrations, a distinct feature of these cells. In 
order to induce fenestrations all cells were grown in medium containing high 
concentrations of vascular endothelial growth factor (VEGF), one hundred times the 
concentration of that in EBM2 medium and compared to those grown in EBM2 alone.  
Our initial studies used transmission EM in an attempt to see fenestrations through 
the whole cell, but these were unsuccessful, the cells fragmented and fenestrations 
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were not obvious. We therefore repeated the studies using scanning EM, where the 
surface of the cells could be seen. Fenestrations were observed on the primary 
glomerular cells, and these increased in the high VEGF medium. GEC2 
demonstrated obvious fenestrations after high VEGF treatment, with a suggestion of 
these at normal VEGF concentrations. Fenestrations could not be induced on 
HUVEC (Figure 31).  
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 Figure 31: Scanning Electron Microscopy of ECs.  
Three ECs (EC) types were grown on glass coverslips either in EBM2 
medium or EBM2 with vascular endothelial growth factor (VEGF) at 
100x the normal concentration. In the left hand panels whole cells are 
seen. In the middle panel the surface of the cells at 80 000 times 
magnification, and in the right hand panels at the same magnification 
after treatment with high VEGF. The cells have villi on their surface and 
on PGEC fenestrations are seen (arrowed) which increase after 
treatment with VEGF. In GEC2 fenestrations are seen only after high 
VEGF treatment. HUVEC do not demonstrate fenestrations. HUVEC = 
human umbilical vein EC; PGEC = PGEC; GEC2 = immortalised 
glomerular EC line. 
 
7.2 Characterisation: presence of CD31 and vWF 
Characteristic features of EC include expression of CD31 (important for endothelial-
endothelial as well as leukocyte-endothelial interactions) and vWf (that is stored 
within Weibel Palade bodies and released as multimeric molecules in response to EC 
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stimulation). The presence of CD31 was confirmed on all three EC types by flow 
cytometry and immunocytochemistry ( 
Figure 34).  As expected, levels of CD31 were not increased by TNFα stimulation 
since CD31 is not influenced by TNFα stimulation alone.  
 
In addition to these studies, we checked that the commercial primary GEC were a 
pure CD31 exressing population by cell sorting on MoFlo (by another laboratory at 
our request). The population was 93% pure (data not shown). 
 
Flow cytometry plots were gated to exclude dead cells and debris. Examples of 
forward/side scatter plots with gating are shown (Figure 32). 
 
 
Figure 32: Forward side scatter plots for flow cytometry.  
Cell populations were gated to exclude dead cells and cell debris. 
Examples are shown for HUVEC and GEC2 for unpermeabilised 
experiments. 
 
Immunocytochemistry was undertaken using IgG1 antibody; isotype controls for 
experiments with and without TNFα and permeabilised cells are shown below (Figure 
33) for comparison to all following immunocytochemistry data. 
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Figure 33: Immunocytochemistry controls.  
All experiments for immunocytochemistry were performed with IgG1 
antibodies and all control antibodies are for cells before and after 
treatment with TNFα and after permebilisation. 
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Figure 34: Expression of CD31 in all three cell types confirms their 
endothelial derivation.  
CD31 is expressed in HUVEC, primary GEC and GEC2. It is seen around 
the edges of the cells by immunohistochemistry staining (primary 
antibody anti-CD31; secondary rabbit anti-mouse immunoglobulins-
FITC conjugated) and is present by flow cytometry (primary antibody, 
anti-CD31; secondary anti-mouse immunoglobulins-FITC) compared to 
an isotype control (mouse IgG1κ murine myeloma). Expression of CD31 
was unaffected by TNFα. 
 
vWF was also found in all three cell types by flow cytometry and 
immunocytochemistry. With immunocytochemistry, the vWF appears punctuate 
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within the Weibel-Palade bodies that are stained after permeabilising the cells (Figure 
35). 
 
 
Figure 35: Expression of vWF in all three cell types confirms their 
endothelial derivation.  
vWF is expressed in HUVEC, primary GEC and GEC2. It appears 
punctuate in the Weibel Pallade bodies by immunohistochemistry 
staining after cell permeabilisation (primary antibody anti-vWF; 
secondary rabbit anti-mouse immunoglobulins-FITC conjugated) and is 
present by flow cytometry (primary antibody, anti-vWF and secondary 
anti-mouse immunoglobulins-FITC) compared to an isotype control 
(mouse IgG1κ murine myeloma) 
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 7.3 Expression of adhesion molecules: E-selectin, ICAM and 
VCAM 
7.3.1 E-selectin 
 
E-selectin expression was confirmed on all three cell types by flow cytometry, 
immunocytochemistry (Figure 36) and ELISA (Figure 37). E-selectin was up-
regulated on all three cell types by TNFα and IL-1β.  
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 Figure 36: E-selectin expression on HUVEC, primary GEC and GEC2 by 
immunohistochemistry and flow cytometry.  
E-selectin is seen by immunocytochemistry staining (primary antibody 
anti-E-selectin; secondary rabbit anti-mouse immunoglobulins-FITC 
conjugated) and is present by flow cytometry (primary antibody, anti-E-
selectin and secondary anti-mouse immunoglobulins-FITC) compared 
to an isotype control (mouse IgG1κ murine myeloma). All cells were 
treated with TNFα prior to immunocytochemistry staining. By flow 
cytometry, expression of E-selectin was increased by TNFα in HUVEC 
andGEC2 but is less convincing on PGEC. 
 
In ELISA, EC were either left unstimulated or stimulated with TNFα at 100u/ml, or IL-
1β at 5x10-9g/ml for four hours (Figure 37). Of the two sets of stimulated wells, one 
set looked for surface expression of E-selectin and the other was permeabilsed to 
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look for total cell E-selectin. The basal levels were compared with the stimulated or 
permeabilsed levels to ascertain if there was significant up-regulation of E-selectin. 
HUVEC up-regulated E-selectin in response to TNFα, basal expression of E-selectin 
was significantly different than surface expressed (p=0.005) or total E-selectin 
(p=0.03). This was also true of primary GEC (up-regulation p=0.0003; permeabilsed 
p=0.006) and GEC2 (up-regulation p=0.0002; permeabilsed p=0.0003). IL-1β also 
caused significant up-regulation of E-selectin in all three cell types (HUVEC, surface 
p=0.003; permeablised 0.011; PGEC surface p=<0.001; permeablised <0.001; GEC2 
surface p=0.009; permeablised 0.003). There were equal numbers of cells in each 
well within each plate when compared with crystal violet. 
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 Figure 37: E-selectin is expressed in HUVEC, primary GEC and GEC2 by 
ELISA.  
E-selectin was detected by ELISA (primary antibody, anti-E-selectin; 
secondary antibody, HRP-conjugated sheep anti-mouse IgG) and was 
up-regulated by TNFα and IL-1β. Upreg E-selectin = after treatment with 
cytokines; Total E-selectin = permeabilised cells enabling detection of 
intracellular E-selectin. (n=3). Comparison with T test. 
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 ELISA was also performed on HUVEC and GEC2 after treating the cells with 
hydrogen peroxide at 1 millimolar for 1 hour in order to induce selectins (Figure 38). 
Selectins were induced on GEC2 but not on HUVEC by this method. It is possible 
that the hydrogen peroxide damaged the HUVEC and this was why selectins were 
not up-regulated. From other experiments the GEC2 seemed to be more robust. 
 
Figure 38: E-selectin is expressed in GEC2 after treatment with 
hydrogen peroxide.  
E-selectin was up-regulated by hydrogen peroxide at 1millimolar on 
GEC2 but not on HUVEC by ELISA (primary antibody, anti-E-selectin; 
secondary antibody, HRP-conjugated sheep anti-mouse IgG). Upreg E-
selectin = after treatment with cytokines; Total E-selectin = 
permeabilised cells enabling detection of intracellular E-selectin. n=3. 
Comparison with T test. 
 
In initial ELISAs GEC1 was also tested by stimulating with TNFα. The GEC1 line did 
not express E-selectin on unstimulated cells, this could not be up-regulated and 
permeabilsing the cells did not lead to detection of any E-selectin (Figure 39). 
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 Figure 39:  E-selectin is not expressed on GEC1.  
E-selectin was not detected by ELISA (primary antibody, anti-E-selectin; 
secondary antibody, HRP-conjugated sheep anti-mouse IgG). Upreg E-
selectin = after treatment with cytokines; Total E-selectin = 
permeabilised cells enabling detection of intracellular E-selectin. n=3. 
Comparison with T test. 
 
7.3.2 ICAM-1 
 
ICAM-1 was expressed on all three cell types after 12 hours treatment with TNFα or 
IL-1β as demonstrated by flow cytometry (unpermeabilsed cells) (Figure 40), and 
ELISA, (Figure 41).  
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 Figure 40: ICAM-1 expression on HUVEC, primary GEC and GEC2 by 
flow cytometry.  
ICAM-1 was detected by flow cytometry (primary antibody, anti-ICAM-1 
and secondary anti-mouse immunoglobulins-FITC) compared to an 
isotype control (mouse IgG1κ murine myeloma) on HUVEC and GEC2 
but less convincingly on PGEC. Expression of ICAM-1 was increased by 
TNFα. 
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ICAM-1 (Figure 41) was up-regulated on HUVEC by TNFα (surface p=<0.001; 
permeablised 0.002); on PGEC (surface p=0.002; permeablised p=<0.002); and on 
GEC2 (surface p=0.002; permeablised <0.001). IL-1β also up-regulated ICAM-1 on 
all three cell types (HUVEC, surface p=<0.001; permeablised =<0.001; PGEC 
surface p=0.003; permeablised 0.002; GEC2 surface p=0.002; permeablised 
p=<0.001) 
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 Figure 41: ICAM-1 is expressed on HUVEC, primary GEC and GEC2 by 
ELISA.  
ICAM-1 was detected by ELISA (primary antibody, anti-ICAM-1; 
secondary antibody, HRP-conjugated sheep anti-mouse IgG) and was 
up-regulated by TNFα and IL1-β. Upreg ICAM = after treatment with 
cytokines; Total ICAM = permeabilised cells enabling detection of 
intracellular ICAM-1 (n=3). Comparison with T test. 
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7.3.3 VCAM-1 
 
VCAM-1 expression was tested by flow cytometry, immunocytochemistry (Figure 42) 
and ELISA (Figure 43) after stimulation with TNFα or IL-1β for 24 hours.  
 
Figure 42: VCAM-1 is expressed on HUVEC but was not detected on 
primary GEC and GEC2. 
All cells were treated with 24 hours of TNFα before 
immuncytochemistry for VCAM-1. VCAM-1 is seen by 
immunohistochemistry staining (primary antibody anti-VCAM-1; 
secondary rabbit anti-mouse immunoglobulins-FITC conjugated) on 
HUVEC but not on the other EC. VCAM-1 was detected by flow 
cytometry (primary antibody, anti-VCAM-1 and secondary anti-mouse 
immunoglobulins-FITC) compared to an isotype control (mouse IgG1κ 
murine myeloma) on HUVEC but was only detected in very small 
amounts on primary GEC and GEC2 after stimulation by TNFα. 
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 VCAM-1 was found on HUVEC by immunohistochemistry, flow cytometry and ELISA 
(Figure 43) when stimulated with TNFα (up-regulated p=0.028; permeabilised cells 
p=0.046) but was not detected above basal levels with IL-1β in ELISA. VCAM-1 was 
not detected on either of the glomerular EC by immunohistochemistry and only in 
very small amounts by flow cytometry. It was not detected in ELISA on TNFα or IL-1β 
stimulated cells above basal levels (Figure 43). It was also not detected when the 
cells were permeabilsed.  
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 Figure 43: VCAM-1 is detected by ELISA in HUVEC but not glomerular 
EC.  
VCAM-1 was detected by ELISA (primary antibody, anti-VCAM-1; 
secondary antibody, HRP-conjugated sheep anti-mouse IgG) on HUVEC 
and was up-regulated by TNFα. Intracellular VCAM-1 was detected after 
cell permeabilisation. There was no difference from basal levels after 
 179
stimulation by IL1-β. On primary GEC and GEC2, VCAM-1 was not 
reliably detected and was not up-regulated by cytokines (n=3). 
Comparison with T test. Upreg VCAM-1 = after treatment with 
cytokines; Total VCAM-1 = permeabilised cells enabling detection of 
intracellular VCAM-1. 
 
7.3.3.1 Western blotting for VCAM-1 
 
Having found VCAM-1 on the surface of HUVEC but not on glomerular EC we 
performed Western Blotting on all the cell types to check if the protein was present in 
the cells. We were able to find bands at the correct molecular weight for VCAM-1 
between 90-100kDa in all three cell types (Figure 44). In a non-reduced Western blot 
on HUVEC, VCAM-1 was demonstrated at a molecular weight of 90kD. In primary 
GEC and GEC2 the VCAM-1 bands appear at 100kD. This may represent different 
isoforms of the protein, discussed further below. In a reduced sample all three 
endothelial types demonstrate bands at 90kD, HUVEC and PGEC demonstrate 2 
bands, while GEC2 has only one. We concluded that although the VCAM-1 protein 
was therefore being synthesised, it was only expressed in low levels on the cell 
surface of glomerular cells, perhaps because of different isoforms. The observation 
that banding was similar between primary GEC and GEC2, adds confidence to the 
interpretation that VCAM isoforms are different in glomerular cells. 
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 Figure 44: Western Blotting for VCAM-1.  
In a non-reduced sample, on HUVEC, VCAM-1 is demonstrated at a 
molecular weight of 90kD. In primary GEC and GEC2 the VCAM-1 bands 
appear at 100kD. This may represent different isoforms of the protein. 
In a reduced sample all three endothelial types demonstrate bands at 
90kD, HUVEC and PGEC demonstrate 2 bands, while GEC2 has only 
one. 
 
7.4 Functional studies in flow 
Having established the presence or absence of adhesion molecules on the various 
EC types, we wished to explore the function of these adhesion molecules in flow. 
 
Selectins and ICAM-1 are needed for capture of neutrophils in the adhesion cascade. 
Selectins engage fast flowing neutrophils from the circulation and cause them to roll 
on an EC surface. Firm adhesion is mediated through neutrophil integrins binding to 
ICAM-1. VCAM-1 is used by PBL for capture onto EC monolayers. VCAM-1 can 
support capture from flow and rolling adhesion through VLA-4 integrin, but if the 
integrin is activated the adhesion becomes stable and stationary.  
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Initial experiments established that GEC1 did not support adhesion of neutrophils 
(which was expected since this cell line did not express selectins). Further use of this 
line was therefore abandoned in favour of GEC2. We also checked that the medium 
the EC were grown in did not affect their function. Finally we compared the EC in 
supporting neutrophil and subsequently PBL binding. 
 
7.4.1 GEC1 behaviour in flow 
 
The cell line was tested in the flow model to ascertain whether neutrophils could be 
captured from flow. In the absence of any other stimulus no cells could be captured 
on GEC1 in a TNFα titration. Levels of TNFα were increased to 1000units/ml on 
GEC1 but at 15 minutes after inflow no neutrophils remained adhered compared to 
700-800 neutrophils adhering to HUVEC at 100units/ml TNFα (data not shown). 
Experiments were also repeated with a second stimulus of patient ANCA (with 
normal IgG as a control). Very small numbers of cells could be captured onto GEC1 
with very high levels of TNFα and halving the wall shear stress to 0.05Pa. Even 
under these conditions the number of cells captured was low when compared to 
HUVEC which had been stimulated with only 2units/ml of TNFα and where the wall 
shear stress was higher at 0.1Pa (Figure 45). It is interesting that in the presence of 
ANCA, and even of control IgG some capture could be induced. The behaviour of the 
captured neutrophils on GEC1 as compared to HUVEC is difficult to comment on due 
to the very low number of neutrophils captured on GEC1, but in general any captured 
neutrophils were stationary rather than rolling. 
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Stimulation with IL-1β and histamine did not induce capture of neutrophils on the 
GEC1. Histamine was also used to stimulate the cells continuously for 20 minutes by 
infusion with the neutrophils. Histamine causes P-selectin to be expressed on the cell 
surface of ECs and thus would be expected to increase neutrophil capture. This 
affect is seen within 20 minutes, but did not cause any neutrophil capture with this 
cell line. 
Figure 45: Comparing neutrophil capture and behaviour on GEC1 and 
HUVEC.  
HUVEC captured more neutrophils even when the wall shear stress was 
halved on GEC1 (0.05Pa) and the TNFα concentration was increased to 
1000units/ml (compared to 2units/ml on HUVEC). Data shown at 15 
minutes. n=3 
 
7.4.2 Comparison of HUVEC, primary GEC and GEC2 in flow 
 
7.4.2.1 Comparing mediums 
 
In order to compare the three types of EC in flow, we wished to make sure that as 
much as possible, all factors were equal. Until this point, HUVEC had been grown in 
medium as described in the methods, which is cheaper than the EBM2 medium used 
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for the primary GEC and cell lines, which will not grow in the HUVEC medium. An 
initial set of experiments was therefore carried out in order to check that HUVEC 
grown in these two media behaved similarly in flow. 
 
HUVEC were stimulated with 0, 2 and 100 units of TNFα. At 11 minutes, total 
numbers of neutrophils captured were the same in the two media, however, the 
percentage of cells migrating varied (p=0.032). Due to this difference, all further 
comparisons between EC types were conducted with HUVEC which had been grown 
in the same media (i.e.EBM2) to the primary and immortalised cells. 
Figure 46: Capture and behaviour of neutrophils on HUVEC grown in 
EBM2 or normal medium.  
In the flow model, HUVEC were stimulated with 0, 2, 100 units of TNFα. 
Data was collected at 2 minute intervals and is shown at 11 minutes. 
Total capture is similar between the two media, but migration behaviour 
is significantly higher on EBM2 (p=0.032). Wall shear stress =0.1Pa, 
n=5. 
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7.4.2.2 Comparison of HUVEC, Primary GEC and GEC2: neutrophil capture 
 
The EC cell types were compared for neutrophils captured after being treated with no 
cytokine, TNFα and IL-1β at various concentrations and hydrogen peroxide. These 
flow experiments were performed taking multiple data comparisons at 2 minute time 
intervals and all this data was compared in ANOVA. To present this data in graph 
form with all time points is very complex, so for simplicity, data are shown at 5 
minutes only (although all the data exists for all these comparisons). In some 
instances although the five minute comparative data doesn’t look as if it matches the 
statistics, the ANOVA is taken from the entire data set. 
Comparison after TNFα stimulation 
 
The three cell types were compared to see if unstimulated ECs captured neutrophils 
and whether the behavior of the neutrophils differed. As with HUVEC experiments 
previously, very small numbers of neutrophils were captured by any ECs (less than 
35 per mm2 per 106 cells perfused) and there was no significant difference in capture 
of behavior between the EC types (data not shown). 
 
The three endothelial types were then compared after stimulation with 2units/ml of 
TNFα. When all three cell types were compared together there were significant 
differences only in the number of neutrophils captured. When this was further 
dissected, HUVEC was not different from either of the other cell types, but the 
numbers of neutrophils captured was different when comparing primary and GEC2 
(p=0.017) (Figure 47). The significance of these findings are however difficult to 
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interpret as perhaps with a small increase in TNFα, capture would have been greater 
on GEC2 particularly since at higher doses of TNFα the three cell types behaved the 
same. 
 
In a highly stimulated system, when the EC had been stimulated with 100units/ml 
TNFα, the three EC demonstrated similar numbers of cells captured, and similar 
behavior, only different in the amount of migration which was increased on GEC2 
compared to the two primary cell types (Figure 47). 
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Figure 47: Comparing endothelial types capturing neutrophils in flow 
after stimulation with TNFα.  
HUVEC, PGEC and GEC2 were compared for capture and behaviour of 
neutrophils in the flow model after stimulation with 2units/ml TNFα or 
100units/ml TNFα. Less neutrophils were captured on GEC2 compared 
to PGEC with 2units/ml TNFα (p=0.017) but behaviour was similar. 
Capture was the same on all EC with 100units/ml TNFα and behaviour 
was similar. Wall shear stress =0.1Pa, n=5. 
 
Comparison after IL-1β stimulation and hydrogen peroxide treatment 
 
These experiments were performed comparing HUVEC with the primary glomerular 
cells only. Under the influence of a low level of IL-1β (5 x 10-10g/ml), there were 
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significantly less cells captured by PGEC (p=0.001) than HUVEC, and the proportion 
of static cells on PGEC were also less (p=0.005). Thus the cells captured on PGEC 
were either rolling or had migrated (Figure 48).  
 
Comparing PGEC with HUVEC under the influence of high levels of IL-1β there was 
significantly more capture on HUVEC (p=0.015). As previously, there was a 
significantly greater proportion of neutrophils static on HUVEC (p=<0.001) and more 
rolling on HUVEC (p=0.006) (Figure 48). 
 
When HUVEC and PGEC were compared under the influence of H2O2 (1 millimolar) 
the resulting neutrophil capture was very different. HUVEC captured substantial 
numbers of neutrophils whereas PGEC did not (p=<0.001). The neutrophils captured 
on HUVEC rolled or were static, very few migrated (Figure 48). 
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 Figure 48: Neutrophils on HUVEC and PGEC after stimulation with IL-1β 
or H2O2.  
Using the flow model, neutrophils were captured less onto PGEC than 
HUVEC when stimulated with high IL-1β (5 x 10-9g/L) (p=0.001), low IL-1β 
(5 x 10-10g/L) (p=0.015) or H2O2 (p=<0.001) where PGEC did not capture 
neutrophils. A greater proportion of neutrophils were static on HUVEC 
compared to PGEC with low (p=0.005) and high (p=<0.001) IL-1β, and 
rolling was also less on PGEC (p=<0.001). Data shown only at 5 minutes 
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but ANOVA performed on all data to 15 minutes. Wall shear stress 
=0.1Pa, n=3. 
7.4.2.3 Comparison of HUVEC and Primary GEC: peripheral blood lymphocyte 
capture 
 
When EC were treated with TNFα there was very little difference in neutrophil 
capture on primary GEC compared to HUVEC, and this finding was consistent with 
the previous findings that selectins and ICAM-1 were present on all three cell types. 
However because of the lack of VCAM-1 on the glomerular cells, we postulated that 
this would affect lymphocyte capture. We therefore repeated the flow experiments 
with HUVEC and PGEC and stimulated these with 100units TNFα for 24 hours in 
order to upregulate VCAM-1. We flowed human peripheral lymphocytes over the 
monolayers and observed capture and behaviour. PBLs adhered to both HUVEC and 
PGEC but significantly less to PGEC (p=0.036) in keeping with the reduced /absent 
surface expression of VCAM-1 found in the initial studies (Figure 49). There was no 
difference in the proportion of PBL rolling, undergoing static adhesion or migrating on 
the different EC types once they had been captured. 
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Figure 49: Capture and behaviour of peripheral blood lymphocytes 
(PBLs) on HUVEC and PGEC. 
PBL are captured significantly less onto PGEC than HUVEC (p=0.036) in 
the flow model. The behaviour of PBL is similar on the two EC types 
(blue, rolling cells; red, static cells and yellow, migrated cells). Wall 
shear stress = 0.1Pa, n=3. 
Blockade of VCAM-1 and its ligand VLA4 
 
In order to check that the binding we were observing was VCAM-1 dependent we 
initially blocked VCAM-1 on the surface of the EC, and subsequently blocked its 
ligand VLA4 on the PBL. Blocking VCAM-1 on the endothelial surface (Figure 50) 
reduced binding on both HUVEC and PGEC (HUVEC p=0.007; PGEC p=0.037).  
 
Blockade of the VCAM-1 ligand VLA-4 on the PBL reduced binding but this did not 
reach significance (Figure 50). There was no difference between control treated and 
untreated cells in either experiment. Thus the PGEC, although expressing reduced 
amounts of VCAM-1, must be expressing enough to support minimal adhesion of 
PBL. 
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Figure 50: Peripheral blood lymphocyte capture after blockade of 
VCAM-1 and VLA-4.  
Using the flow model, peripheral blood lymphocytes (PBLs) capture 
onto human umbilical vein ECs (HUVEC) and PGECs (PGEC) were 
compared without treatment of the EC, to EC treatment with CD18 
(control) or anti-VCAM-1 antibodies. Blockade of VCAM-1 results in a 
significant reduction in adhesion on both cell types compared to 
control (HUVEC p=0.007; PGEC p=0.037). n=3; wall shear stress = 0.1Pa. 
Subsequently PBLs were untreated or treated with control (anti CD18) 
or anti-VLA-4 antibodies. Blockade of VLA-4 results in a non-significant 
reduction in adhesion on both cell types compared to control. All the 
data has been compared to untreated cells and expressed as a ratio. IC 
= isotype control. 
 
7.5 Immunohistochemistry of whole kidney for VCAM-1 
From the above studies we had established that VCAM-1 appeared to have reduced 
expression on glomerular endothelium and this had functional consequences in 
terms of PBL capture. We postulated that this may be a protective mechanism in the 
kidney to prevent cell capture and inflammation. We wished to explore VCAM-1 
expression in vasculitis, to establish if the expression of VCAM-1 is up-regulated 
here. Using immunohistochemistry we stained kidney sections of a patient with 
vasculitis and looked at glomeruli which were histologically relatively unaffected by 
the disease, those that were actively affected and those that had been inflamed and 
were sclerosed, or scarred, and no longer functional. We observed that the VCAM-1 
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expression was minimal in glomeruli unaffected by vasculitis, was up-regulated by 
the process of inflammation and was almost absent again after scarring and 
shrinkage of the glomerulus, where there was little if any functional endothelium 
present to express VCAM-1 (Figure 51). 
Figure 51: VCAM-1 staining on human kidney.  
In a patient with Wegener’s Granulomatosis VCAM-1 is not expressed 
on the endothelium of an unaffected glomerulus. In the same kidney 
section glomeruli with vasculitic lesions have up-regulated expression 
of VCAM-1. Once the glomeruli are scarred and sclerotic the expression 
of VCAM-1 is reduced as functional endothelium dies. 
 
7.6 RNA arrays 
After comparison of the three endothelial types as described and functional studies, 
we wished to explore gene expression. The three cell types were compared by RNA 
array analysis using the whole human genome. Firstly by predictive analysis 
microarrays (PAM) the cells grouped according to their derivation as three distinct 
groups, PGEC, HUVEC and GEC2 (Figure 52). There were six samples in each 
group. The PGEC and the GEC2 grouped together while the HUVEC divided into two 
groups within the population (Figure 52). The groups were compared to each other 
for the number of genes that were significantly different from each other, PGEC 
compared to HUVEC had 3% of different  genes; GEC2 compared to HUVEC 3%, 
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and PGEC compared to GEC2 11%.  The immortalised and primary GEC were more 
different from each other by these analyses than to HUVEC. 
 
Using significance analysis microarrays (SAM) set to a 0% false positive discovery 
rate, comparing all three populations together, 322 genes were different. For PGEC 
versus HUVEC 22 genes were different; for PGEC versus GEC2 793 genes were 
different and for GEC2 versus HUVEC 39 genes differed.  The reason for the 
difference in these numbers is the variability seen within the HUVEC genes, thus 
genes that might well be significant have to be discounted due to too high a variability 
within the HUVEC population. The GEC populations are more consistent internally, 
and hence significant differences are more easily discerned when these are 
compared. 
 
We next looked for specific gene expression. vWF has 2 genes and in comparing the 
two primary cells, vWF was expressed four times more in HUVEC than PGEC. 
Expression in PGEC compared to GEC2 was similar, that is, there was less than a 2 
fold difference in expression of these genes. Specifically looking at adhesion 
molecule gene expression we found that E-selectin was similarly expressed in 
HUVEC and PGEC but ICAM-1 was expressed less (0.23) in PGEC than HUVEC. 
This may be part of the explanation as to why in some of our assays neutrophil 
capture was reduced on glomerular cells. 
 
VCAM-1, which has 2 genes, was expressed similarly in HUVEC and PGEC, but 
more highly in PGEC compared to GEC2 (5.7 and 2 times for each gene). 
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Figure 52: RNA arrays, predictive analysis microarrays (PAM).  
The ECs tested fall into three distinct populations (PGECs, blue; human 
umbilical vein ECs (HUVEC), yellow; immortalised glomerular ECs 
(GEC2), red). The HUVEC divide into two populations. 5 samples in 
each group. 
 
We were particularly interested in the difference in adhesion molecule surface 
expression and particularly the pathways governing expression of VCAM-1 on the 
cell surface. Post-translational modification of VCAM-1 in the endoplasmic reticulum 
and Golgi adds an α2 6-linked sialic acid, which may affect adhesion (Abe, Smith et 
al. 1999). We therefore looked to see if the gene encoding the enzyme Galß1-
4GlcNAcα2,6-sialyltransferase (ST6N) responsible for the addition of this sialic acid 
was different between HUVEC and GEC.  
 
We found that the gene was similarly expressed in PGEC and GEC2 in the 6 
samples tested, but was more highly expressed in HUVEC (comparing PGEC to 
HUVEC the gene was expressed four times more in HUVEC when the samples were 
averaged), and importantly this difference was consistent within the sample groups 
(Figure 53). 
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 Figure 53: Expression of ST6N gene in PGEC compared to HUVEC.  
Using RNA array analysis, the ST6N gene is expressed 4x more highly 
in HUVEC compared to PGEC and this is relatively consistent between 
the 6 samples in each group. 
 
7.7 Discussion 
ECs have different functions depending on their location. Macrovascular endothelia 
such as HUVEC are functionally required to carry blood from the mother to the foetus 
and are not required to undertake the complex filtering function of glomerular 
microvascular endothelium. Glomerular endothelium is distinct in its structure and 
function. 
 
7.7.1 Appearance of EC under phase contrast and electron microscopy 
 
The EC grew in monolayers and appeared similar to each other. There was no 
bunching or overlap of cells and they retained a characteristic ‘cobblestone’ 
appearance under phase contrast microscopy. Under electron microscopy the 
primary glomerular cells demonstrated fenestrations which were increased in the 
presence of high concentrations of VEGF, fenestrations were also demonstrated in 
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GEC2 under conditions of high VEGF, but were not induced in HUVEC. This is in 
agreement with physiological appearances of the cells and confirms their EC 
derivation. It is interesting that HUVEC could not be induced to fenestrate in these 
studies and demonstrates a further important difference between these and 
microvascular cells. 
 
7.7.2 GEC1 
 
The GEC cell line 1 did not efficiently capture neutrophils from flow, and there was 
very little capture even when treated with high concentrations of TNFα. These cells 
could be induced to capture more neutrophils if the neutrophils had been exposed to 
ANCA, but this capture remained inefficient when compared to HUVEC. ILβ-1 and 
histamine did not induce neutrophil capture on this cell line.  
 
It is likely that during passage this cell line has been corrupted. From the ELISA data 
it did not express E-selectin and therefore cannot capture cells in flow. This problem 
has been encountered before in previous experiments in our laboratory on another 
immortalised dermal cell line (unpublished data) and may reflect the complex 
cardohydrate-based post-translational modifications that have to occur for functional 
selectin molecules to be synthesised. vWF was also very minimal on 
immunohistochemistry and since vWF exists with P-selectin in Weibel-Palade bodies, 
we postulate that the mechanism transporting these molecules to the cell surface 
may have become disrupted in these cells, which would add another reason for poor 
expression of selectins overall. The appearance of the cells under phase contrast 
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microscopy and the presence of CD31 on immunohistochemistry makes it likely that 
these cells are endothelial, and that there had not been an inadvertent selection for 
another cell type (such as fibroblasts) during passage. 
 
Other workers have reported such problems with EC lines. In one study four different 
immortalised endothelial lines were used to study interactions with lymphocytes, and 
compared to HUVEC or human dermal microvascular ECs (HDMEC). When 
stimulated with TNFα, the HUVEC and HDMEC supported rolling and adhesion of 
lymphocytes, but none of the immortalised lines did. Cell surface expression of E-
selectin was only seen on HUVEC and HDMEC.  Immunohistochemistry showed 
some of the cell lines to express E-selectin intracellularly, suggesting impaired post 
translational processing or transport, and some did not even express E-selectin 
mRNA, suggesting impaired transcription (Oostingh, Schlickum et al. 2007). 
 
In light of these experiments, further work with the cell line GEC1 was abandoned, 
and the full reasons for these findings were not further explored. 
 
7.7.3 CD31 and vWF 
 
Initial studies verified the phenotype of PGEC, GEC2 and HUVEC as endothelial 
using CD31 and vWF.  
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7.7.3.1 Lymphatic cell contamination 
 
There is no specific marker for endothelial cells, and it should be noted that lymphatic 
endothelial cells also express CD31 (but not vWF) and have previously been derived 
from vascular EC in vitro (Groger, Loewe et al. 2004) raising the possibility of 
transformation of vascular EC to lymphatic EC in our experiments. However since our 
cells also stained for vWF we are confident this was not the case. 
 
7.7.4 E-selectin, ICAM-1 and VCAM-1 
 
To explore the potential functionality of glomerular endothelium in immune and 
inflammatory responses, the expression of E-selectin, ICAM-1 and VCAM-1 were 
assessed on resting and cytokine-activated, as well as on permeabilised cells. 
Although the results of the ELISA confirm that all three adhesion molecules could be 
detected above basal levels after permeabilisation, the levels were not consistently 
higher than levels after cytokine stimulation. This could indicate that all the protein is 
expressed on the cell surface, with none within the cytoplasm, which seems unlikely, 
or that the permeablisation was not very effective. It is known that cells can close 
holes made in their surface, and it is possible that because detergent was not used 
with application of the secondary antibody, complete permeabilsation was not 
achieved. 
 
Our data demonstrated that E-selectin was present and surface expression was up-
regulated by TNFα and IL-1β on all three cell types by ELISA. Flow cytometry on 
HUVEC and GEC2, and immunohistochemistry supported these findings. Flow 
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cytometry on PGEC was less convincing. This may be due to problems with the 
fragility of the PGEC cells as discussed elsewhere, the low numbers of cells used or 
due to technical problems with the methodology. 
 
 Factors governing paucity of glomerular endothelial expression of E-selectin in vivo 
are clearly complex given that these cells have the potential to express this molecule, 
as evidenced by both this and previous studies where E-selectin expression was 
induced in cultured glomeruli by exposure to exogenous IL-1β, TNFα and Interferon-γ 
(Savage, Brooks et al. 1997). E-selectin was induced on cultured human GEC and 
HUVEC by TNFα (Murakami, Morioka et al. 2001). 
 
H2O2 was used to upregulate selectins on the EC surface, so it is surprising that this 
could not be demonstrated in these studies with HUVEC. This substance is however 
known to be toxic to cells and it may be that in these concentrations, in static 
conditions, EC are being damaged. 
 
ICAM-1 was similarly expressed and up-regulated on all EC tested although as with 
the E-selectin the flow cytometry data for PGEC was of limited value for similar 
reasons as discussed for E-selectin expression. Unfortunately the antibodies 
available did not allow for immunohistochemistry so this data is not available for 
ICAM-1. There is a disparity between the expression of ICAM-1 demonstrated by 
ELISA and that by flow cytometry, likely to be due to limited numbers of poor quality 
cells used in the flow cytometry experiments. However, although VCAM-1 was clearly 
detected on resting HUVEC and expression was up-regulated by TNFα, it was 
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detected in very low amounts on glomerular EC using flow cytometry and not 
detected using immunocytochemistry. Thus, although VCAM-1 was detected on 
resting PGEC by ELISA, there was little expression on cytokine-stimulated PGEC 
and on resting or cytokine-stimulated GEC2. This contrasts with previous reports 
suggesting that VCAM-1 was induced on cultured human GEC after 6 hours 
exposure to IL1β or TNFα (Park, Chang et al. 1998; Murakami, Morioka et al. 2001). 
The present studies did show that VCAM-1 was detected by Western blotting on all 
three EC types, although there was evidence of possible variability of isoform 
expression between HUVEC and glomerular cells from the molecular weigh profiles. 
HUVEC and primary GEC demonstrated 2 bands between 90-100kD (Woodside, 
Kram et al. 2006) under reducing conditions. In HUVEC the bands were equally dark, 
but on primary GEC the higher molecular weight band was heavier. On GEC2 there 
appeared to be only one band at the higher molecular weight. VCAM-1 is known to 
exist in three alternative spliced forms on ECs, the more frequent form has 7 domains 
and the other widely recognized form has 6 domains, both have been found in 
HUVEC (Cybulsky, Fries et al. 1991; Hession, Tizard et al. 1991; Osborn, Vassallo et 
al. 1994).  A further form with 8 domains has also been described (Kilger, Needham 
et al. 1995). All these isoforms are said to support PBL binding. VLA-4 binds to 
domains 1 and 4. In a study of VCAM-1 binding ability, the 7 domain isoform was 
found to bind with higher affinity and was a more efficient agonist of VLA-4 function 
than the 6 domain form (Woodside, Kram et al. 2006).  If the different isoforms have 
differing abilities to be transported to the cell surface, this could explain the variation 
in VCAM-1 expression between the EC types. The domain 6 isoform of VCAM-1 
lacks domain 4, but binding of PBL to VCAM-1 has been reported to be dependent 
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on domain 1 (Abe, Ballantyne et al. 1996; Konstantopoulos, Kukreti et al. 1997). 
Domain 4 has been suggested to be important for strengthening adhesion 
(Needham, Van Dijk et al. 1994). 
 
The low levels of VCAM-1 expression on normal renal endothelium in this study may 
be relevant to disease processes. It is possible that under normal circumstances the 
kidney is protected from leukocyte interaction by expressing low levels of VCAM-1 
and when this becomes disrupted, inflammation ensues. For example, in AAV, 
neutrophil-endothelial interaction increased by the presence of ANCA may in part be 
driven by aberrant VCAM-1/ neutrophil interaction (Reinhardt, Elliott et al. 1997). In 
mice, neutrophils appear in some situations, to bind to MPO via the ligand VLA-4 
which is also the ligand binding VCAM-1 (Kuligowski, Kwan et al. 2009). Additionally, 
in renal biopsies from patients with vasculitis, VCAM-1 was found in glomerular 
endocapillary cells and was associated with more severe lesions (Pall, Howie et al. 
1996). In a subsequent study VCAM-1 was again found in vasculitis in human renal 
tissue (Arrizabalaga, Sole et al. 2008) where abnormal VCAM-1 and ICAM-1 were 
seen in the tubules of more than 80% of patient samples and in the glomerular tuft in 
more than 60%. VCAM-1 was associated with leukocyte infiltration, suggesting that 
VLA-4 bearing leukocytes are contributing to glomerular injury. This association was 
also found where VCAM-1 was expressed in tubular and vascular areas in biopsy 
specimens of patients with vasculitis. VCAM-1 was a good marker of necrotising 
extra-capillary damage and was thought to be crucial for macrophage recruitment to 
these areas (Rastaldi, Ferrario et al. 1996).   
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7.7.5 Functional comparison of HUVEC, PGEC and GEC2 
 
The choice of media is important as the environment in which the cells are grown will 
change their behaviour. Not only does this have implications for experiments where 
comparisons are made in the behaviour of neutrophils on the EC surface, but also 
has implications about how closely these cells are reflecting the behaviour of their 
counterparts in vivo. Clearly, if the environment in which the cells develop has a huge 
impact on their ability to capture cells, it may be rather futile to look at these cells 
when they have been grown in standard in vitro conditions. In other words, the 
glomerulus may indeed demonstrate very different properties in cell capture to the 
umbilical cord, but this may be influenced by the environment and particular 
cytokines found there, rather than the type of EC per se. 
 
When unstimulated, the three EC types were comparable in that they did not capture 
neutrophils. This is an important finding because if neutrophils were captured on 
unstimulated glomerular ECs this would have implications for disease processes 
within the glomerulus. 
 
The only difference between the three cell types when stimulated with small amounts 
of TNFα was the difference between the numbers of cells captured on primary GEC 
and GEC2.  The behaviour of neutrophils on the three cell types was similar once the 
cells were captured, and there were no significant differences between HUVEC and 
the glomerular cells. 
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Unlike in the system where only a low level of TNFα was used, the highly stimulated 
system did not demonstrate differences in capture or rolling, but only in migration. 
Under the influence of TNFα neutrophils undergo more migration on any EC but this 
was demonstrated to be increased on GEC2 more than HUVEC or primary cells. A 
more detailed discussion of cell lines and the possible problems involved with them is 
undertaken later in this thesis, and because of this complicating factor, further studies 
were concentrated on the comparison of the two primary cells, HUVEC and PGEC. 
 
In these experiments with TNFα on PGEC compared to HUVEC we therefore 
concluded that neutrophil capture and behaviour was similar between the cell types. 
These results were expected in light of the findings that E-selectin and ICAM-1 was 
similarly expressed on both cell types. 
 
We subsequently explored this theory in more detail by looking at the EC under the 
influence of IL-1β and H2O2. Under the influence of IL-1β at two concentrations, a 
cytokine elevated in AAV, fewer cells were captured on the glomerular cells and 
within the population of captured neutrophils, there was proportionally more rolling or 
migrating behavior. Cells in the glomerulus influenced by IL-1β therefore seem to 
either roll or migrate suggesting that they can pass through the EC layer more easily 
than on HUVEC. H2O2 induces selectins on the surface of EC but is also toxic to the 
cells. The differences seen in cell capture between HUVEC and PGEC could 
therefore be explained either by the fact that HUVEC is less sensitive to toxicity or 
that HUVEC more readily up-regulates selectins. If the later is the case, this may 
explain the increased rolling and static behaviour seen in the previous experiments, 
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and the ability of HUVEC to capture more cells than glomerular EC. If there were 
actually less expressed selectin in the glomerulus this could be a protective 
mechanism for the kidney, ensuring that neutrophils are only captured to migrate if 
the conditions are highly inflamed. The neutrophils captured however migrated more 
across the EC which may also be an advantage, as neutrophils remaining in the 
circulation would block small capillaries. If they are moved effectively through the EC 
layer to the tissues where they are needed for an effector response, any problems 
deriving from infective organisms would be cleared quickly. Such a theory would not 
be applicable to the umbilical cord which is a conduit vessel and would not need 
neutrophils to move across it’s endothelium for a tissue response. In conclusion, 
although initial experiments suggested that glomerular EC and HUVEC were similar 
in supporting neutrophil adhesion and behaviour, subsequent work suggests that it 
may not be reliable to use HUVEC to extrapolate about the behavior of other types of 
EC, which despite being grown in in vitro environments, nevertheless seem to retain 
distinct properties of their own. 
 
7.7.6 Functional aspects of PBL 
 
We examined the functionality of glomerular endothelial VCAM-1 expression using 
PBLs, since previous studies have shown that VCAM-1 and E-selectin, but not ICAM-
1, are capable of supporting the adhesion of T-cells to endothelium under flow 
conditions (Konstantopoulos, Kukreti et al. 1997). Peripheral blood lymphocytes 
utilise VLA-4 to bind to endothelial VCAM-1 (Carlos, Schwartz et al. 1990; Carlos, 
Kovach et al. 1991).  Interestingly we found that recruitment of PBLs to glomerular 
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EC was reduced compared to HUVEC, although the cells that were recruited 
behaved similarly on each EC tested. This recruitment was blocked on all types of 
EC by blocking VCAM-1 or its ligand VLA-4, indicating that although there is reduced 
recruitment on glomerular EC, it remains VCAM-1 dependent. This is strong evidence 
that, despite low levels of VCAM-1 expression on glomerular cells, its presence is of 
functional relevance, in accord with up-regulation of VCAM-1 within diseased 
glomeruli. 
 
7.7.7 RNA arrays 
 
RNA arrays demonstrated importantly that the cells were grouped into their three 
distinct groups and were different from each other. However, PGEC and GEC2 were 
more different from each other than from HUVEC in some of these analyses, and this 
influenced further studies where the comparison was focused on the two primary cell 
lines.  
 
In comparing specific genes we looked at gene expression for adhesion molecules 
and found that E-selectin and ICAM-1 were similarly expressed in the two primary 
cell lines. Interestingly ICAM-1 expression was reduced in PGEC and although this 
did not seem to affect neutrophil adhesion at high levels of TNFα, this may be part of 
the explanation as to why there were some differences with reduction of capture onto 
PGEC with IL-1β and low levels of TNFα. We did not detect differing levels of ICAM-1 
on the surface by flow cytometry or ELISA, but these methods may not be sensitive 
enough to detect subtle differences. 
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 We attempted to look for reasons why VCAM-1 was not as highly expressed on the 
cell surface of GEC, and looked at the gene responsible for the enzyme Galß1-
4GlcNAcα2,6-sialyltransferase (ST6N) responsible for the addition of sialic acid to the 
protein. This is a post-translational modification which may affect adhesion (Abe, 
Smith et al. 1999). The gene was expressed less in PGEC compared to HUVEC. We 
postulate that this may contribute to the reduction in VCAM-1 expression on the GEC 
surface. 
Given more time the microarray data would ideally be validated by quantitative 
polymerase chain reaction. 
 
In summary we identify significant differences between GEC and HUVEC and 
suggest that it is not always acceptable to extrapolate from HUVEC to microvascular 
EC. In particular we found that VCAM-1 surface expression is reduced on glomerular 
cells and this resulted in reduced capture of PBLs onto this EC. Given that the kidney 
handles a large volume of blood it is important that it is protected from unnecessary 
leukocyte recruitment, down-regulation of adhesion molecules on the endothelial 
surface may be crucial in this role. Altered expression in disease states may 
contribute to glomerular damage during vasculitis and other inflammatory glomerular 
diseases. 
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8. DISCUSSION 
8.1 Early experiments and optimisation of models 
8.1.1 The flow model: applicability and reproducibility 
 
The flow model was first set up in 1993 and has been used to study a wide variety of 
interactions between flowing cells on various surfaces including selectins and ECs 
(Buttrum, Hatton et al. 1993). 
 
8.1.1.1 How good is it as a model? 
 
The flow model enables interactions of neutrophils, ECs and ANCA to be studied in 
real time and for interactions to be directly observed. It also enables interactions to 
be dissected, so that only interactions between the neutrophil and selectins can be 
studied by coating the slides with P-selectin rather than an EC monolayer. Different 
EC types may also be studied in this model. 
 
The model is limited as the ECs have not been grown under normal environmental 
conditions. They are not subject to the same chemokine/cytokine influences as occur 
in their native cellular beds, nor usually, to the influence of specific fluid shear. They 
are also detached from the cells making up the vessel walls such as smooth muscle 
cells and perictyes. This is likely to alter the adhesion cell profile of the cells in vitro. 
 
Results from the model are reproducible providing there are no changes in the 
reagents used. Different batches of P-selectin may bind differently to the surface of 
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glass microslides and different batches of cytokines have varying potencies. There is 
also variation among neutrophils, ECs and antibodies used in the experiments, so 
some variation between different experiments is likely. 
 
The flow model is a relatively difficult technique to master and is restricted in the 
number of treatments that can be used in any one experiment. Slides cannot be left 
out of medium for long, and preparations of neutrophils especially have to be used 
within a short time frame before apoptosis takes place. In addition, each slide must 
be grown in specialised plates, usually with 3 or 6 slides at a time. This limits the size 
of experiments usually to six slides per experiment.  
 
8.1.1.2 Capture of neutrophils from flow 
 
Neutrophils are captured from flow in humans by selectin molecules expressed on 
the surface of ECs which bind to their ligands on neutrophils. Selectins are expressed 
on HUVEC and primary GEC, and up-regulated by cytokines such as TNFα as 
demonstrated, and if they are not present, as on the GEC cell line 1, neutrophils are 
not efficiently captured.  
 
The captured neutrophils roll on activated endothelium and in the presence of a 
secondary stimulus convert to stationary adhesion due to engagement of integrin 
receptors on the neutrophil surface, which bind ligands such as ICAM-1. 
 
This secondary stimulus can be provided by bacterial agents such as fMLP, and also 
by patient ANCA, although not by all patient ANCA as demonstrated. Chimeric anti-
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PR3, of a single subclass and directed against one epitope can also provide this 
stimulus. 
 
8.1.1.3 Receptor expression on HUVEC compared to the P-selectin model 
 
In order to be able to study interactions of ECs and neutrophils, a simplified model 
was used where P-selectin was coated onto the microslides. In this model, 
neutrophils could not transmigrate as there was no EC layer, and any interactions 
between the neutrophils and the selectin surface were due to the interaction of 
neutrophils with selectins. Because the model is simple, variation is reduced. 
 
8.1.1.4 Previous work with ANCA in the flow model 
 
There have been three previous papers examining the influence of ANCA on 
neutrophils in flow. In the first paper microslides were covered with a layer of 
activated platelets, and neutrophils which were treated with patient ANCA or normal 
IgG immediately prior to infusion, were perfused over the platelets. ANCA, but not 
normal IgG stopped the neutrophils rolling and this effect was transient, returning to 
baseline at 15 minutes. Antibodies blocking the FcγRIIa and the integrin 
CD11b/CD18 stopped this effect (Radford, Savage et al. 2000).  
 
In the second paper, neutrophils were treated with ANCA or normal IgG and perfused 
over ECs activated with 100units/ml (highly activated) or 2units/ml (minimally 
activated) of TNFα. On highly activated endothelium, most of the neutrophils 
transmigrated and this remained unchanged with untreated neutrophils, those treated 
 210
with normal IgG and those treated with patient ANCA. On minimally activated EC, 
untreated neutrophils were compared to neutrophils treated with ANCA. There was a 
significant increase in adhesion and transmigration when ANCA was used. There 
was no difference between neutrophils treated with ANCA immediately before 
infusion, 5 minutes or 15 minutes before infusion. Antibodies were used to block 
CD18, which disrupted adhesion and CD11a, which did not. Treatment of EC with 
ANCA alone, with subsequent perfusion of neutrophils did not cause neutrophil 
adherence (Radford, Luu et al. 2001). 
 
In the third paper, antibodies were used to block integrins and CXC receptors. 
Neutrophils exposed to ANCA were studied on highly and minimally activated 
endothelium. CD11a/CD18, CD11b/CD18 and CXCR2 were found to be important in 
adhesion and transmigration in both models, but CD11b/CD18 was more important in 
the minimally activated model (Calderwood, Williams et al. 2005).  
 
8.1.2 Patient ANCA: variability of pathogenicity 
 
8.1.2.1 Patient ANCA activates neutrophils and varies in pathogenicity  
 
In recent experiments reported above, we confirmed that neutrophils treated with 
ANCA were arrested on a P-selectin surface to a greater extent than neutrophils 
treated with normal IgG. In contrast to the experiments reported by Radford et al, 
pure P-selectin and not layered platelets were used. There was variability between 
different patient ANCA. 
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The finding that ANCA promotes adhesion and migration of neutrophils on HUVEC is 
also supported by recent experiments above. In addition to Radford et al, it was 
found that there were significant differences between neutrophils treated with normal 
IgG and those treated with ANCA on highly activated endothelium. This may be due 
to variation in the TNFα batch used, which allows differences to be seen in the recent 
experiments which were not obvious in the experiments reported in the Radford et al 
paper. On minimally activated endothelium, we confirmed that that there is a 
significant difference between untreated neutrophils and those treated with ANCA. In 
addition, there was a significant difference between normal IgG and patient ANCA on 
the behaviour of neutrophils, suggesting that this is not simply a function of IgG on 
the neutrophil, but is a specific effect of ANCA. 
 
8.1.2.2 ANCA pathogenicity and the relevance of superoxide production 
 
It has been suggested previously that ANCA may act on neutrophils causing them to 
change in shape and become trapped inside small capillaries where they degranulate 
and cause damage (Cockwell, Brooks et al. 1999). This theory is not supported by 
the data in the experiments above which found that ANCA actually promotes 
adhesion and transmigration of neutrophils across the vessel wall in the presence of 
cytokines. It may be that ANCA, by causing the neutrophils to activate, simply 
promotes infiltration into the tissues of activated neutrophils, and these then set up 
an inflammatory response leading to tissue destruction. 
 
There is additional evidence that the response of neutrophils to ANCA is 
dysregulated, that abnormal signalling pathways are set up (Williams, Ben-Smith et 
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al. 2003) and that the neutrophil undergoes dysregulated apoptosis (Harper, Ren et 
al. 2000) which may contribute to this pro-inflammatory state. 
 
ANCA activation of the neutrophil leads to two major actions: the superoxide 
response and the release of proteolytic enzymes. There is some evidence that 
mediation of endothelial damage may be by proteolytic enzymes (Lu, Garfield et al. 
2006) rather than superoxide. In this paper vWF release from damaged EC by fMLP 
and ANCA, was caused by serine proteases rather than by superoxide. Such findings 
would be supported by work from this thesis. The superoxide responses were not 
always related to the findings in the flow model. Patient 220054 elicited a good 
superoxide response, but was not affective in stopping neutrophils in the flow model, 
patient 220028 elicited responses in both superoxide and flow and patient 220115 
did not illicit a significant superoxide response, but did stop neutrophils in flow. 
 
8.1.2.3 Why patient ANCA varies in pathogenicity 
 
It is not clear why there is variation in responses of patient ANCA in various assays. 
The amount of ANCA in each sample is not known, only the total concentration of 
IgG, so that in some samples there could be very little ANCA, and between the 
various patient ANCA tested the concentration of ANCA is likely to be very variable. It 
is difficult to quantify or isolate patient ANCA from IgG fractions. The patient samples 
used in these studies were tested to confirm they were positive by ELISA for ANCA.  
 
All the patient ANCA tested in the flow model induced superoxide responses, but not 
all ANCA tested in our lab elicit a superoxide response (unpublished data). Co-
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workers in our laboratory have demonstrated that all the ANCA used in the flow 
model increase IL8 release from neutrophils, but again not all ANCA induce this 
response. 
 
It may be that there is a genuine variation in ANCA activity in different assays, and 
this is currently a subject of ongoing investigation in our laboratory (unpublished 
work). All patient samples were isolated during acute, severe disease; patients 
undergoing plasma exchange have either pulmonary haemorrhage or end-stage 
renal failure. None of the patient ANCA were from patients in remission or with mild 
disease. Additionally, patients were all presenting for the first time with vasculitis; 
there were no patients with relapsed disease. The amount of time that the disease 
had been present before presentation is unknown. Due to the nature of the disease, 
many patients will have a long period of non-specific symptoms prior to acute 
presentation. This would allow the development of IgG subclass switching, and 
accumulation of IgG4, and could conceivably account for some of the variation in 
ANCA activity. In addition, subclasses of ANCA may be influencing pathogenicity and 
it is interesting to note that Patient 220054, whose IgG was the least effective at 
causing neutrophils to adhere had a very different subclass profile to the other patient 
samples, with an over representation of IgG2. 
 
Patient ANCA is polyclonal and although generally directed against either PR3 or 
MPO, is known to be directed against more than one epitope on these molecules. It 
may be that ANCA directed against some epitopes are more pathogenic than others, 
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and it has also been proposed that some ANCA may bind to the activate enzymes 
PR3 and MPO and inactivate them (van der Geld, Tool et al. 2002).  
 
Variability may also be dependent on the neutrophil response to the antibody, and 
therefore be dependent on neutrophil factors. Neutrophils may express different 
levels of target antigens (von Vietinghoff, Tunnemann et al. 2007), there may be 
differences in FcR polymorphisms (Edberg, Wainstein et al. 1997) or polymorphisms 
between signalling proteins. Differences between neutrophil donors are currently 
being explored in our laboratory. 
 
8.2 Interactions of immunoglobulin and neutrophils: normal IgG 
versus ANCA and the effect of IgG subtype 
8.2.1 Interaction of neutrophils on solid phase IgG 
 
In order to assess whether the subclass of ANCA IgG was important in activation of 
the neutrophil, we first wished to explore the interaction between normal IgG and 
neutrophils. Because neutrophils are not activated by normal IgG in fluid phase, and 
require crosslinking of many Fc receptors, we designed experiments where IgG was 
presented in solid phase allowing neutrophils to sample many Fc receptors at once. 
This was achieved by coating glass microslides with each IgG subclass. Current 
thinking was supported by our studies where neutrophils bound avidly to IgG3, less to 
IgG1 and minimally to IgG2 and IgG4 (Jefferis and Kumararatne 1990). The 
neutrophils adhered to the surface and spread out, extending pseudophilia across 
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the surface and exhibiting random movement, pulling themselves into odd shapes as 
they encountered more and more IgG.   
 
IgG3 was the most potent subclass at binding neutrophils. It has also been reported 
as being pathogenically important in vasculitic disease (Mulder, Stegeman et al. 
1995), and to bind Fc receptors more avidly than the other subclasses. This is 
explained by its structure with a long hinge region allowing the protein flexibility and 
increased binding (Burton and Woof 1992). 
 
We looked at the roles of the constitutive receptors CD16 and CD32 in neutrophil 
adhesion in flow conditions, and found that while all subclasses are affected by 
blocking these, there is a differential utilization of the receptors. Thus, CD16 was 
more important in IgG3-mediated adhesion under flow, while CD32 was more 
important for IgG1 and 2 mediated adhesion.  
 
When we examined the role of CD18, part of the integrin complex, blocking resulted 
in a reduction in the spreading behaviour, neutrophils no longer extended 
psuedophilia across the cell surface. This behaviour is an active process, requiring 
cell signalling, because when we abolished the ability of the cell to signal by chelating 
intracellular calcium with BAPTA-AM, the behaviour was inhibited. This is perhaps 
unsurprising, but in addition, adhesion to the IgG surface was reduced, indicating that 
capture is also an active process requiring cell signalling. 
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8.2.2 Interaction of neutrophils with ANCA subclass 
 
ANCA activity has been detected in all four IgG subclasses and there is evidence that 
different subclasses of ANCA IgG have different effects on neutrophil activation. One 
proposed mechanism of ANCA stimulation of neutrophils is the colligation of PR3 
antigen with CD32/CD16. Since IgG4 has not been reported to ligate these receptors 
in primed neutrophils, IgG4 ANCA would not be expected to stimulate a superoxide 
response. Experiments with fresh human neutrophils (which do not express CD64, 
only CD32/CD16) and samples of human ANCA IgG1, 3 and 4 from different 
patients, all were able to elicit a superoxide response. Deglycosylation of ANCA IgG 
resulted in loss of its activating ability consistent with CD32/CD16 involvement, since 
deglycosylation impairs binding of IgG to these receptors while deglycosylated IgG 
may still bind to CD64. IgG4 was also capable of neutrophil activation suggesting that 
it can activate via CD32/CD16 receptors (Holland, Hewins et al. 2004). 
 
8.2.3 The importance of subclasses in other autoimmune disease 
 
Subclass of IgG has been reported as having a role in influencing the pathogenesis 
of many other diseases. In Rheumatoid Arthritis, anti-fibrinogen antibodies are 
predominately IgG1 and IgG4. IgG1 is produced in a predominantly Th1 response 
(the traditional theory for RA), whereas IgG4 requires IL-4, predominately a Th2 
response. Other cells can secrete IL-4 and in the vicinity of B cells this could result in 
a class switch to IgG4 (Chapuy-Regaud, Nogueira et al. 2005). 
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In Goodpasture’s disease, where the autoimmune immunoglobulin is directed against 
type IV collagen, experiments in rats have shown that IgG2a and IgG2b antibodies 
result in severe nephritis, where IgG1 results only in mild nephritis (Kohda, Okada et 
al. 2004). IgG2a and 2b induce proteinuria where as IgG1 did not, and this effect was 
due to induction of infiltration of inflammatory cells into the glomerulus (Kado, Kohda 
et al. 2006). 
 
In Myasthenis Gravis anti-receptor autoantibodies were predominately IgG1 and thus 
able to activate complement, and IgG4 which is unable to activate complement 
(Romi, Skeie et al. 2000). The cell mediated response involves both Th1 and Th2 
lymphocytes and a Th1 response alone was not necessarily associated with severe 
disease.  
 
Systemic lupus erythematosis has multiple autoantibodies. The frequent occurrence 
of a rise in IgG2 anti-nucleohistone and IgG1 anti-dsDNA in patients prior to a renal 
relapse suggests that, besides IgG1 subclass autoantibodies, IgG2 subclass 
antibodies to nucleohistone have a particular pathophysiological role in lupus 
nephritis (Bijl, Dijstelbloem et al. 2002). 
 
While all four IgG anti-beta2-GPI antibody subclasses were represented in patients 
with anti phospholipid syndrome, there appeared to be a significant overall skewing 
towards to the IgG2 subclass (Guerin, Casey et al. 1999).  
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8.2.4 Why we wished to develop chimeric anti-PR3 
 
Patient ANCA is polyclonal, directed against more than one epitope on PR3 or MPO, 
and sometimes to epitopes on both, and is represented in all four IgG subclasses. It 
is difficult to isolate from patients, and requires obtaining plasma exchange fluid. 
Because the disease is treated after this this initial presentation, it is very rare for 
patients to undergo plasma exchange repeatedly, and thus from each patient there is 
a limited supply of ANCA. 
 
Total IgG is isolated from plasma exchange fluid and it is difficult to quantify how 
much ANCA there is in the sample as ELISA is not quantitative. The concentration of 
ANCA within the total IgG is low, making it impractical to isolate the ANCA fraction 
alone. 
 
Chimeric anti-PR3 was thus developed in our laboratory in order to provide a 
standard source of ANCA, whose epitope specificity, subclass and concentration was 
known. 
 
8.2.5 Evidence that chimeric anti-PR3 behaves in the same way as patient ANCA 
 
In functional studies in our laboratory prior to the current thesis, superoxide studies 
indicate that responses from IgG1 and IgG3 are similar to each other and to patient 
ANCA (Colman, Hussain et al. 2007). In this study, inhibition chemiluminesence 
indicates that chimeric PR3-ANCA of subclass IgG1 and IgG3 bind to the high affinity 
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receptor FcγR1 similarly to their control. IgG4 has also been confirmed to illicit a 
superoxide response (Hussain, in press). 
 
8.2.6 Differences between chimeric PR3-ANCA and patient ANCA  
 
Higher concentrations of chimeric PR3-ANCA are needed to cause neutrophil 
adhesion and migration in the flow model than patient ANCA which probably has a 
concentration of less than 10μg/ml in these experiments. This may be due to the fact 
that chimeric PR3-ANCA is directed against a single epitope, whereas in patient 
ANCA where multiple epitopes could be bound by different ANCA molecules, the Fc 
regions could then crosslink (this is discussed further below). It is generally accepted 
that signalling pathways reach thresholds of action and that weak and strong signals 
through the same pathway can trigger different outcomes. Thus the same pathway 
triggered at a high threshold may induce differentiation but when triggered at low 
threshold may induce proliferation. ANCA signalling pathways have been studied 
within our laboratory and it is already established that superoxide and adhesion 
pathways are different and engage different transduction molecules (Williams and 
Savage 2005). Conceivably migration and adhesion are therefore driven by separate 
signalling pathways, or migration requires stronger signals to reach a threshold. It is 
possible that with monoclonal ANCA where only one antibody binds to one molecule 
of PR3 small microdomains of signalling molecules are engaged. In polyclonal ANCA 
where two ANCA could bind to the same PR3 molecule, ‘mats’ of antibody could form 
and cause coalescence of these microdomains into larger lipid platforms triggering 
stronger/different signalling pathways.  
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 The saturation binding by ANCA to neutrophils is unknown, but is likely to vary 
depending on neutrophil donor as there is variation in PR3 expression on neutrophils. 
This is a subject of ongoing investigation in our laboratory. 
 
8.2.7 IgG subclass affects ANCA function and is dependent on Fc receptor type 
 
Previous studies in our laboratory have already established that there is a difference 
in functional outcomes between different subclasses of ANCA (Table 7) ((Colman, 
Hussain et al. 2007) and Hussain in press). The affinity of chimeric PR3-ANCA to 
bind to PR3 (by surface plasma resonance) varied where IgG3 binds more slowly but 
also dissociates more slowly than IgG1. In IL-8 studies, both IgG1 and IgG3 PR3-
ANCA induced IL-8 release from neutrophils, but IgG3 was more potent. IgG4 did not 
induce IL-8 release. In degranulation studies, all three caused degranulation, but 
IgG1 and IgG4 were more potent than IgG3. In studies of static adhesion both IgG1 
and IgG3 ANCA caused more neutrophil adhesion than their controls and there were 
similar amounts of binding between the two subclasses. Blocking studies explored 
the roles of CD32 and CD16. Initially it was established that Fc portions of the 
antibody were necessary for superoxide response; F(ab’)2 fragments did not illicit 
superoxide production. Whole IgG was also deglycoslylated and again this abolished 
neutrophil superoxide production suggesting that correct glycosylation of the protein 
is necessary for function. Pre-incubation of neutrophils with blocking antibody to 
CD32, but not CD16, inhibited liberation of superoxide by IgG1 and IgG4 PR3-ANCA. 
In degranulation blocking CD32 prevented IgG1 and IgG4 responses, and blocking 
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CD16 blocked IgG3 response. In the IL-8 studies CD16, but not CD32 was important 
in all three subclasses (Hussain et al). 
 
In the present studies, we took these observations forward by studying the effects of 
ANCA subclass in flow. These studies, on P-selectin and HUVEC established that 
IgG3 PR3-ANCA is a potent activator of neutrophils, causing them to be converted 
from rolling to static adhesion in flow. This was blocked by blockade of CD16 and 
CD32. IgG1 PR3-ANCA was also affective in activating neutrophils and causing an 
increase in static adhesion, and, although potent, its effect was not as great as IgG3 
on HUVEC. Blocking CD16, but not CD32 reduced this activation.  
 
Fc receptor function may be useful to explore in designing therapeutic targets in 
disease. Taken together, the above studies demonstrate that specific functions of 
neutrophils, as well as specific subclasses vary in their use of Fc receptors. There is 
also a difference between the predominant Fc receptors used by neutrophils when 
engaging normal IgG (CD32 for IgG1 and 2; CD16 for IgG3) and pathogenic ANCA 
(CD16 more important for IgG3 and IgG1) and causing the neutrophil to adhere 
under flow conditions. 
 
IgG4 PR3-ANCA was very interesting, as prior to these studies this was thought to be 
a benign, blocking antibody, but it appears to have pathogenic potential. It was 
reported to only engage via CD64, which is not present on the non-activated 
neutrophils in the present studies that only express the constitutive receptors CD32 
and CD16. However, in our studies, IgG4 caused a superoxide response and in flow 
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conditions, although less potent than the other two subclasses tested, was able to 
cause static adhesion of neutrophils, this must therefore have involved CD32/CD16. 
This was over a longer time frame and to a lesser extent than either IgG1 or IgG3. In 
studies blocking CD32 and CD16, no effects were seen on IgG4, but this was due to 
the early time points used in these experiments (IgG4 did not cause static adhesion 
until at least 4 minutes in P-selectin experiments), a practical problem due to limited 
resources left for these studies, making long experiments impossible. 
 
8.3 Comparison of umbilical vein and glomerular endothelial cell 
types 
We wished to examine two questions with these studies; ‘are glomerular ECs 
targeted in AAV because of a distinct phenotype?’ and, ‘is it relevant to use HUVEC 
as a substitute for GEC when investigating AAV?’ We have established from these 
studies that glomerular ECs are distinct from HUVEC and display different functional 
characteristics. Extrapolating from HUVEC to GEC is not reliable and may lead to 
erroneous conclusions concerning the functionality of these cells. GEC display 
distinct features, including a distinct adhesion molecule profile and we postulate that 
the differences that we have found between the EC types may be relevant in 
explaining the pathogenesis of vasculitis. 
 
8.3.1 Appearance and structure 
 
From our studies we confirm that in in vitro culture, PGEC are fenestrated and the 
GEC2 cell line could be fenestrated with high concentrations of VEGF, but was not 
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convincingly fenestrated in low concentrations of VEGF. HUVEC could not be 
fenestrated. 
 
8.3.2 Adhesion molecules  
 
From these studies we showed that HUVEC and GEC both have E-selectins and 
ICAM-1 on their surface, which support neutrophil rolling and adhesion. Initial studies 
in flow using neutrophils on a TNFα stimulated surface showed no difference 
between HUVEC and GEC.  
 
VCAM-1 was not detected or detected only in very small amounts on the surface of 
GEC, but was present on HUVEC. VCAM-1 supports the binding of lymphocytes to 
EC and when studied under flow conditions, PBL binding to GEC was reduced 
compared to HUVEC. By Western Blotting VCAM-1 was present in all the EC and we 
therefore concluded that either there must be two isoforms of the protein, one more 
functional than the other; or that there must be a difference in the post translational 
modification of this protein to the cell surface in GEC reducing its expression. RNA 
arrays revealed differences between the cell types, and investigation of the specific 
pathways involving post-translational modification of VCAM-1 revealed a reduction in 
expression of the ST6N gene in PGEC responsible for the sialylation of VCAM-1, 
which potentially alters the adhesion capacity of the protein (Abe, Smith et al. 1999). 
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8.3.3 Why VCAM-1 is reduced on glomerular endothelial cells 
 
The reduction in surface expression of VCAM-1 on GEC may be a protective 
mechanism to ensure that PBL are not recruited to the normal kidney interstium in 
large amounts, which would potentially cause stasis within the renal 
microvasculature.  
 
There are different isoforms of VCAM-1 and although these alternative forms have 
been found to support adhesion of VLA-4 expressing cell lines (Cybulsky, Fries et al. 
1991; Hession, Tizard et al. 1991) there may be different functional characteristics 
between them. The 6 domain (6D) form lacks domain 4. The 6D isoform in soluble 
form has also been reported to bind to its integrin α4β1 (VLA-4) with higher relative 
affinity than the 7D isoform, but in physiological conditions under shear force, cells 
adhered more avidly to the 7D isoform, which induced cell spreading at lower 
concentrations than the 6D form (Woodside, Kram et al. 2006). 
 
In vasculitis, VCAM-1, which is not present on undamaged glomeruli was found in 
necrotizing-extracapillary lesions (Rastaldi, Ferrario et al. 1996). The infiltrating 
leukocytes were activated in the damaged glomeruli, but where VCAM-1 was positive 
and the glomerulus undamaged, the infiltrating cells were predominantly 
macrophages. The authors concluded that VCAM-1 was a good marker of necrotizing 
extra-capillary damage. In another study, abnormal VCAM-1 expression was seen in 
more than 60% of patients’ glomeruli with PR3-ANCA vasculitis (Arrizabalaga, Sole 
et al. 2008). These studies were confirmed by our work on whole kidney sections 
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where we found VCAM-1 was expressed and up-regulated in affected glomeruli in 
patients with vasculitis. 
 
Although much research in AAV has focused on the neutrophil, the role of the 
lymphocyte in this disease has also been extensively investigated. T cells and 
monocytes are the predominant cells in inflammatory vascular infiltrates in AAV 
(Gephardt, Ahmad et al. 1983) and antibody isotype switching requires T-cell 
cytokines, such as IL4, so that T cells must be crucial in the disease, but whether 
they are important in the effector stage of the disease remains under debate. T cell 
responses are altered in AAV, activated circulating T cells display a Th1 cytokine 
profile (Gutfleisch, Baumert et al. 1993; Ludviksson, Sneller et al. 1998) as do T cells 
derived from granuloma of AAV patients (Moosig, Csernok et al. 1998). Whether the 
T cell responses are ANCA-antigen specific however remains debatable with 
conflicting evidence. T cells specific for ANCA antigens have been found in normal 
patients as well as those with AAV (Brouwer, Stegeman et al. 1994; Griffith, Coulthart 
et al. 1996; Winek, Mueller et al. 2004). The abnormal T cell responses may be 
driven by other antigens such as bacteria (Mayet, Marker-Hermann et al. 1999). 
 
There is no evidence in the literature pertaining to the interaction of PBL on the 
endothelium in AAV. Since we have found that VCAM-1 is reduced on normal 
stimulated glomerular endothelium and that this leads to a reduction in PBL capture, 
we postulate that this may be a protective mechanism designed to prevent the 
glomerular vasculature being clogged with inflammatory cells. If this protective 
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mechanism was to become disrupted, specific targeting of the renal vascular bed 
may be a consequence. 
 
8.3.4 Why vasculitis targets particular endothelial cell beds 
 
There are some existing theories to explain why AAV targets particular endothelial 
beds, and these largely centre on the interaction of the neutrophils with ANCA. 
 
Planted antigens (Ruth, Kitching et al. 2006), whereby degranulated neutrophils 
leave MPO in the glomerulus, which then acts as an antigen for accumulation of 
ANCA, may explain the continuation of inflammation in one vascular bed. At renal 
biopsy however, ANCA deposition is not seen, the pathology generally considered to 
be “pauci-immune” (only scant immune deposits present). Notwithstanding this, 
immune deposits can be observed in renal vasculitis and, indeed, their presence has 
been correlated with more severe disease (Haas and Eustace 2004).  
 
If ECs have genuinely different profiles and therefore the potential to recruit 
neutrophils to a different extent, this may explain the targeting of specific vascular 
beds. The interaction of ANCA with neutrophils is known to cause abnormal 
signalling pathways within the neutrophil, and if this causes abnormal activation, local 
defence mechanisms may be overridden. If the adhesion molecule profile varies 
within endothelial beds, neutrophils may become trapped and not cleared, setting up 
a nidus of inflammation. 
 
 227
Anti-EC antibodies have been detected in patients with WG and these have been 
found to selectively bind to unstimulated nasal, kidney and lung ECs. This binding 
was lost upon treatment of these cells with IFNγ and TNFα. The authors therefore 
suggested that these antibodies may be an initiator of vasculitis (Holmen, 
Christensson et al. 2004). 
 
8.3.5 Development of the cell line, advantages and problems of cell lines 
 
Cell lines can be very useful in the study of endothelium. Primary cells are difficult 
and expensive to obtain and grow, and are usually only able to be passaged to 
passage 7 before their phenotype becomes very altered and they are no longer 
behaving in the same way as early passage cells. Immortalised cell lines can be 
passaged many times and retain the same phenotype. Our collaborators in Bristol 
have developed a cell line for GEC and allowed us to study it. Contrary to their 
original findings however, the first cell line (GEC1) seemed to have been changed in 
some way so that it did not express E-selectin or vWF on the cell surface, and these 
findings were supported by its inability to support capture of neutrophils from flow. 
The second line (GEC2) did express selectins. 
 
Co-workers in our laboratory have studied a human dermal cell line, human 
microvascular ECs (HMEC-1) and found that this was also unable to support 
neutrophil adhesion in flow (unpublished data). It may be that the mechanism 
allowing the expression of selectins within the cell is easily disrupted by transforming 
these cells. 
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 This is supported by a paper examining four immortalised cell lines compared to 
HUVEC which found that HUVEC and primary dermal cells supported rolling and 
binding of lymphocytes but none of the cell lines did (Oostingh, Schlickum et al. 
2007). Immunocytochemistry of these cells showed some immortalised lines to have 
intracellular but not surface E-selectin, suggesting translation but defective post-
translational processing. Some of the cell lines had no selectin expression suggesting 
impaired transcription. 
 
In our studies we found some differences between PGEC and GEC2 which meant 
that we were concerned about substituting the cell line for primary cells. RNA arrays 
showed the PGEC and GEC2 to be more different from each other than either was 
from HUVEC in terms of the numbers of genes that were significantly different. The 
cells were grouped into their three distinct groups by PAM RNA array analysis but 
again the two GEC EC were more different to each other than either were from 
HUVEC. In addition, in flow studies, differences in adhesion between PGEC and 
GEC2 were detected in studies using neutrophils on minimally TNFα stimulated EC. 
In culture the GEC2 cells were more robust than either the PGEC or HUVEC. 
Conclusions comparing GEC and HUVEC were therefore predominantly where 
PGEC had been compared to HUVEC. 
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8.3.6 Can HUVEC be used to represent GEC? 
 
From these studies HUVEC cannot be reliably used to represent GEC. From RNA 
arrays they have different gene profile expressions and GEC express lower amounts 
of VCAM-1 on the surface. This results in functional differences in leukocyte capture. 
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9. IMPACT OF RESEARCH STUDIES CARRIED OUT IN THIS 
THESIS 
9.1 Personal development 
This thesis has enabled me to greatly increase my understanding of vasculitis, of 
disease processes and of immunological mechanisms in general. It has facilitated the 
development of my critical thinking and assessment of exisiting research. I have 
developed and used many methodologies, gaining skills in scientific processes to 
address mechanistic questions. 
 
9.2 Understanding disease mechanisms 
9.2.1 Patient ANCA 
 
• Polyclonal patient ANCA promote neutrophil activation and increase migration 
across an endothelial surface rather than frustrating it. 
• Different ANCA and different neutrophil donors cause different responses and 
vary in pathogenicity. 
 
9.2.2 IgG subclass effects on neutrophil activation by normal IgG and ANCA IgG 
 
9.2.2.1 Normal IgG and neutrophils 
 
• IgG subclasses in solid phase can capture neutrophils. Subclass affect has not 
been previously demonstrated. IgG3 is most efficient at capture, IgG1 is less 
efficient and IgG2 and IgG4 are inefficient. 
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• Neutrophil adhesion to IgG3 is dependent on CD32 and CD16, but CD16 is 
more important. 
• IgG1 and IgG2 are dependent on both CD32 and CD16, but CD32 is more 
important. 
• CD18 is important in allowing neutrophil spreading on an IgG surface. 
• Adhesion and behaviour of neutrophils are both active processes and require 
cell signalling. 
 
9.2.2.2 ANCA IgG and neutrophils 
 
• IgG1 and IgG3 PR3-ANCA cause neutrophil activation and static adhesion to 
P-selectin surfaces and HUVEC. IgG3 is more potent than IgG1 on HUVEC. 
• IgG4-PR3 ANCA is also activatory, this must be mediated through 
CD32/CD16 in contrast to previous literature. 
• CD16 is important in adhesion after neutrophil activation by IgG3 and IgG1 
PR3-ANCA. 
• CD16 influences IgG3 PR3-ANCA activation of neutrophil adhesion. 
 
9.2.3 Endothelial Comparisons 
 
• Cell lines are not entirely reliable as a substitute for primary cells, they have 
different RNA profiles and different functional outcomes in capture of 
neutrophils from flow. 
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• HUVEC and GEC have different adhesion molecule profiles in that GEC has 
reduced surface expression of VCAM-1. 
• Reduced VCAM-1 surface expression results in reduced PBL capture onto 
GEC compared to HUVEC which may protect the kidney from inflammation. 
• Vasculitis may target kidney beds if this protective mechanism is disrupted.  
• HUVEC cannot reliably be used as a substitute for GEC. 
 
9.3 Implications for patient therapies 
Current strategies for therapy in immune mediated disease tend to be broadly 
immunosuppressive and result in significant morbidity. Studies which reveal the 
details of the immune disruption in these diseases could lead to highly specific 
therapies leaving the majority of the immune response unaffected and therefore 
vastly reducing the side effects of treatment. In the studies in this thesis pertaining to 
exploration of IgG subclass, ANCA IgG3 is highly pathogenic and may represent the 
most significant contributory factor to disease pathogenesis. It may eventually be 
possible to manipulate specific subclasses in individual patients. Additionally the Fc 
receptor which is being utilised in order to activate neutrophils may provide a specific 
therapeutic target. 
 
Regarding the work on endothelial cells, the reason why AAV targets specific 
endothelial beds may be due to adhesion molecule profiles and their disruption in 
disease. Inducing or suppressing specific adhesion molecules in these beds may 
enable blockade of inflammation and subsequent amelioration of damage here. It 
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may be that blockade of molecules upregulated by the disease process, such as 
VCAM-1 in the kidney, could therefore change the profile of the disease. 
 
9.4 Further work  
This thesis has lead to some interesting findings and it would be useful to explore 
these further. Firstly, pertaining to the subclasses of ANCA, IgG3 appears to be 
extremely pathogenic. IgG1 is clearly also an active subclass, and even IgG4 is not 
benign. It would be useful to study large cohorts of patients and test individual patient 
ANCA in vivo to see if these findings are true of polyclonal ANCA, and also to study 
whether there is a trend towards more benign disease with chronicity and a switch to 
IgG4 ANCA. 
 
Manipulation of ANCA subclass, by use of animal models, may also be of therapeutic 
benefit. 
 
Regarding the work on endothelial cells, it would be useful to look more closely at the 
role of lymphocytes on diseased glomerular cells, and to see if the recruitment here 
was different to that in healthy glomeruli. Initially animal models would be helpful. It 
would be interesting also, to see if the levels of adhesion molecules and adhesion of 
leukoctyes differed on EC such as lung, which is also targeted by AAV, and compare 
this to microvasular cells such as intestine, which are not often involved in the 
vasculitis disease process.  
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Finally it would be interesting to look at patient neutrophils and compare the 
interactions on EC in the flow adhesion model of neutrophils from normal donors to 
those of patients with vasculitis, to asertain if there are specific differences in 
neutrophils from AAV patients. 
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10. APPENDIX 
10.1 Solutions and Buffers 
10.1.1 Immunohistochemistry 
 
10.1.1.1 1M Tris base stock solution 
 
48.44g Tris Base (Sigma) 
400ml deionised water 
 
10.1.1.2 Tris-buffered saline (TBS) 
 
100ml Tris base stock solution 
1900ml deionised water 
17.6g Sodium Chloride (Sigma) 
Corrected to pH 7.6 with concentrated HCL 
 
10.1.1.3 10mM Citrate buffer  
 
Tri-sodium citrate (dihydrate) 2.94g (Sigma) 
1000 ml distilled water  
Corrected to pH 6.0 with concentrated HCl 
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10.1.2 Western blotting 
 
10.1.2.1 Resolving Gel 
 
% Gel 10% 12.5% 15% 17% 
Acrylamide 2.5ml 3.13ml 3.75 ml 4.25 ml 
Bis-acrylamide 650 µl 515 µl 400 µl 300 µl 
Tris PH 8.8 3.73 ml 3.73 ml 3.73 ml 3.73 ml 
10% SDS 100 µl 100 µl 100 µl 100 µl 
10% APS 67 µl 100.5 µl 67 µl 67 µl 
TEMED 5 µl 7.5 µl 5 µl 5 µl 
Water 2.948 ml 2.503 ml 1.998ml 1.548 ml 
 
 
10.1.2.2 Stacking gel 
 
% Gel 5% 
Acrylamide 1 ml 
Bis-acrylamide 520 µl 
Tris PH 8.8 1 ml 
10% SDS 80 µl 
10% APS 80 µl 
TEMED 8 µl 
Water 5.312 ml 
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10.1.2.3 TRIS PH6.8 (or 8.8) 
 
12.1g trisma base 
200mls water 
pH to relevant pH 
 
10.1.2.4 10X Running Buffer 
 
30.2G Tris Base 
100ml 10% SDS  
187.6g Glycine 
1L deionised water 
 
10.1.2.5 1X Running Buffer  
 
12.11G Tris Base 
2g SDS  
57.65g Glycine 
2L deionised water 
 
10.1.2.6 10X TBS - PH 7.6 
 
24.2 G Tris Base 
80g NaCl 
1L deionised water  
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 10.1.2.7 1 X TBS-T 
 
100ml  10X TBS 
900ml deionised water  
1ml Tween 20 
 
10.1.2.8 5% Blocking buffer 
 
2.5g Marvel  
50ml TBS-T 
 
10.1.2.9 Transfer buffer 
 
2.93g Glycine 
5.81g Tris 
0.375g SDS 
200ml Methanol 
800ml deionised water 
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10.1.2.10 6x SDS-Page loading buffer (10mls) 
 
 Stock Amount needed 
0.35M Tris                                     1 molar 3.5ml 
10.28% SDS                                powder 1.28g 
36% Glycerol                                75% 4.8ml 
0.6M DTT or 5% B-
mercaptoethanol                         
100ml 0.5ml 
Bromophenol blue                         powder Until blue 
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